10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2020

or

☐ TRANSITION REPORT UNDER SECTION13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________ to __________

Commission file number: 000-54817

DIGITAL LOCATIONS, INC.

(Exact name of registrant as specified in its charter)

Nevada	20-5451302
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

3700 State Street, Suite 350, Santa Barbara, California 93105

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (805) 456-7000

Securities registered under Section 12(b) of the Exchange Act: None.

Securities registered under Section 12(g) of the Exchange Act: Common Stock, $0.001 par value per share

Indicate by check mark whether the registrant (1) has filed all reports required by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒    No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒    No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☒	Smaller reporting company	☒
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐    No ☒

The number of shares of registrant’s common stock outstanding, as of November 13, 2020 was 128,626,450.

DIGITAL LOCATIONS, INC.

INDEX

PART I: FINANCIAL INFORMATION
ITEM 1	FINANCIAL STATEMENTS (Unaudited)	3
	Condensed Balance Sheets	3
	Condensed Statements of Operations	4
	Condensed Statements of Stockholders’ Deficit	5
	Condensed Statements of Cash Flows	7
	Notes to Condensed Financial Statements	8
ITEM 2	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	31
ITEM 3	QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK	38
ITEM 4	CONTROLS AND PROCEDURES	38
PART II: OTHER INFORMATION
ITEM 1	LEGAL PROCEEDINGS	39
ITEM 1A	RISK FACTORS	39
ITEM 2	UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS	39
ITEM 3	DEFAULTS UPON SENIOR SECURITIES	39
ITEM 4	MINE SAFETY DISCLOSURES	39
ITEM 5	OTHER INFORMATION	39
ITEM 6	EXHIBITS	40
SIGNATURES		44

2

PART I – FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

DIGITAL LOCATIONS, INC.
Condensed Balance Sheets
	September 30,			December 31,
	2020			2019
	(Unaudited)
ASSETS
Current assets:
Cash	$	35,637		$	8,275
Prepaid expenses		-			2,808
Total current assets		35,637			11,083
Property and equipment, net		109			595
Operating lease right to use		-			7,708
Total assets	$	35,746		$	19,386
LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current liabilities:
Accounts payable	$	218,049		$	126,478
Accrued expenses and other current liabilities		10,899			3,332
Accrued interest, notes payable		756,523			581,610
Operating lease liability		-			7,708
Derivative liabilities		6,423,060			6,160,895
PPP loan payable		9,501			-
Convertible note payable, in default		29,500			29,500
Convertible notes payable – related parties ($25,980 in default)		58,600			58,600
Convertible notes payable ($395 in default at September 30, 2020), net of discount of $119,412 and $258,518, respectively		2,467,374			2,378,405
Total current liabilities		9,973,506			9,346,528
Total liabilities		9,973,506			9,346,528
Stockholders’ deficit:
Preferred stock, $0.001 par value; 20,000,000 shares authorized:
Series B, 15,055 and 16,155 shares issued and outstanding at September 30, 2020 and December 31, 2019, respectively		15			16
Series D, 0 and 1,000 shares issued and outstanding at September 30, 2020 and December 31, 2019, respectively		-			1
Common stock, $0.001 par value; 2,000,000,000 shares authorized, 123,331,517 and 1,049,380 shares issued and outstanding at September 30, 2020 and December 31, 2019, respectively		123,332			1,049
Additional paid-in capital		26,501,422			25,937,634
Accumulated deficit		(36,562,529	)		(35,265,842	)
Total stockholders’ deficit		(9,937,760	)		(9,327,142	)
Total liabilities and stockholders’ deficit	$	35,746		$	19,386

See notes to condensed financial statements

3

DIGITAL LOCATIONS, INC.

Condensed Statements of Operations

(Unaudited)

	Three Months Ended September 30,						Nine Months Ended September 30,
	2020			2019			2020			2019
Revenues	$	-		$	-		$	-		$	-
Operating expenses:
General and administrative		77,250			91,153			249,836			287,580
Depreciation and amortization		162			(1	)		486			359
Bad debt expense		-			356,851			-			356,851
Total operating expenses		77,412			448,003			250,322			644,790
Loss from operations		(77,412	)		(448,003	)		(250,322	)		(644,790	)
Other income (expense):
Interest expense		(142,803	)		(246,490	)		(490,448	)		(727,290	)
Gain (loss) on change in derivative liabilities		270,671			300,750			(555,917	)		3,904,122
Total other income (expense)		127,868			54,260			(1,046,365	)		3,176,832
Income (loss) from continuing operations before income taxes		50,456			(393,743	)		(1,296,687	)		2,532,042
Provision for income taxes		-			-			-			-
Income (loss) from continuing operations net of income taxes		50,456			(393,743	)		(1,296,687	)		2,532,042
Loss from discontinued operations, net of income taxes		-			(64,315	)		-			(269,693	)
Net income (loss)	$	50,456		$	(458,058	)	$	(1,296,687	)	$	2,262,349
Weighted average number of shares outstanding:
Basic		102,068,248			404,229			41,829,022			272,022
Diluted		5,800,706,942			404,229			41,829,022			16,445,029
Net income (loss) from continuing operations per common share:
Basic	$	0.00		$	(0.97	)	$	(0.03	)	$	9.31
Diluted	$	0.00		$	(0.97	)	$	(0.03	)	$	0.15
Net income (loss) from discontinued operations per common share:
Basic	$	0.00		$	(0.16	)	$	(0.00	)	$	(0.99	)
Diluted	$	0.00		$	(0.16	)	$	(0.00	)	$	(0.99	)
Total net income (loss) per common share:
Basic	$	0.00		$	(1.13	)	$	(0.03	)	$	8.32
Diluted	$	0.00		$	(1.13	)	$	(0.03	)	$	0.14

See notes to condensed financial statements

4

DIGITAL LOCATIONS, INC.

Condensed Statement of Stockholders’ Deficit

Nine Months Ended September 30, 2020 (Unaudited)

	Series B Preferred Stock						Series C Preferred Stock				Series D Preferred Stock						Common Stock				Additional Paid-in			Accumulated
	Shares			Amount			Shares		Amount		Shares			Amount			Shares		Amount		Capital			Deficit			Total
Balance, December 31, 2019		16,155		$	16			-	$	-		1,000		$	1			1,049,380	$	1,049	$	25,937,634		$	(35,265,842	)	$	(9,327,142	)
Issuance of common stock for conversion of notes payable and accrued interest payable		-			-			-		-		-			-			112,501,754		112,502		144,049			-			256,551
Issuance of common stock for conversion of Series B preferred stock		(1,100	)		(1	)		-		-		-			-			9,777,778		9,778		(9,777	)		-			-
Reverse split rounding of shares		-			-			-		-		-			-			2,605		3		(3	)		-			-
Redemption of Series D preferred stock		-			-			-		-		(1,000	)		(1	)		-		-		1			-			-
Settlement of derivative liabilities		-			-			-		-		-			-			-		-		429,518			-			429,518
Net loss		-			-			-		-		-			-			-		-		-			(1,296,687	)		(1,296,687	)
Balance, September 30, 2020		15,055		$	15			-	$	-		-		$	-			123,331,517	$	123,332	$	26,501,422		$	(36,562,529	)	$	(9,937,760	)

See accompanying notes to condensed financial statements.

5

DIGITAL LOCATIONS, INC.

Condensed Statement of Stockholders’ Deficit

Nine Months Ended September 30, 2019 (Unaudited)

	Series B Preferred Stock				Series C Preferred Stock						Series D Preferred Stock				Common Stock				Additional Paid-in		Accumulated
	Shares		Amount		Shares			Amount			Shares		Amount		Shares		Amount		Capital		Deficit			Total
Balance, December 31, 2018		16,155	$	16		36,000		$	36			-	$	-		181,111	$	181	$	25,533,544	$	(38,207,267	)	$	(12,673,490	)
Issuance of common stock for conversion of notes payable and accrued interest payable		-		-		-			-			-		-		333,080		333		134,476		-			134,476
Settlement of derivative liabilities		-		-		-			-			-		-		-		-		143,692		-			143,692
Return and cancellation of Series C preferred stock		-		-		(36,000	)		(36	)		-		-		-		-		36		-			-
Close out EllisLab Corp. equity accounts		-		-		-			-			-		-		-		-		316,985		-			316,985
Net income		-		-		-			-			-		-		-		-		-		2,262,349			2,262,349
Balance, September 30, 2019		16,155	$	16		-		$	-			-	$	-		326,476	$	514	$	26,128,733	$	(35,944,918	)	$	(9,815,655	)

See accompanying notes to condensed financial statements.

6

DIGITAL LOCATIONS, INC

Condensed Statements of Cash Flows 

(Unaudited)

	Nine Months Ended September 30,
	2020			2019
Cash flows from operating activities:
Net income (loss)	$	(1,296,687	)	$	2,262,349
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization		486			360
Amortization of debt discount to interest expense		291,872			544,686
(Gain) loss on change in derivative liabilities		555,917			(3,904,122	)
Bad debt expense		-			356,851
Changes in assets and liabilities:
(Increase) decrease in prepaid expenses		2,808			(9,231	)
Increase (decrease) in:
Accounts payable		91,571			18,585
Accrued expenses		18,317			2,326
Accrued interest, notes payable		198,577			182,604
Change in net assets of discontinued operations		-			10,843
Net cash used in operating activities		(137,139	)		(534,749	)
Cash flows from investing activities		-			-
Cash flows from financing activities:
Proceeds from convertible notes payable		155,000			517,000
Proceeds from PPP loan		9,501			-
Net cash provided by financing activities		164,501			517,000
Net increase (decrease) in cash		27,362			(17,749	)
Cash, beginning of period		8,275			19,232
Cash, end of period	$	35,637		$	1,483
Supplemental Disclosure:
Cash paid for income taxes	$	-		$	-
Cash paid for interest		-			-
Non-cash financing and investing activities:
Debt discount for derivative liabilities	$	135,766		$	517,000
Common shares issued in conversion of debt		256,551			134,476
Common shares issued in conversion of Series B preferred shares		1			-
Reverse split rounding of shares		3			-
Redemption of Series D preferred stock		1			-
Settlement of derivative liabilities		429,518			143,692
Increase in other assets and operating lease liability		-			18,352

See notes to condensed financial statements

7

DIGITAL LOCATIONS, INC.

Notes to Condensed Financial Statements

Nine Months Ended September 30, 2020

(Unaudited)

1. ORGANIZATION AND BASIS OF PRESENTATION

Organization

Digital Locations, Inc. (the “Company”) was incorporated in the State of Nevada on August 25, 2006 as Zingerang, Inc. On April 2, 2007, the Company changed its name to Carbon Sciences, Inc. and on November 14, 2017, the Company changed its name to Digital Locations, Inc.

On November 30, 2018, the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) pursuant to which EllisLab, Inc., an S Corporation owned 100% by Rick Ellis, merged with and into EllisLab Corp., a newly formed subsidiary of the Company (the “Merger”). EllisLab, Inc. builds software for web professionals and provides related support services.

On September 30, 2019, the Company, entered into an Agreement for the Purchase and Sale of Capital Stock of EllisLab Corp. (the “EllisLab Corp. Sale Agreement”) with Rick Ellis to sell to Rick Ellis all of the issued and outstanding shares of EllisLab Corp. for $10,000 and the 36,000 shares of the Company’s Series C preferred stock acquired by Rick Ellis in the Merger, which represents all of the issued and outstanding shares of the Series C preferred stock. In connection with the EllisLab Corp. Sale Agreement, the covenant not to compete and the lockup of stock consideration entered into in connection with the Merger were terminated and the parties’ obligations thereunder were released. Pursuant to the Ellis Lab Corp. Sale Agreement, the Company effectively divested itself of the Ellis Lab business and discontinued it.

Consequently, the revenues and expenses for EllisLab Corp. are reported as “Loss from discontinued operations, net of income taxes” in our condensed statements of operations for the three months and nine months ended September 30, 2019. The EllisLab Corp. assets and liabilities have been retroactively reclassified as assets and liabilities of discontinued operations. See Note 3. All significant intercompany accounts and transactions have been eliminated.

In November 2019, the Company announced its plan to focus its resources on developing a portfolio of cell tower sites to help meet the expected demand of rapidly growing 5G networks. The Company’s goal is to become a “landlord” of tomorrow’s wireless communications assets.

Effective February 14, 2020, the Company effected a reverse split of its common stock at a ratio of one for two hundred twenty-five shares (1:225) (the “Stock Split”) with the filing of a Certificate of Amendment to its Articles of Incorporation with the Secretary of State of Nevada. The Company has given retroactive effect for the Stock Split in its financial statements and notes thereto for all periods presented.

Basis of Presentation

The accompanying unaudited condensed financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all normal recurring adjustments considered necessary for a fair presentation have been included. Operating results for the three months and nine months ended September 30, 2020 are not necessarily indicative of the results that may be expected for the year ending December 31, 2020. For further information refer to the financial statements and notes thereto included in the Company’s Form 10-K for the year ended December 31, 2019.

8

Going Concern

The accompanying financial statements are prepared using accounting principles generally accepted in the United States of America applicable to a going concern, which contemplate the realization of assets and liquidation of liabilities in the normal course of business. As of September 30, 2020, our current liabilities exceeded our current assets by $9,937,869 and we had a total stockholders’ deficit of $9,937,760. In addition, subsequent to the EllisLab Corp. Sale Agreement which closed on September 30, 2019, the Company does not have any sources of revenues, and has reported negative cash flows from operations since inception. The Company currently does not have the cash resources to meet its operating commitments for the next twelve months and expects to have ongoing requirements for capital investment to implement its business plan. These factors, among others, raise substantial doubt that the Company will be able to continue as a going concern for a reasonable period of time.

The ability of the Company to continue as a going concern is dependent upon, among other things, raising additional capital. The Company has obtained operating funds primarily from the issuance of convertible debt. Management believes this funding will continue and will provide the additional cash needed to meet the Company’s obligations as they become due. There can be no assurance, however, that the Company will be successful in accomplishing its objectives. Without such additional capital we may be required to cease operations. The accompanying financial statements do not include any adjustments that might result should the Company be unable to continue as a going concern.

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

The significant accounting policies of the Company are disclosed in Note 2 to the Notes to Financial Statements included in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on April 14, 2020. The following summary of significant accounting policies of the Company is presented to assist in understanding the Company’s interim financial statements. The financial statements and notes are representations of the Company’s management, which is responsible for their integrity and objectivity. These accounting policies conform to accounting principles generally accepted in the United States of America and have been consistently applied in the preparation of the financial statements.

Use of Estimates

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the accompanying financial statements. Significant estimates made in preparing these financial statements include the estimate of useful lives of property and equipment and intangible assets, operating lease obligations, impairment of assets, the deferred tax valuation allowance, the fair value of stock options and derivative liabilities. Actual results could differ from those estimates.

Property and Equipment

The Company’s property and equipment is stated at cost, and is depreciated using the straight-line method over the estimated useful life of the related asset as follows:

Computer equipment	3-5 years
Office furniture and equipment	7 years

9

Maintenance and repairs are charged to expense as incurred. Significant renewals and betterments will be capitalized. At the time of retirement or other disposition of equipment, the cost and accumulated depreciation will be removed from the accounts and the resulting gain or loss, if any, will be reflected in operations.

The Company assesses the recoverability of property and equipment by determining whether the depreciation and amortization of these assets over their remaining life can be recovered through projected undiscounted future cash flows. The amount of equipment impairment, if any, will be measured based on fair value and is charged to operations in the period in which such impairment is determined by management.

Derivative Liabilities

We have identified the conversion features of our convertible notes payable and Series B preferred stock and certain stock options and warrants as derivatives. Where the number of common shares to be issued under these agreements is indeterminate, the Company has concluded that the equity environment is tainted, and all additional options, warrants and convertible debt and equity are included in the value of the derivatives. We estimate the fair value of the derivatives using the Black-Scholes pricing model and a multinomial lattice model based on projections of various potential future outcomes. We estimate the fair value of the derivative liabilities at the inception of the financial instruments, at the date of conversions to equity and at each reporting date, recording a derivative liability, debt discount, additional paid-in capital and a gain or loss on change in derivative liabilities as applicable. These estimates are based on multiple inputs, including the market price of our stock, interest rates, our stock price volatility, variable conversion prices based on market prices as defined in the respective agreements and probabilities of certain outcomes based on management projections. These inputs are subject to significant changes from period to period and to management’s judgment; therefore, the estimated fair value of the derivative liabilities will fluctuate from period to period, and the fluctuation may be material.

Fair Value of Financial Instruments

Disclosures about fair value of financial instruments, require disclosure of the fair value information, whether or not recognized in the balance sheet, where it is practicable to estimate that value. As of September 30, 2020 and December 31, 2019, we believe the amounts reported for cash, prepaid expenses, accounts payable, accrued expenses and other current liabilities, accrued interest - notes payable and convertible notes payable approximate fair value because of their short maturities.

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASC”) Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include:

• Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;

• Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

• Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

10

We measure certain financial instruments at fair value on a recurring basis. Liabilities measured at fair value on a recurring basis are as follows at September 30, 2020 and December 31, 2019:

	Total		Level 1		Level 2		Level 3
September 30, 2020:
Derivative liabilities	$	6,423,060	$	-	$	-	$	6,423,060
Total liabilities measured at fair value	$	6,423,060	$	-	$	-	$	6,423,060
December 31, 2019:
Derivative liabilities	$	6,160,895	$	-	$	-	$	6,160,895
Total liabilities measured at fair value	$	6,160,895	$	-	$	-	$	6,160,895

During the nine months ended September 30, 2020, the Company had the following activity in its derivative liabilities account:

	Convertible Notes Payable			Series B Preferred Stock			Stock Options			Total
Derivative liabilities at December 31, 2019	$	3,606,194		$	2,535,359		$	19,342		$	6,160,895
Addition to liabilities for new debt/shares issued		135,766			-			-			135,766
Elimination of liabilities for debt conversions		(194,663	)		(234,855	)		-			(429,518	)
Change in fair value		(239,466	)		812,674			(17,291	)		555,917
Derivative liabilities at September 30, 2020	$	3,307,831		$	3,113,178		$	2,051		$	6,423,060

Revenue Recognition

On January 1, 2018, we adopted Accounting Standards Update No. 2014-09, “Revenue from Contracts with Customers” (Topic 606), which supersedes the revenue recognition requirements in Accounting Standards Codification (ASC) Topic 605, “Revenue Recognition” (Topic 605). The Company had no operating revenues prior to the Merger. Effective December 1, 2018, the Company’s revenues, included in loss from discontinued operations, were derived primarily from the sale of monthly and annual tech support subscriptions and partnership fees, and from software applications that customers purchase via the Company’s online store. Sales were processed using a real-time payment processing company. Revenue from product sales is recorded net of processing costs.

Under Topic 606, revenue is recognized when control of the promised goods or services is transferred to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services.

We determine revenue recognition through the following steps:

· identification of the contract, or contracts, with a customer;

· identification of the performance obligations in the contract;

· determination of the transaction price;

11

· allocation of the transaction price to the performance obligations in the contract; and

· recognition of revenue when, or as, we satisfy a performance obligation.

Amounts collected from customers for support subscriptions and partnership fees with a contract life of one month or greater are recorded as deferred revenue and recognized over the life of the contract.

Subsequent to the EllisLab Corp. Sale Agreement, which closed on September 30, 2019, the Company does not have any sources of revenues.

Income (Loss) per Share

Basic net income or loss per common share is computed by dividing net income or loss by the weighted average number of common shares outstanding. Diluted net income or loss per common share is computed by dividing net income or loss by the sum of the weighted average number of common shares outstanding and the dilutive potential common share equivalents then outstanding. Potential dilutive common share equivalents consist of shares issuable upon the exercise of outstanding stock options and warrants to acquire common stock, using the treasury stock method and the average market price per share during the period, and shares issuable upon exercise of convertible notes payable and convertible preferred stock.

Basic weighted average number common shares outstanding are reconciled to diluted weighted average number of common shares outstanding as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2020		2019		2020		2019
Basic weighted average number of shares		102,068,248		404,229		41,829,022		272,022
Dilutive effect of:
Series B preferred stock		5,018,333,333		-		-		3,263,636
Convertible notes payable		680,305,361		-		-		12,909,371
Diluted weighted average number of shares		5,800,706,942		404,229		41,829,022		16,445,029

Operating Lease

On September 5, 2017, we entered into an operating sublease for office space. The base rent for the sublease is $1,000 per month for a period of one year and month-to-month thereafter.

On January 1, 2019, we adopted Financial Accounting Standards Board (“FASB”) ASC 842, “Leases.” ASC 842 requires recognition of assets and liabilities for the rights and obligations created by leases and new disclosures about leases. We adopted ASC 842 using the optional modified retrospective transition method. Under this transition method, we did not recast the prior period financial statements presented.

The adoption of ASC 842 resulted in the measurement and recognition of an operating lease liability and corresponding right-of use asset (included in other assets) in the amount of $18,352 as of January 1, 2019. The operating lease liability was measured as the present value of assumed remaining lease payments using an estimated incremental borrowing rate. We amortize the right-of-use asset over the term of the lease. The right-of-use asset was fully amortized as of September 30, 2020.

12

Recently Issued Accounting Pronouncements

There were no new accounting pronouncements issued by the FASB during the nine months ended September 30, 2020 and through the date of filing of this report that the Company believes will have a material impact on its financial statements.

Reclassifications

Certain amounts in the condensed financial statements for the prior year periods have been reclassified to conform to the presentation for the current year periods.

NOTE 3 – MERGER AND SUBSEQUENT SALE

On November 30, 2018, the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) with the EllisLab, Inc., Rick Ellis (“Ellis”), and EllisLab Corp., a newly formed Nevada corporation and wholly owned subsidiary of the Company, pursuant to which EllisLab, Inc. merged with and into EllisLab Corp. (the “Merger”). Pursuant to the terms of the Merger Agreement, Ellis received 36,000 shares of the Company’s newly designated Series C Convertible Preferred Stock, with a stated value of $100 per share, in exchange for the cancellation of all common shares of EllisLab, Inc. owned by Ellis, which shares represented 100% of the issued and outstanding capital stock of EllisLab, Inc. The separate legal existence of EllisLab, Inc. ceased, and EllisLab Corp. became the surviving company. The acquisition of EllisLab, Inc. in the Merger has been accounted for as a purchase, and the accounts of EllisLab Corp. were consolidated with those of the Company as of December 1, 2018.

On September 30, 2019, the Company, entered into an Agreement for the Purchase and Sale of Capital Stock of EllisLab Corp. (the “EllisLab Corp. Sale Agreement”) with Ellis to sell to Ellis all of the issued and outstanding shares of EllisLab Corp. for $10,000 and the 36,000 shares of the Company’s Series C Convertible Preferred Stock owned by him, which represents all of the issued and outstanding shares of the Series C Convertible Preferred Stock. Pursuant to the Ellis Lab Corp. Sale Agreement, the Company effectively divested itself of the Ellis Lab business and discontinued it. Consequently, the revenues and expenses for EllisLab Corp. are reported as “Loss from discontinued operations, net of income taxes” in our condensed statements of operations for the three months and nine months ended September 30, 2019. When presented, the EllisLab Corp. assets and liabilities have been retroactively reclassified as assets and liabilities of discontinued operations

NOTE 4 – PROPERTY AND EQUIPMENT

Property and equipment consisted of the following:

	September 30, 2020			December 31, 2019
Computer equipment	$	12,303		$	12,303
Office furniture and equipment		1,459			1,459
Total		13,762			13,762
Less accumulated depreciation		(13,653	)		(13,167	)
Net	$	109		$	595

Depreciation expense was $162 and $(1) for the three months ended September 30, 2020 and 2019, respectively and $486 and $359 for the nine months ended September 30, 2020 and 2019, respectively.

13

5. CONVERTIBLE NOTES PAYABLE

Convertible Promissory Note of $29,500 in Default

On March 14, 2013, we entered into an agreement to issue a 5% convertible promissory note in the principal amount of $29,500, which is convertible into shares of our common stock at a conversion price equal to the lesser of $1.50 per share or the closing price per share of common stock recorded on the trading day immediately preceding the date of conversion. The note, with a principal balance of $29,500 at September 30, 2020 and December 31, 2019, matured on March 14, 2015, and is currently in default.

Convertible Promissory Notes – Related Parties of $58,600

On December 31, 2012, we issued 5% convertible promissory notes to two employees in exchange for services rendered in the aggregate amount of $58,600. The notes are convertible into shares of our common stock at a conversion price equal to the lesser of $2.00 per share or the closing price per share of common stock recorded on the trading day immediately preceding the date of conversion. We recorded a total debt discount of $57,050 related to the conversion feature of the notes, which has been fully amortized to interest expense, along with a derivative liability at inception. One of the notes with a principal balance of $25,980 at September 30, 2020, matured on December 31, 2014 and is currently in default. The maturity date of a second note with a principal balance of $32,620 at September 30, 2020 has been extended to December 31, 2020.

March 2016 Convertible Promissory Note – $1,000,000

On March 4, 2016, we entered into an agreement to issue a 10% convertible promissory note in the aggregate principal amount of up to $1,000,000 (the “March 2016 $1,000,000 CPN”). The lender may advance the Company consideration for the note in such amounts as the lender may choose in its sole discretion. The note is convertible into shares of our common stock at a price per share equal to the lesser of: $0.03; 50% of the lowest trade price of our common stock subsequent to the effective date of the note; or the lowest effective price per share granted to any person or entity (exclusive of our officers and directors) to acquire common stock subsequent to the effective date of the note. The note initially matured, with respect to each advance, one year from the effective date of each advance. Subsequently, the lender extended the maturity date, with the note payable upon demand, but in no event later than 60 months from March 4, 2016.

On March 14, 2016, we received proceeds of $27,000 pursuant to the March 2016 $1,000,000 CPN. We recorded a debt discount of $27,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense. During the nine months ended September 30, 2020, we issued the lender a total of 4,175,861 shares of our common stock in consideration for the conversion of principal of $5,445 and accrued interest of $2,213, repaying the debt in full. No gain or loss was recorded since the conversions were completed within the terms of the note agreement.

On March 17, 2016, we received proceeds of $33,000 pursuant to the March 2016 $1,000,000 CPN. We recorded a debt discount of $33,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense. During the nine months ended September 30, 2020, we issued the lender a total of 10,332,228 shares of our common stock in consideration for the conversion of principal of $13,109 and accrued interest of $5,839, resulting in a principal balance of $19,891 as of September 30, 2020. No gain or loss was recorded since the conversions were completed within the terms of the note agreement.

14

On April 11, 2016, we received proceeds of $90,000 pursuant to the March 2016 $1,000,000 CPN. We recorded a debt discount of $90,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On May 20, 2016, we received proceeds of $60,000 pursuant to the March 2016 $1,000,000 CPN. We recorded a debt discount of $60,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On June 22, 2016, we received proceeds of $50,000 pursuant to the March 2016 $1,000,000 CPN. We recorded a debt discount of $50,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On July 6, 2016, we received proceeds of $87,000 pursuant to the March 2016 $1,000,000 CPN. We recorded a debt discount of $87,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On August 8, 2016, we received proceeds of $60,000 pursuant to the March 2016 $1,000,000 CPN. We recorded a debt discount of $60,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On September 13, 2016, we received proceeds of $55,000 pursuant to the March 2016 $1,000,000 CPN. We recorded a debt discount of $55,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On October 17, 2016, we received proceeds of $55,000 pursuant to the March 2016 $1,000,000 CPN. We recorded a debt discount of $55,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On November 8, 2016, we received proceeds of $55,000 pursuant to the March 2016 $1,000,000 CPN. We recorded a debt discount of $55,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On December 6, 2016, we received proceeds of $60,000 pursuant to the March 2016 $1,000,000 CPN. We recorded a debt discount of $60,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On January 10, 2017, we received proceeds of $60,000 pursuant to the March 2016 $1,000,000 CPN. We recorded a debt discount of $60,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On February 13, 2017, we received proceeds of $60,000 pursuant to the March 2016 $1,000,000 CPN. We recorded a debt discount of $60,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On March 9, 2017, we received proceeds of $60,000 pursuant to the March 2016 $1,000,000 CPN. We recorded a debt discount of $60,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

15

On April 12, 2017, we received proceeds of $95,000 pursuant to the March 2016 $1,000,000 CPN. We recorded a debt discount of $95,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On May 8, 2017, we received proceeds of $60,000 pursuant to the March 2016 $1,000,000 CPN. We recorded a debt discount of $60,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

June 2017 Convertible Promissory Note – $500,000

On June 2, 2017, we entered into an agreement to issue a 10% convertible promissory note in the aggregate principal amount of up to $500,000 (the “June 2017 $500,000 CPN”). The lender may advance the Company consideration for the note in such amounts as the lender may choose in its sole discretion. The note is convertible into shares of our common stock at a price per share equal to the lesser of: $0.03; 50% of the lowest trade price of our common stock subsequent to the effective date of the note; or the lowest effective price per share granted to any person or entity (exclusive of our officers and directors) to acquire common stock subsequent to the effective date of the note. The note initially matured, with respect to each advance, one year from the effective date of each advance. Subsequently, the lender extended the maturity date, with the note payable upon demand, but in no event later than 60 months from June 2, 2017.

On June 2, 2017, we received proceeds of $60,000 pursuant to the June 2017 $500,000 CPN. We recorded a debt discount of $60,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On July 10, 2017, we received proceeds of $80,000 pursuant to the June 2017 $500,000 CPN. We recorded a debt discount of $80,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On August 11, 2017, we received proceeds of $80,000 pursuant to the June 2017 $500,000 CPN. We recorded a debt discount of $80,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On September 12, 2017, we received proceeds of $85,000 pursuant to the June 2017 $500,000 CPN. We recorded a debt discount of $85,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On October 13, 2017, we received proceeds of $80,000 pursuant to the June 2017 $500,000 CPN. We recorded a debt discount of $80,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On November 8, 2017, we received proceeds of $75,000 pursuant to the June 2017 $500,000 CPN. We recorded a debt discount of $75,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

December 2017 Convertible Promissory Note – $500,000

On December 14, 2017, we entered into an agreement to issue a 10% convertible promissory note in the aggregate principal amount of up to $500,000 (the “December 2017 $500,000 CPN”). The lender may advance the Company consideration for the note in such amounts as the lender may choose in its sole discretion. The note is convertible into shares of our common stock at a price per share equal to the lesser of: $0.03; 50% of the lowest trade price of our common stock subsequent to the effective date of the note; or the lowest effective price per share granted to any person or entity (exclusive of our officers and directors) to acquire common stock subsequent to the effective date of the note. The note initially matured, with respect to each advance, one year from the effective date of each advance. Subsequently, the lender extended the maturity date, with the note payable upon demand, but in no event later than 60 months from December 14, 2017.

16

On December 14, 2017, we received proceeds of $60,000 pursuant to the December 2017 $500,000 CPN. We recorded a debt discount of $60,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On January 11, 2018, we received proceeds of $70,000 pursuant to the December 2017 $500,000 CPN. We recorded a debt discount of $70,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On February 7, 2018, we received proceeds of $60,000 pursuant to the December 2017 $500,000 CPN. We recorded a debt discount of $60,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On March 8, 2018, we received proceeds of $55,000 pursuant to the December 2017 $500,000 CPN. We recorded a debt discount of $55,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On March 14, 2018, we received proceeds of $6,500 pursuant to the December 2017 $500,000 CPN. We recorded a debt discount of $6,500 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On April 9, 2018, we received proceeds of $77,000 pursuant to the December 2017 $500,000 CPN. We recorded a debt discount of $77,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On May 7, 2018, we received proceeds of $60,000 pursuant to the December 2017 $500,000 CPN. We recorded a debt discount of $60,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On June 7, 2018, we received proceeds of $52,000 pursuant to the December 2017 $500,000 CPN. We recorded a debt discount of $52,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On July 10, 2018, we received proceeds of $35,000 pursuant to the December 2017 $500,000 CPN. We recorded a debt discount of $35,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On August 16, 2018, we received proceeds of $24,500 pursuant to the December 2017 $500,000 CPN. We recorded a debt discount of $24,500 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

August 2018 Convertible Promissory Note – $500,000

On August 17, 2018, we entered into an agreement to issue a 10% convertible promissory note in the aggregate principal amount of up to $500,000 (the “August 2018 $500,000 CPN”). The lender may advance the Company consideration for the note in such amounts as the lender may choose in its sole discretion. The note is convertible into shares of our common stock at a price per share equal to the lesser of: $0.01; 50% of the lowest trade price of our common stock subsequent to the effective date of the note; or the lowest effective price per share granted to any person or entity (exclusive of our officers and directors) to acquire common stock subsequent to the effective date of the note. The note matures, with respect to each advance, one year from the effective date of each advance. Subsequently, the lender extended the maturity date, with the note payable upon demand, but in no event later than 60 months from August 17, 2018.

17

On August 17, 2018, we received proceeds of $10,500 pursuant to the August 2018 $500,000 CPN. We recorded a debt discount of $10,500 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On September 13, 2018, we received proceeds of $30,000 pursuant to the August 2018 $500,000 CPN. We recorded a debt discount of $30,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On October 8, 2018, we received proceeds of $25,000 pursuant to the August 2018 $500,000 CPN. We recorded a debt discount of $25,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On October 26, 2018, we received proceeds of $12,000 pursuant to the August 2018 $500,000 CPN. We recorded a debt discount of $12,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On November 5, 2018, we received proceeds of $25,000 pursuant to the August 2018 $500,000 CPN. We recorded a debt discount of $25,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On November 28, 2018, we received proceeds of $30,000 pursuant to the August 2018 $500,000 CPN. We recorded a debt discount of $30,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On November 30, 2018, we received proceeds of $10,000 pursuant to the August 2018 $500,000 CPN. We recorded a debt discount of $10,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On December 24, 2018, we received proceeds of $50,000 pursuant to the August 2018 $500,000 CPN. We recorded a debt discount of $50,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On January 17, 2019, we received proceeds of $25,000 pursuant to the August 2018 $500,000 CPN. We recorded a debt discount of $25,000 related to the conversion feature of the note, along with a derivative liability at inception. During the nine months ended September 30, 2020, amortization of debt discount was recorded to interest expense in the amount of $1,164 and the debt discount has been fully amortized to interest expense.

On February 25, 2019, we received proceeds of $25,000 pursuant to the August 2018 $500,000 CPN. We recorded a debt discount of $25,000 related to the conversion feature of the note, along with a derivative liability at inception. During the nine months ended September 30, 2020, amortization of debt discount was recorded to interest expense in the amount of $3,836 and the debt discount has been fully amortized to interest expense.

On March 22, 2019, we received proceeds of $25,000 pursuant to the August 2018 $500,000 CPN. We recorded a debt discount of $25,000 related to the conversion feature of the note, along with a derivative liability at inception. During the nine months ended September 30, 2020, amortization of debt discount was recorded to interest expense in the amount of $5,601 and the debt discount has been fully amortized to interest expense.

18

On March 26, 2019, we received proceeds of $15,000 pursuant to the August 2018 $500,000 CPN. We recorded a debt discount of $15,000 related to the conversion feature of the note, along with a derivative liability at inception. During the nine months ended September 30, 2020, amortization of debt discount was recorded to interest expense in the amount of $3,525 and the debt discount has been fully amortized to interest expense.

On April 11, 2019, we received proceeds of $15,000 pursuant to the August 2018 $500,000 CPN. We recorded a debt discount of $15,000 related to the conversion feature of the note, along with a derivative liability at inception. During the nine months ended September 30, 2020, amortization of debt discount was recorded to interest expense in the amount of $4,180 and the debt discount has been fully amortized to interest expense.

On April 19, 2019, we received proceeds of $65,000 pursuant to the August 2018 $500,000 CPN. We recorded a debt discount of $65,000 related to the conversion feature of the note, along with a derivative liability at inception. During the nine months ended September 30, 2020, amortization of debt discount was recorded to interest expense in the amount of $19,536 and the debt discount has been fully amortized to interest expense.

On June 28, 2019, we received proceeds of $30,000 pursuant to the August 2018 $500,000 CPN. We recorded a debt discount of $30,000 related to the conversion feature of the note, along with a derivative liability at inception. During the nine months ended September 30, 2020, amortization of debt discount was recorded to interest expense in the amount of $14,754 and the debt discount has been fully amortized to interest expense.

On July 29, 2019, we received proceeds of $40,000 pursuant to the August 2018 $500,000 CPN. We recorded a debt discount of $40,000 related to the conversion feature of the note, along with a derivative liability at inception. During the nine months ended September 30, 2020, amortization of debt discount was recorded to interest expense in the amount of $23,060 and the debt discount has been fully amortized to interest expense.

On September 27, 2019, we received proceeds of $33,000 pursuant to the August 2018 $500,000 CPN. We recorded a debt discount of $33,000 related to the conversion feature of the note, along with a derivative liability at inception. During the nine months ended September 30, 2020, amortization of debt discount was recorded to interest expense in the amount of $24,434 and the debt discount has been fully amortized to interest expense.

On October 8, 2019, we received proceeds of $25,000 pursuant to the August 2018 $500,000 CPN. We recorded a debt discount of $25,000 related to the conversion feature of the note, along with a derivative liability at inception. During the nine months ended September 30, 2020, amortization of debt discount was recorded to interest expense in the amount of $18,716, resulting in a remaining debt discount of $546 as of September 30, 2020.

October 2019 Convertible Promissory Note – $500,000

On October 31, 2019, we entered into an agreement to issue a 10% convertible promissory note in the aggregate principal amount of up to $500,000 (the “October 2019 $500,000 CPN”). The lender may advance the Company consideration for the note in such amounts as the lender may choose in its sole discretion. The note is convertible into shares of our common stock at a price per share equal to the lesser of: $0.01; 50% of the lowest trade price of our common stock subsequent to the effective date of the note; or the lowest effective price per share granted to any person or entity (exclusive of our officers and directors) to acquire common stock subsequent to the effective date of the note. The note matures, with respect to each advance, one year from the effective date of each advance.

19

On October 31, 2019, we received proceeds of $25,000 pursuant to the October 2019 $500,000 CPN. We recorded a debt discount of $25,000 related to the conversion feature of the note, along with a derivative liability at inception. During the nine months ended September 30, 2020, amortization of debt discount was recorded to interest expense in the amount of $18,716, resulting in a remaining debt discount of $2,117 as of September 30, 2020.

On November 12, 2019, we received proceeds of $25,000 pursuant to the October 2019 $500,000 CPN. We recorded a debt discount of $25,000 related to the conversion feature of the note, along with a derivative liability at inception. During the nine months ended September 30, 2020, amortization of debt discount was recorded to interest expense in the amount of $18,716, resulting in a remaining debt discount of $2,937 as of September 30, 2020.

On December 19, 2019, we received proceeds of $25,000 pursuant to the October 2019 $500,000 CPN. We recorded a debt discount of $25,000 related to the conversion feature of the note, along with a derivative liability at inception. During the nine months ended September 30, 2020, amortization of debt discount was recorded to interest expense in the amount of $18,716, resulting in a remaining debt discount of $5,464 as of September 30, 2020.

January 25, 2019 Convertible Promissory Note – $38,000

Effective January 25, 2019, the Company entered into an agreement to issue a 10% convertible note with an institutional investor in the principal amount of $38,000, which matured on January 25, 2020. The Company received proceeds of $35,000 after an original issue discount of $1,500 and payment of $1,500 in legal fees. The lender, at its option, may convert the unpaid principal balance of, and accrued interest on, the note into shares of the Company’s common stock at a 39% discount from the lowest trading price during the 15 days prior to conversion. The Company may prepay the note during the 180 days from the issuance of the note at redemption premiums ranging from 25% to 45%. After the expiration of 180 days after issuance, the Company has no right of prepayment. We recorded a debt discount of $38,000 related to the conversion feature of the note, along with a derivative liability at inception. During the nine months ended September 30, 2020, amortization of debt discount was recorded to interest expense in the amount of $1,415 and the debt discount has been fully amortized to interest expense. During the nine months ended September 30, 2020, we issued the lender a total of 12,855,132 shares of our common stock in consideration for the conversion of principal of $22,378, accrued interest of $3,800 and fees of $2,000, repaying the debt in full. No gain or loss was recorded since the conversions were completed within the terms of the note agreement.

May 23, 2019 Convertible Promissory Note – $33,000

Effective May 23, 2019, the Company entered into an agreement to issue a 10% convertible note with an institutional investor in the principal amount of $33,000. The note matured on May 23, 2020. The Company received proceeds of $30,000 after an original issue discount of $1,750 and payment of $1,250 in legal fees. The lender, at its option, may convert the unpaid principal balance of, and accrued interest on, the note into shares of the Company’s common stock at a 50% discount from the lowest trading price during the 25 days prior to conversion. The Company may prepay the note during the 180 days from the issuance of the note at redemption premiums ranging from 25% to 45%. After the expiration of 180 days after issuance, the Company has no right of prepayment. We recorded a debt discount of $33,000 related to the conversion feature of the note, along with a derivative liability at inception. During the nine months ended September 30, 2020, amortization of debt discount was recorded to interest expense in the amount of $12,984 and the debt discount has been fully amortized to interest expense. During the nine months ended September 30, 2020, we issued the lender a total of 22,057,971 shares of our common stock in consideration for the conversion of principal of $33,000, accrued interest of $3,300 and fees of $1,750, repaying the debt in full. No gain or loss was recorded since the conversions were completed within the terms of the note agreement.

20

May 24, 2019 Convertible Promissory Note – $33,000

Effective May 24, 2019, the Company entered into an agreement to issue a 10% convertible note with an institutional investor in the principal amount of $33,000. The note matured on May 24, 2020. On January 16, 2020, the note was assigned to another institutional investor. The Company received proceeds of $30,000 after payment of $3,000 of the fees and expenses of the lender and its counsel. The lender, at its option after 180 days from the issuance of the note, may convert the unpaid principal balance of, and accrued interest on, the note into shares of the Company’s common stock at a 39% discount from the lowest trading price during the 15 days prior to conversion. The Company may prepay the note during the 180 days from the issuance of the note at redemption premiums ranging from 20% to 45%. After the expiration of 180 days after issuance, the Company has no right of prepayment. We recorded a debt discount of $33,000 related to the conversion feature of the note, along with a derivative liability at inception. During the nine months ended September 30, 2020, amortization of debt discount was recorded to interest expense in the amount of $7,764 and the debt discount has been fully amortized to interest expense. During the nine months ended September 30, 2020, we issued the lender a total of 6,720,530 shares of our common stock in consideration for the conversion of principal of $19,600 and accrued interest of $1,650, repaying the debt in full. No gain or loss was recorded since the conversions were completed within the terms of the note agreement.

June 27, 2019 Convertible Promissory Note – $33,000

Effective June 27, 2019, the Company entered into an agreement to issue a 10% convertible note with an institutional investor in the principal amount of $33,000. The note matured on June 27, 2020. On January 16, 2020, the note was assigned to another institutional investor. The Company received proceeds of $30,000 after payment of $3,000 of the fees and expenses of the lender and its counsel. The lender, at its option after 180 days from the issuance of the note, may convert the unpaid principal balance of, and accrued interest on, the note into shares of the Company’s common stock at a 39% discount from the lowest trading price during the 15 days prior to conversion. The Company may prepay the note during the 180 days from the issuance of the note at redemption premiums ranging from 20% to 45%. After the expiration of 180 days after issuance, the Company has no right of prepayment. We recorded a debt discount of $33,000 related to the conversion feature of the note, along with a derivative liability at inception. During the nine months ended September 30, 2020, amortization of debt discount was recorded to interest expense in the amount of $16,139 and the debt discount has been fully amortized to interest expense. During the nine months ended September 30, 2020, we issued the lender a total of 16,207,380 shares of our common stock in consideration for the conversion of principal of $33,000 and accrued interest of $1,650, repaying the debt in full. No gain or loss was recorded since the conversions were completed within the terms of the note agreement.

August 13, 2019 Convertible Promissory Note – $33,000

Effective August 13, 2019, the Company entered into an agreement to issue a 10% convertible note with an institutional investor in the principal amount of $33,000. The note matures on August 13, 2020. On January 16, 2020, the note was assigned to another institutional investor. The Company received proceeds of $30,000 after payment of $3,000 of the fees and expenses of the lender and its counsel. The lender, at its option after 180 days from the issuance of the note, may convert the unpaid principal balance of, and accrued interest on, the note into shares of the Company’s common stock at a 39% discount from the lowest trading price during the 15 days prior to conversion. The Company may prepay the note during the 180 days from the issuance of the note at redemption premiums ranging from 20% to 45%. After the expiration of 180 days after issuance, the Company has no right of prepayment. We recorded a debt discount of $33,000 related to the conversion feature of the note, along with a derivative liability at inception. During the nine months ended September 30, 2020, amortization of debt discount was recorded to interest expense in the amount of $20,377 and the debt discount has been fully amortized to interest expense. During the nine months ended September 30, 2020, we issued the lender a total of 16,747,584 shares of our common stock in consideration for the conversion of principal of $33,000 and accrued interest of $2,932, repaying the debt in full. No gain or loss was recorded since the conversions were completed within the terms of the note agreement.

21

August 29, 2019 Convertible Promissory Note – $25,000

Effective August 29, 2019, the Company entered into an agreement to issue a 10% convertible note with an institutional investor in the principal amount of $25,000. The note matures on August 29, 2020. The Company received proceeds of $22,000 after an original issue discount of $1,500 and payment of $1,500 in legal fees. The lender, at its option, may convert the unpaid principal balance of, and accrued interest on, the note into shares of the Company’s common stock at a 50% discount from the lowest trading price during the 25 days prior to conversion. The Company may prepay the note during the 180 days from the issuance of the note at redemption premiums ranging from 25% to 45%. After the expiration of 180 days after issuance, the Company has no right of prepayment. We recorded a debt discount of $25,000 related to the conversion feature of the note, along with a derivative liability at inception. During the nine months ended September 30, 2020, amortization of debt discount was recorded to interest expense in the amount of $13,820 and the debt discount has been fully amortized to interest expense. During the nine months ended September 30, 2020, we issued the lender a total of 17,022,000 shares of our common stock in consideration for the conversion of principal of $24,605 and conversion fees of $7,000, resulting in a principal balance of $395 as of September 30, 2020. No gain or loss was recorded since the conversions were completed within the terms of the note agreement.

March 16, 2020 Convertible Promissory Note – $38,000

Effective March 16, 2020, the Company entered into a 12% convertible note with an institutional investor in the principal amount of $38,000. The note matures March 16, 2021. The Company received net proceeds of $35,000 after payment of $3,000 in legal fees and fees to the lender. The lender, at its option after 180 days from the issuance of the note, may convert the unpaid principal balance of, and accrued interest on, the note into shares of the Company’s common stock at a 45% discount from the lowest trading price during the 20 trading days prior to conversion. The Company may prepay the note during the 180 days from the issuance of the note at a redemption premium of 150%. After the expiration of 180 days after issuance, the Company has no right of prepayment. We recorded a debt discount of $18,766 related to the conversion feature of the note, along with a derivative liability at inception. During the nine months ended September 30, 2020, amortization of debt discount was recorded to interest expense in the amount of $18,766 and the debt discount has been fully amortized to interest expense. During the nine months ended September 30, 2020, we issued the lender a total of 6,383,068 shares of our common stock in consideration for the conversion of principal of $38,000 and accrued interest of $2,280, repaying the debt in full. No gain or loss was recorded since the conversions were completed within the terms of the note agreement.

June 22, 2020 Convertible Promissory Note – $28,000

Effective June 22, 2020, the Company entered into a 12% convertible note with an institutional investor in the principal amount of $28,000. The note matures June 22, 2021. The Company received net proceeds of $25,000 after payment of $3,000 in legal fees and fees to the lender. The lender, at its option after 180 days from the issuance of the note, may convert the unpaid principal balance of, and accrued interest on, the note into shares of the Company’s common stock at a 45% discount from the lowest trading price during the 20 trading days prior to conversion. The Company may prepay the note during the 180 days from the issuance of the note at a redemption premium of 150%. After the expiration of 180 days after issuance, the Company has no right of prepayment. We recorded a debt discount of $28,000 related to the conversion feature of the note, along with a derivative liability at inception. During the nine months ended September 30, 2020, amortization of debt discount was recorded to interest expense in the amount of $7,671, resulting in a remaining debt discount of $20,329 as of September 30, 2020. The note had a principal balance of $28,000 as of September 30, 2020.

22

July 7, 2020 Convertible Promissory Note – $33,000

Effective July 7, 2020, the Company entered into a 12% convertible note with an institutional investor in the principal amount of $33,000. The note matures July 7, 2021. The Company received net proceeds of $30,000 after payment of $3,000 in legal fees and fees to the lender. The lender, at its option after 180 days from the issuance of the note, may convert the unpaid principal balance of, and accrued interest on, the note into shares of the Company’s common stock at a 45% discount from the lowest trading price during the 20 trading days prior to conversion. The Company may prepay the note during the 180 days from the issuance of the note at a redemption premium of 150%. After the expiration of 180 days after issuance, the Company has no right of prepayment. We recorded a debt discount of $33,000 related to the conversion feature of the note, along with a derivative liability at inception. During the nine months ended September 30, 2020, amortization of debt discount was recorded to interest expense in the amount of $6,521, resulting in a remaining debt discount of $26,479 as of September 30, 2020. The note had a principal balance of $33,000 as of September 30, 2020.

July 8, 2020 Convertible Promissory Note – $40,000

Effective July 8, 2020, the Company entered into an agreement to issue a 10% convertible note with an institutional investor in the principal amount of $40,000. The note matures on July 8, 2021 and the Company has no right of prepayment. The Company received proceeds of $35,000 after an original issue discount of $2,200 and payment of $2,800 in legal fees. The lender, at its option, may convert the unpaid principal balance of, and accrued interest on, the note into shares of the Company’s common stock at a 50% discount from the lowest trading price during the 25 days prior to conversion. After the expiration of 180 days after issuance, the Company has no right of prepayment. We recorded a debt discount of $40,000 related to the conversion feature of the note, along with a derivative liability at inception. During the nine months ended September 30, 2020, amortization of debt discount was recorded to interest expense in the amount of $7,574, resulting in a remaining debt discount of $32,426 as of September 30, 2020. The note had a principal balance of $40,000 as of September 30, 2020.

August 18, 2020 Convertible Promissory Note – $33,000

Effective August 18, 2020, the Company entered into a 12% convertible note with an institutional investor in the principal amount of $33,000. The note matures August 18, 2021. The Company received net proceeds of $30,000 after payment of $3,000 in legal fees and fees to the lender. The lender, at its option after 180 days from the issuance of the note, may convert the unpaid principal balance of, and accrued interest on, the note into shares of the Company’s common stock at a 45% discount from the lowest trading price during the 20 trading days prior to conversion. The Company may prepay the note during the 180 days from the issuance of the note at a redemption premium of 150%. After the expiration of 180 days after issuance, the Company has no right of prepayment. We recorded a debt discount of $33,000 related to the conversion feature of the note, along with a derivative liability at inception. During the nine months ended September 30, 2020, amortization of debt discount was recorded to interest expense in the amount of $3,888, resulting in a remaining debt discount of $29,112 as of September 30, 2020. The note had a principal balance of $33,000 as of September 30, 2020.

Total accrued interest payable on notes payable was $756,523 and $581,610 as of September 30, 2020 and December 31, 2019, respectively.

23

6. PPP LOAN PAYABLE

A loan to the Company in the principal amount of $9,501 was approved under the terms and conditions of the Paycheck Protection Program of the United States Small Business Administration (“SBA”) and the CARES Act (2020) (H.R. 748) (15 U.S.C. 636 et seq.) (the “Act”) and was funded in May 2020. The loan may be forgiven pursuant to the provisions of the Act.

7. CAPITAL STOCK

At September 30, 2020, the Company’s authorized stock consisted of 2,000,000,000 shares of common stock, with a par value of $0.001 per share. The Company is also authorized to issue 20,000,000 shares of preferred stock, with a par value of $0.001 per share. The rights, preferences and privileges of the holders of the preferred stock will be determined by the Board of Directors prior to issuance of such shares.

Series B Preferred Stock

On March 2, 2016, the Company filed a Certificate of Designation for its Series B Preferred Stock (the “Series B Certificate”) with the Secretary of State of Nevada designating 30,000 shares of its authorized preferred stock as Series B Preferred Stock. The shares of Series B Preferred Stock have a par value of $0.001 per share.

The total face value of this entire series is three million dollars ($3,000,000). Each share of Series B Preferred Stock has a stated face value of One Hundred Dollars ($100) (“Share Value”) and is convertible into shares of fully paid and non-assessable shares of common stock of the Company.

As of September 30, 2020 and December 31, 2019, the Company had 15,055 and 16,155 shares of Series B Preferred Stock outstanding, respectively, with a face value of $1,505,500 and $1,615,500, respectively. These shares were issued in March 2016 for the redemption and cancellation of $1,615,362 of convertible promissory notes and $264,530 of accrued interest payable. Effective February 26, 2020, William Beifuss, Jr., the Company’s President, converted 1,100 shares of Series B preferred stock into 9,777,778 shares of the Company’s common stock. Mr. Beifuss previously acquired the Series B shares from a lender in a private transaction.

The holders of outstanding shares of the Series B Preferred Stock (the “Series B Holders”) are entitled to receive dividends pari passu with the holders of Common Stock, except upon a liquidation, dissolution and winding up of the Company, in which case the Series B Preferred Stock has a preference. Such dividends will be paid equally to all outstanding shares of Series B Preferred Stock and Common Stock, on an as-if-converted basis with respect to the Series B Preferred Stock. The Series B Holders may elect to use the most favorable conversion price for the purpose of determining the as-if-converted number of shares.

In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, the Series B Holder shall be entitled to receive, out of the assets of the Company available for distribution to its shareholders upon such liquidation, whether such assets are capital or surplus of any nature, an amount equal to one hundred dollars ($100) for each such share of the Series B Preferred Stock (as adjusted for any combinations, consolidations, stock distributions, stock splits or stock dividends with respect to such shares), plus all dividends, if any, declared and unpaid thereon as of the date of such distribution, before any payment is made or any assets distributed to the holders of the Common Stock. After such payment, the remaining assets of the Company will be distributed to the holders of Common Stock.

24

If the assets to be distributed to the Series B Holders are insufficient to permit the receipt by such Holders of the full preferential amounts, then all of such assets will be distributed among such Holders ratably in accordance with the number of such shares then held by each such Holder.

The sale of all or substantially all of the Company’s assets, any consolidation or merger of the Company with or into any other entity or person, or any other corporate reorganization, in which the stockholders of the Company immediately prior to such consolidation, merger or reorganization, own less than fifty percent (50%) of the Company’s voting power immediately after such consolidation, merger or reorganization, or any transaction or series of related transactions to which the Company is a party in which in excess of fifty percent (50%) of the Company’s voting power is transferred, excluding any consolidation or merger effected exclusively to change the domicile of the Company, is deemed to be a liquidation, dissolution or winding up.

The Series B Preferred Stock is convertible into Common Stock.

The Series B Holder has the right, at any time, at its election, to convert all or part of the Share Value into shares of Common Stock. The conversion price is the lesser of (1) Fifty Percent (50%) of the lowest trade price of Common Stock recorded on any trade day after December 12, 2012 or (2) the lowest effective price per share granted to any person or entity, including the Series B Holder but excluding officers and directors of the Company, to acquire Common Stock, or adjusted, whether by operation of purchase price adjustment, settlement agreements, exchange agreements, reset provision, floating conversion or otherwise, any outstanding warrant, option or other right to acquire Common Stock or outstanding Common Stock equivalents (the “Conversion Price”).

The conversion formula is as follows: The number of shares receivable upon conversion equals the Share Value divided by the Conversion Price. A conversion notice (the “Conversion Notice”) may be delivered to Company by any method of the Series B Holder’s choice (including but not limited to email, facsimile, mail, overnight courier, or personal delivery), and all conversions will be cashless and not require further payment from the Holder. If no objection is delivered from the Company to the Series B Holder, with respect to any variable or calculation reflected in the Conversion Notice, within 24 hours of delivery of the Conversion Notice, the Company will thereafter be deemed to have irrevocably confirmed and ratified such notice of conversion and waived any objection. The Company will deliver the shares of Common Stock from any conversion to the Series B Holder (in any name directed by the Series B Holder) within three (3) business days of Conversion Notice delivery. If the Company is participating in the Depository Trust Company (“DTC”) Fast Automated Securities Transfer (“FAST”) program, then upon request of the Holder and provided that the shares to be issued are eligible for transfer under Rule 144 of the Securities Act of 1933, as amended (the “Securities Act”), or are effectively registered under the Securities Act, the Company will cause its transfer agent to electronically issue the Common Stock issuable upon conversion to the Holder through the DTC Direct Registration System (“DRS”). If the Company is not participating in the DTC FAST program, then the Company agrees in good faith to apply and cause the approval for participation in the DTC FAST program.

The Conversion Price is subject to equitable adjustments for stock splits, stock dividends or rights offerings by the Company relating to the Company’s securities or the securities of any subsidiary of the Company, combinations, recapitalization, reclassifications, extraordinary distributions and similar events. No fractional shares of the Common Stock shall be issuable upon the conversion of shares of the Series B Preferred Stock and the Company shall pay the cash equivalent of any fractional share upon such conversion.

If the Company fails to deliver shares in accordance with the required time frame, then for each conversion, a penalty of $1,500 per day will be assessed for each day after the third business day (inclusive of the day of the conversion) until share delivery is made. Such penalty may be converted into Common Stock at the Conversion Price or payable in cash, at the sole option of the Series B Holder (under the Holder’s and the Company’s expectations that any penalty amounts shall tack back to the original date of the issuance of Series B Preferred Stock, consistent with applicable securities laws).

25

In no event will the Series B Holder be entitled to convert any Series B Preferred Stock, such that upon conversion the sum of (1) the number of shares of Common Stock beneficially owned by the Holder and its affiliates (other than shares of Common Stock which may be deemed beneficially owned through the ownership of the unconverted portion of this Series B Preferred Stock or the unexercised or unconverted portion of any other security of the Company subject to a limitation on conversion or exercise analogous to these limitations), and (2) the number of shares of Common Stock issuable upon the conversion of Series B Preferred Stock, would result in beneficial ownership by the Holder and its affiliates of more than 4.99% of the outstanding shares of Common Stock. The limitations on conversion may be waived by the Holder upon, at the election of the Series B Holder, not less than 61 days prior notice to the Company, and the provisions of the conversion limitation shall continue to apply until such 61st day (or such later date, as determined by the Series B Holder, as may be specified in such notice of waiver).

Except as required by law, the Series B Holders are not entitled to vote, as a separate class or otherwise, on any matter presented to the stockholders of the Company for their action or consideration at any meeting of stockholders of the Company (or by written consent of stockholders in lieu of meeting). Each Holder of outstanding shares of Series B Preferred Stock will be entitled, on the same basis as holders of Common Stock, to receive notice of such action or meeting.

So long as any shares of the Series B Preferred Stock remain outstanding, the Company will not, without first obtaining the approval (by vote or written consent, as provided by law) of the holders of at least a majority of the then outstanding shares of Series B Preferred Stock voting together as one class: (a) alter or change the rights, preferences or privileges of the shares of the Series B Preferred Stock so as to affect materially and adversely such shares; or (b) create any new class of shares having preference over the Series B Preferred Stock.

The Series B Holder has the right, at its sole discretion, to elect a fixed conversion price for the Series B Preferred Stock. The Fixed Conversion Price may not be lower than the Conversion Price. The Company will not, by amendment of its Certificate of Incorporation, bylaws or through any reorganization, transfer of assets, consolidation, merger, scheme of arrangement, dissolution, issue or sale of securities, or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of the Series B Certificate, and will at all times carry out all the provisions of the Series B Certificate.

Series C Preferred Stock

In November 2018, the Company filed a Certificate of Designation for its Series C Preferred Stock (the “Series C Certificate”) with the Secretary of State of Nevada designating 36,000 shares of its authorized preferred stock as Series C Preferred Stock. The shares of Series C Preferred Stock have a par value of $0.001 per share. The total face value of this entire series is three million six hundred thousand dollars ($3,600,000). Each share of Series C Preferred Stock has a stated face value of One Hundred Dollars ($100) (“Share Value”) and is convertible into shares of fully paid and non-assessable shares of common stock of the Company.

As discussed in Note 3, the Company issued 36,000 shares of Series C Preferred Stock to the owner of the common stock of EllisLab, Inc. in the Merger, which shares were surrendered and cancelled on September 30, 2019 pursuant to the sale of EllisLab Corp.

The holders of outstanding shares of the Series C Preferred Stock (the “Series C Holders”) shall be entitled to receive dividends pari passu (on a pro rata basis) with the holders of Series B Preferred Stock and Common Stock, except upon a liquidation, dissolution and winding up of the Company. Such dividends shall be paid equally to all outstanding shares of Series C Preferred Stock, Series B Preferred Stock and common stock, on an as-if-converted basis with respect to the Series C Preferred Stock and Series B Preferred Stock.

26

In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, the Holder of each outstanding share of the Series C Preferred Stock shall be entitled to receive, on a pro rata basis with the outstanding Series B Preferred Stock, out of the assets of the Company available for distribution to its shareholders upon such liquidation, whether such assets are capital or surplus of any nature, an amount equal to one hundred dollars ($100.00) for each such share of the Series C Preferred Stock (as adjusted for any combinations. consolidations, stock distributions, stock splits or stock dividends with respect to such shares), plus all dividends, if any, declared and unpaid thereon as of the date of such distribution, before any payment shall be made or any assets distributed to the holders of common stock, and, after such payment, the remaining assets of the Company shall be distributed to the holders of common stock.

Each share of Series C Preferred Stock is convertible into twenty thousand (20,000) shares of the Company’s fully paid and nonassessable shares of common stock, as adjusted. The Series C Preferred Stock have the respective rights, privileges and designations as are set forth in the Certificate of Designations, Preferences, Rights and Limitations of Series C Preferred Stock appended hereto as Exhibit 4.1. The Series C Preferred Stock contains a blocker that prevents the Holder from converting the Series C Preferred Stock if such exercise would result in beneficial ownership of more than 4.99% of the outstanding shares of the Company’s stock, without at least 61 days of prior notice. Under the Series C Preferred Stock, the Holder is also subject to the Rule 144 restrictions of an affiliate.

Except as required by law or as specifically provided in the Certificate of Designation, the Series C Holders shall not be entitled to vote, as a separate class or otherwise, on any matter presented to the stockholders of the Company for their action or consideration at any meeting of stockholders of the Company (or by written consent of stockholders in lieu of meeting); provided, however, that each Series C Holder shall be entitled, on the same basis as holders of Common Stock, to receive notice of such action or meeting.

Series D Preferred Stock

On November 27, 2019, the Company filed a Certificate of Designation for its Series D Preferred Stock (the “Series D Certificate”) with the Secretary of State of Nevada which designates 1,000 shares of the Company’s preferred stock par value $0.001 per share as Series D Preferred Stock. William E. Beifuss, Jr., the Company’s President and Chief Executive Officer, was issued 1,000 shares of Series D Preferred Stock valued at $15,000 by an independent valuation firm, which shares were outstanding as of December 31, 2019. The 1,000 shares of Series D preferred stock were automatically redeemed on January 11, 2020, 45 days after the effective date of the Series D Certificate.

Pursuant to the terms of the Designation, holders of Series D Preferred Stock shall not be entitled to dividends or a liquidation preference and shall have no conversion rights. For so long as any shares of the Series D Preferred Stock remain issued and outstanding, the holders thereof, voting separately as a class, shall have the right to vote in an amount equal to fifty-one percent (51%) of the total voting power of the Company’s shareholders. Such vote shall be determined by the holder(s) of a majority of the then issued and outstanding shares of Series D Preferred Stock.

The shares of the Series D Preferred Stock shall be automatically, and without any required action by the Company or the holders thereof, redeemed by the Company at their par value on the first to occur of the following triggering events: (i) a date forty-five (45) days as after the Effective Date, (ii) on the date that Mr. Beifuss. ceases, for any reason, to serve as officer, director or consultant of the Company, it being understood that if Mr. Beifuss continues without interruption to serve thereafter in one or more capacities as officer, director or consultant of the Company this shall not be considered a cessation of service, or (iii) on the date that the Company’s shares of common stock first trade on any national securities exchange and such listing is conditioned upon the elimination of the preferential voting rights of the Series D Preferred Stock set forth in the Certificate of Designation.

27

Common Stock

Effective February 14, 2020, the Company effected a reverse split of its common stock at a ratio of one for two hundred twenty-five shares (1:225) with the filing of a Certificate of Amendment to its Articles of Incorporation with the Secretary of State of Nevada. The Company has given retroactive effect for the reverse stock split in its financial statements and notes thereto for all periods presented.

As of September 30, 2020 and December 31, 2019, the Company had 123,331,517 and 1,049,380 shares of common stock issued and outstanding, respectively.

During the nine months ended September 30, 2020, the Company issued a total of 122,279,532 shares of common stock: 112,501,754 shares for the conversion of $222,137 of principal of convertible notes payable, accrued interest payable of $23,664, and fees of $10,750; 9,777,778 shares for the conversion of 1,100 shares of Series B preferred stock recorded at par value; and 2,605 shares for the rounding of shares in the February 2020 reverse stock split recorded at par value of $3. In connection with the convertible debt and Series B preferred stock conversions, the Company reduced derivative liabilities by $429,518. There was no gain or loss on settlement of debt due to the conversions occurring within the terms of the convertible notes.

During the nine months ended September 30, 2019, the Company issued a total of 333,080 shares of common stock at fair value in consideration for the conversion of $125,521 of convertible promissory notes, accrued interest payable of $9,038 and fees of $250. In connection with the debt conversions, the Company reduced derivative liabilities by $143,692. There was no gain or loss on settlement of debt due to the conversions occurring within the terms of the convertible notes.

8. STOCK OPTIONS AND WARRANTS

As of September 30, 2020, the Board of Directors of the Company had granted non-qualified stock options and warrants exercisable for a total of 177,778 shares of common stock to its employees, officers, and consultants.

We recognized no stock-based compensation expense for the three months and nine months ended September 30, 2020 and 2019.

As of September 30, 2020, we had no unrecognized stock-based compensation expense.

28

A summary of the Company’s stock options and warrants as of September 30, 2020, and changes during the nine months then ended is as follows:

	Shares			Weighted Average Exercise Price		Weighted Average Remaining Contract Term (Years)		Aggregate Intrinsic Value
Outstanding at December 31, 2019		184,001		$	1.544		8.65
Granted		-		$	-
Exercised		-		$	-
Forfeited or expired		(6,223	)	$	13.50
Outstanding at September 30, 2020		177,778		$	1.13		8.17	$	-

The aggregate intrinsic value in the preceding table represents the total pretax intrinsic value, based on the closing price of our common stock of $0.0095 as of September 30, 2020, which would have been received by the holders of in-the-money options and warrants had the holders exercised their options and warrants as of that date.

9. DERIVATIVE LIABILITIES

The fair value of the Company’s derivative liabilities is estimated at the issuance date and is revalued at each subsequent reporting date. We estimate the fair value of derivative liabilities associated with our convertible notes payable, Series B preferred stock and warrants using a multinomial lattice model based on projections of various potential future outcomes. Where the number of warrants or common shares to be issued under these agreements is indeterminate, the Company has concluded that the equity environment is tainted, and all additional warrants and convertible debt and equity are included in the value of the derivatives.

The significant assumptions used in the valuation of the derivative liabilities at September 30, 2020 are as follows:

Conversion to stock	Monthly
Stock price on the valuation date	$	0.0095
Risk free interest rates	0.00% - 2.84		%
Years to maturity	0.08 - 15.0
Expected volatility	86.6%–549.2		%

The value of our derivative liabilities was estimated as follows at:

	September 30, 2020		December 31, 2019
Convertible notes payable	$	3,307,831	$	3,606,194
Series B preferred stock		3,113,178		2,535,359
Warrants		2,051		19,342
Total	$	6,423,060	$	6,160,895

29

The calculation input assumptions are subject to significant changes from period to period and to management’s judgment; therefore, the estimated fair value of the derivative liability will fluctuate from period to period, and the fluctuation may be material.

10. RELATED PARTY TRANSACTIONS

Pursuant to a written consulting agreement, dated May 31, 2013 and amended effective November 1, 2016, William E. Beifuss, Jr., our current President, Chief Executive Officer and Acting Chief Financial Officer, is to receive fees for services of $10,000 per month. Fees payable to Mr. Beifuss of $80,000 and $10,000 are included in accounts payable as of September 30, 2020 and December 31, 2019, respectively.

As discussed in Note 7, the Company issued 36,000 shares of Series C Preferred Stock to Rick Ellis, the former Chief Executive Officer of the Company and Chief Executive Officer of EllisLab Corp., in the EllisLab Corp. Merger, which shares were surrendered and cancelled on September 30, 2019 pursuant to the EllisLab Corp. Sale Agreement.

As discussed in Note 7, in November 2019, the Company issued to Mr. Beifuss 1,000 shares of Series D Preferred Stock for services valued at $15,000 by an independent valuation firm. The shares were automatically redeemed in January 2020, 120 days after the effective date of the related Series D Preferred Stock Certificate.

As discussed in Note 7, effective February 26, 2020, Mr. Beifuss converted 1,100 shares of Series B preferred stock into 9,777,778 shares of the Company’s common stock. Mr. Beifuss previously acquired the Series B shares from a lender in a private transaction. The transaction was recorded at the par value of the common stock.

See Note 5 for discussion of convertible notes payable with related parties.

11. COMMITMENTS AND CONTINGENCIES

Operating Lease

On September 5, 2017, we entered into an operating sublease for office space. The base rent for the sublease is $1,000 per month for a period of one year and month-to-month thereafter. Management has assumed a three-year life for the sublease arrangement. On January 1, 2019, we adopted ASC 842, “Leases,” which resulted in the recognition of an operating lease liability and corresponding right-of use asset (“ROU”) in the amount of $18,352.

As of September 30, 2020 and December 31, 2019, the operating lease liability (recorded as a current liability) and ROU asset had a balance of $0 and $7,708, respectively.

For the three months ended September 30, 2020 and 2019, the Company recognized operating lease cost of $3,000. For the nine months ended September 30, 2020 and 2019, the Company recognized operating lease cost of $9,000.

12. SUBSEQUENT EVENTS

Management has evaluated subsequent events according to the requirements of ASC TOPIC 855, and has reported the following:

Convertible Notes

Effective October 1, 2020, the Company entered into a 12% convertible note with an institutional investor in the principal amount of $33,000. The note matures on October 1, 2021. The Company received net proceeds of $30,000 after payment of $3,000 in legal fees and other fees to the lender. The lender, at its option after 180 days from the issuance of the note, may convert the unpaid principal balance of, and accrued interest on, the note into shares of the Company’s common stock at a 45% discount from the lowest trading price during the 20 trading days prior to conversion. The Company may prepay the note during the 180 days from the issuance of the note at a redemption premium of 150%. After the expiration of 180 days after issuance, the Company has no right of prepayment.

Effective November 9, 2020, the Company entered into a 12% convertible note with an institutional investor in the principal amount of $35,000. The note matures on November 9, 2021. The Company received net proceeds of $31,500 after payment of $3,500 in legal fees and fees to the lender. The lender, at its option after 180 days from the issuance of the note, may convert the unpaid principal balance of, and accrued interest on, the note into shares of the Company’s common stock at a 45% discount from the lowest trading price during the 20 trading days prior to conversion. The Company may prepay the note during the 180 days from the issuance of the note at a redemption premium of 150%. After the expiration of 180 days after issuance, the Company has no right of prepayment. 

Convertible Note Conversions

Subsequent to September 30, 2020, a lender converted a $5,440 of principal of the March 2016 $1,000,000 CPN and $2,502 of accrued interest into 5,294,933 shares of the Company’s common stock.

30

ITEM 2: MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Certain statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” below, and elsewhere in this report, are not related to historical results, and are forward-looking statements. Forward-looking statements present our expectations or forecasts of future events. You can identify these statements by the fact that they do not relate strictly to historical or current facts. These statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. Forward-looking statements frequently are accompanied by such words such as “may,” “will,” “should,” “could,” “expects,” “plans,” “intends,” “anticipates,” “believes,” “estimates,” “predicts,” “potential” or “continue,” or the negative of such terms or other words and terms of similar meaning. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance, achievements, or timeliness of such results. Moreover, neither we nor any other person assumes responsibility for the accuracy and completeness of such forward-looking statements. We are under no duty to update any of the forward-looking statements contained herein after the date of this report. Subsequent written and oral forward looking statements attributable to us or to persons acting in our behalf are expressly qualified in their entirety by the cautionary statements and risk factors set forth in our annual report on Form 10-K for the year ended December 31, 2019 filed with the SEC on April 14, 2020, and in other reports filed by us with the SEC.

You should read the following description of our financial condition and results of operations in conjunction with the condensed financial statements and accompanying notes included in this report.

Current Overview

On November 30, 2018, the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) pursuant to which EllisLab, Inc., an S Corporation owned 100% by Rick Ellis, merged with and into EllisLab Corp., a newly formed subsidiary of the Company (the “Merger”). EllisLab, Inc. builds software for web professionals and provides related support services. Pursuant to the terms of the Merger Agreement, Ellis received 36,000 shares of the Company’s newly designated Series C Convertible Preferred Stock, with a stated value of $100 per share, in exchange for the cancellation of all common shares of EllisLab, Inc. owned by Ellis, which shares represented 100% of the issued and outstanding capital stock of EllisLab, Inc. The separate legal existence of EllisLab, Inc. ceased, and EllisLab Corp. became the surviving company.

On September 30, 2019, the Company, entered into an Agreement for the Purchase and Sale of Capital Stock of EllisLab Corp. (the “EllisLab Corp. Sale Agreement”) with Rick Ellis to sell to Rick Ellis all of the issued and outstanding shares of EllisLab Corp. for $10,000 and the 36,000 shares of the Company’s Series C Convertible Preferred Stock acquired by Rick Ellis in the Merger, which represented all of the issued and outstanding shares of the Company’s Series C Convertible Preferred Stock. Pursuant to the Ellis Lab Corp. Sale Agreement, the Company effectively divested itself of the Ellis Lab business and discontinued it.

Consequently, the revenues and expenses for EllisLab Corp. are reported as “loss from discontinued operations, net of income taxes” in our condensed statements of operations for the three months and nine months ended September 30, 2019. Where presented, the EllisLab Corp. assets and liabilities have been retroactively reclassified as assets and liabilities of discontinued operations.

31

We are an early stage developer of 5G small cell tower sites for the 5G revolution. 5G wireless networks are expected to be 100 times faster than current 4G LTE networks. This will enable global scale killer applications such as self-driving cars, the Internet of things (IOT), mobile streaming of 4K videos, real-time hologram-based collaboration, and lag-free high-definition gaming.

To realize this vision, many new 5G small antennas are needed because high frequency 5G signals cannot travel farther than 100 meters. Currently, most of the nation does not have the infrastructure or number of small cell antennas to deliver on the promises of 5G. It is estimated that more than 1 million new 5G small cell sites must be added in the United States alone.

To rapidly enter the market and to help solve this massive challenge, Digital Locations plans to partner or co-develop a portfolio of 5G small cell sites to help meet the demands of 5G networks. Our goal is to become a “landlord” of tomorrow’s wireless communications assets.

The accompanying financial statements are prepared using accounting principles generally accepted in the United States of America applicable to a going concern, which contemplate the realization of assets and liquidation of liabilities in the normal course of business. As of September 30, 2020, our current liabilities exceeded our current assets by $9,937,869 and we had a total stockholders’ deficit of $9,937,760. In addition, subsequent to the EllisLab Corp. Sale Agreement which closed on September 30, 2019, the Company does not have any sources of revenues, and has reported negative cash flows from operations since inception. The Company currently does not have the cash resources to meet its operating commitments for the next twelve months and expects to have ongoing requirements for capital investment to implement its business plan. These factors, among others, raise substantial doubt that the Company will be able to continue as a going concern for a reasonable period of time.

The ability of the Company to continue as a going concern is dependent upon, among other things, raising additional capital. The Company has obtained operating funds primarily from the issuance of convertible debt. Management believes this funding will continue and will provide the additional cash needed to meet the Company’s obligations as they become due. There can be no assurance, however, that the Company will be successful in accomplishing its objectives. Without such additional capital we may be required to cease operations. The accompanying financial statements do not include any adjustments that might result should the Company be unable to continue as a going concern.

Results of Operations

Three Months and Nine Months Ended September 30, 2020 Compared to the Three Months and Nine Months Ended September 30, 2019

Revenues

As discussed above, revenues and expenses of EllisLab Corp. are combined and presented as loss from discontinued operations, net of income taxes in our condensed statements of operations. Therefore, we reported no revenues for the three months and nine months ended September 30, 2020 and 2019. On September 30, 2019, we sold EllisLab Corp. and currently have no other sources of revenues.

General and Administrative Expenses

General and administrative expenses decreased to $77,250 in the three months ended September 30, 2020 from $91,153 in the three months ended September 30, 2019 and decreased to $249,836 in the nine months ended September 30, 2020 from $287,580 in the nine months ended September 30, 2019. The decreases are due primarily to decreased salaries in the current fiscal year and a decrease in professional fees.

32

Depreciation and Amortization Expense

Our investment in property and equipment currently is not material to our operations. Depreciation expense was $162 and $(1) for the three months ended September 30, 2020 and 2019, respectively, and $486 and $359 for the nine months ended September 30, 2020 and 2019, respectively.

Bad Debt Expense

From December 1, 2018 through September 30, 2019, we provided operating advances to EllisLab Corp. totaling $356,851, which advances were eliminated in our consolidated financial statements. Pursuant to the sale of EllisLab Corp. on September 30, 2019, we agreed to forgive these operating advances and $356,851 was recorded as a bad debt expense in our statements of operations for the three months and nine months ended September 30, 2019. We had no bad debt expense in the current year periods.

Other Income (Expense)

Total other income was $127,868 for the three months ended September 30, 2020 compared to total other income of $54,260 for the three months ended September 30, 2019. Total other expense was $1,046,365 for the nine months ended September 30, 2020 compared to total other income of $3,176,832 for the nine months ended September 30, 2019. The total other income reported for these periods resulted from a gain on change in derivative liabilities, partially offset by interest expense, and total other expense resulting from a loss on change in derivative liabilities combined with interest expense.

Our interest expense decreased to $142,803 for the three months ended September 30, 2020 from $246,490 for the three months ended September 30, 2019 and decreased to $490,448 for the nine months ended September 30, 2020 from $727,290 for the nine months ended September 30, 2019. The decrease in interest expense in the current fiscal year resulted primarily from lower amortization of debt discount as we had multiple convertible notes payable fully converted to common stock during the current fiscal year.

We reported a gain on change in derivative liabilities of $270,671 and $300,750 in the three months ended September 30, 2020 and 2019, respectively. We reported a loss on change in derivative liabilities of $555,917 in the nine months ended September 30, 2020 compared to a gain on change in derivative liabilities of $3,904,122 in the nine months ended September 30, 2019. We estimate the fair value of the derivatives associated with our convertible notes, certain stock options, and our Series B Preferred Stock using a multinomial lattice model based on projections of various potential future outcomes. These estimates are based on multiple inputs, including the market price of our stock, interest rates, our stock price volatility, variable conversion prices based on market prices as defined in the respective agreements, and probabilities of certain outcomes based on management projections. These inputs are subject to significant changes from period to period and to management’s judgment; therefore, the estimated fair value of the derivative liabilities will fluctuate from period to period, and the fluctuation may be material.

Loss from Discontinued Operations

Our loss from discontinued Ellis Lab Corp. operations was $64,315 for the three months ended September 30, 2019 and $269,693 for the nine months ended September 30, 2019.

33

Net Income (Loss)

As a result of the above, we reported net income of $50,456 for the three months ended September 30, 2020 compared to a net loss of $458,058 for the three months ended September 30, 2019. We reported a net loss of $1,296,687 for the nine months ended September 30, 2020 compared to net income of $2,262,349 for the nine months ended September 30, 2019. Where net income is reported in any given period, we have reported a gain on change in derivative liabilities.

Liquidity and Capital Resources

As of September 30, 2020, we had total current assets of $35,637, comprised of cash, and total current liabilities of $9,973,506, resulting in a working capital deficit of $9,937,869. Included in our current liabilities at September 30, 2020 are derivative liabilities totaling $6,423,060, which we do not anticipate will require cash payments to settle.

We have funded our operations primarily from the proceeds of convertible notes payable. During the nine months ended September 30, 2020, we received $155,000 of net proceeds from five convertible notes payable. We also received proceeds of $9,501 from a PPP loan in May 2020. These funds have not been sufficient to meet our operating needs, including payroll and payments to our key consultants.

During the nine months ended September 30, 2020, we used net cash of $137,139 in operating activities as a result of our net loss of $1,296,687, partially offset by non-cash expenses totaling $848,275, decrease in prepaid expenses of $2,808 and increases in accounts payable of $91,571, accrued expenses of $18,317 and accrued interest, notes payable of $198,577.

During the nine months ended September 30, 2019, we used net cash of $534,749 in operating activities as a result of our net income of $2,262,349, non-cash expenses totaling $901,897, increases in accounts payable of $18,585, accrued expenses of $2,326, accrued interest, notes payable of $182,604 and change in net assets of discontinued operations of $10,843, offset by non-cash gain of $3,904,122 and increase in prepaid expenses of $9,231.

During the nine months ended September 30, 2020 and 2019, we had no net cash provided by or used in investing activities.

Net cash provided by financing activities during the nine months ended September 30, 2020 was $164,501, comprised of proceeds from convertible notes payable of $155,000 and proceeds from PPP loan of $9,501. Net cash provided by financing activities for the nine months ended September 30, 2019 was $517,000, comprised of proceeds from convertible notes payable.

Historically, proceeds received from the issuance of debt have been sufficient to fund our current operating expenses. We estimate that we will need to raise substantial capital or financing over the next twelve months in order to explore business expansion opportunities and provide the necessary capital to meet our other general and administrative expenses. We anticipate that we will incur operating losses in the next twelve months. Our revenue is not expected to exceed our investment and operating costs in the next twelve months. Therefore, our future operations are dependent on our ability to secure additional financing. Recently, funding opportunities have been limited due to downturns in U.S. equity and debt markets resulting from the world-wide Coved 19 pandemic. Financing transactions, if available, may include the issuance of equity or debt securities, obtaining credit facilities, or other financing mechanisms. However, the trading price of our common stock and continued downturn in the U.S. equity and debt markets could make it more difficult to obtain financing through the issuance of equity or debt securities.

34

Even if we are able to raise the funds required, it is possible that we could incur unexpected costs and expenses or experience unexpected cash requirements that would force us to seek alternative financing. Furthermore, if we issue additional equity or debt securities, stockholders may experience additional dilution or the new equity securities may have rights, preferences, or privileges senior to those of existing holders of our common stock. The inability to obtain additional capital may restrict our ability to grow and may reduce our ability to continue to conduct business operations. If we are unable to obtain additional financing, we may have to curtail our marketing and development plans and possibly cease our operations.

Our prospects must be considered considering the risks, expenses, and difficulties frequently encountered by companies in their early stage of operations. To address these risks, we must, among other things, seek growth opportunities through investment and acquisitions, implement and successfully execute our business strategy, respond to competitive developments, and attract, retain and motivate qualified personnel. We cannot assure that we will be successful in addressing such risks, and the failure to do so could have a material adverse effect on our business prospects, financial condition and results of operations.

Future Impact of Covid-19

The future impact of the Covid-19 pandemic on companies is evolving and we are currently unable to assess with certainty the broad effects of Covid-19 on our business. As of September 30, 2020, the Company had no material assets that would be subject to impairment or change in valuation due to Covid-19. However as of September 30, 2020, the reported values of the Company’s material convertible debt and derivative liabilities are based on multiple factors, including the market price of our stock, interest rates, our stock price volatility, variable conversion prices based on market prices as defined in the respective agreements and probabilities of certain outcomes based on management projections. We believe these inputs will be subject to even more significant changes due to the impact on capital markets of Covid-19, and the future estimated fair value of these liabilities may fluctuate materially from period to period.

Without a current source of revenue, we are currently dependent on debt or equity financing to fund our operations and execute our business plan. We believe that the impact on capital markets of Covid-19 may make it more costly and more difficult for us to access these sources of funding.

Critical Accounting Policies

Our significant accounting policies are disclosed in Note 2 to our consolidated financial statements. The following is a summary of those accounting policies that involve significant estimates and judgment of management.

Use of Estimates

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the accompanying financial statements. Significant estimates made in preparing these financial statements include the estimate of useful lives of property and equipment and intangible assets, impairment of assets, the deferred tax valuation allowance, the fair value of stock options and derivative liabilities. Actual results could differ from those estimates.

35

Derivative Liabilities

We have identified the conversion features of our convertible notes payable and Series B preferred stock and certain stock options and warrants as derivatives. Where the number of common shares to be issued under these agreements is indeterminate, the Company has concluded that the equity environment is tainted, and all additional options, warrants and convertible debt and equity are included in the value of the derivatives. We estimate the fair value of the derivatives using the Black-Scholes pricing model and a multinomial lattice model based on projections of various potential future outcomes. We estimate the fair value of the derivative liabilities at the inception of the financial instruments, at the date of conversions to equity and at each reporting date, recording a derivative liability, debt discount, additional paid-in capital and a gain or loss on change in derivative liabilities as applicable. These estimates are based on multiple inputs, including the market price of our stock, interest rates, our stock price volatility, variable conversion prices based on market prices as defined in the respective agreements and probabilities of certain outcomes based on management projections. These inputs are subject to significant changes from period to period and to management’s judgment; therefore, the estimated fair value of the derivative liabilities will fluctuate from period to period, and the fluctuation may be material.

Fair Value of Financial Instruments

Disclosures about fair value of financial instruments, require disclosure of the fair value information, whether or not recognized in the balance sheet, where it is practicable to estimate that value. As of September 30, 2020 and December 31, 2019, the Company believes the amounts reported for cash, prepaid expenses, accounts payable, accrued expenses and other current liabilities, accrued interest - notes payable, notes payable and convertible notes payable approximate fair value because of their short maturities.

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASC”) Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include:

• Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;

• Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

• Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

36

We measure certain financial instruments at fair value on a recurring basis. Liabilities measured at fair value on a recurring basis are as follows at September 30, 2020 and December 31, 2019:

	Total		Level 1		Level 2		Level 3
September 30, 2020:
Derivative liabilities	$	6,423,060	$	-	$	-	$	6,423,060
Total liabilities measured at fair value	$	6,423,060	$	-	$	-	$	6,423,060
December 31, 2019:
Derivative liabilities	$	6,160,895	$	-	$	-	$	6,160,895
Total liabilities measured at fair value	$	6,160,895	$	-	$	-	$	6,160,895

Revenue Recognition

On January 1, 2018, we adopted Accounting Standards Update No. 2014-09, “Revenue from Contracts with Customers” (Topic 606), which supersedes the revenue recognition requirements in Accounting Standards Codification (ASC) Topic 605, “Revenue Recognition” (Topic 605). The Company had no operating revenues prior to the Merger. Effective December 1, 2018, the Company’s revenues, included in loss from discontinued operations, were derived primarily from the sale of monthly and annual tech support subscriptions and partnership fees, and from software applications that customers purchase via the Company’s online store. Sales were processed using a real-time payment processing company. Revenue from product sales is recorded net of processing costs.

Under Topic 606, revenue is recognized when control of the promised goods or services is transferred to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services.

We determine revenue recognition through the following steps:

· identification of the contract, or contracts, with a customer;

· identification of the performance obligations in the contract;

· determination of the transaction price;

· allocation of the transaction price to the performance obligations in the contract; and

· recognition of revenue when, or as, we satisfy a performance obligation.

Amounts collected from customers for support subscriptions and partnership fees with a contract life of one month or greater are recorded as deferred revenue and recognized over the life of the contract.

Subsequent to the agreement to sell EllisLab Corp. on September 30, 2019, the Company does not have any sources of revenues.

Stock-Based Compensation

Stock-based compensation is measured at the grant date based on the value of the award granted using either the Black-Scholes option pricing model or a multinomial lattice model based on projections of various potential future outcomes and recognized over the period in which the award vests. For stock awards no longer expected to vest, any previously recognized stock compensation expense is reversed in the period of termination. The stock-based compensation expense is included in general and administrative expenses.

37

Recently Issued Accounting Pronouncements

Although there are several new accounting pronouncements issued or proposed by the FASB, which the Company has adopted or will adopt, as applicable, the Company does not believe any of these accounting pronouncements has had or will have a material impact on its financial position or results of operations.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Based on an evaluation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act) required by paragraph (b) of Rule 13a-15 or Rule 15d-15, as of September 30, 2020, our Chief Executive Officer and Acting Chief Financial Officer has concluded that our disclosure controls and procedures were not effective in ensuring that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms. Our Chief Executive Officer and Acting Chief Financial Officer also concluded that, as of September 30, 2020, our disclosure controls and procedures were not effective in ensuring that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Acting Chief Financial Officer, to allow timely decisions regarding required disclosure.

Management’s Report on Internal Control over Financial Reporting

We are responsible for establishing and maintaining adequate internal control over financial reporting in accordance with Exchange Act Rule 13a-15. With the participation of our Chief Executive Officer and Acting Chief Financial Officer, our management conducted an evaluation of the effectiveness of our internal control over financial reporting as of September 30, 2020 based on the criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013). Based on this evaluation, management concluded that our internal control over financial reporting was not effective as of September 30, 2020, based on those criteria. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected.

A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis. We have identified the following material weaknesses:

1.	As of September 30, 2020, we did not maintain effective controls over the control environment. Specifically, the Board of Directors does not currently have any independent members. Since this entity level control has a pervasive effect across the organization, management has determined that this circumstance constitutes a material weakness.
2.	As of September 30, 2020, due to the inherent issue of segregation of duties in a small company, we have relied heavily on entity or management review controls and engaged an outside financial consultant to lessen the issue of segregation of duties over accounting, financial close procedures and controls over financial statement disclosure. Accordingly, management has determined that this control deficiency constitutes a material weakness.
3.	As of September 30, 2020, we did not establish a formal written policy for the approval, identification, and authorization of related party transactions.

Because of these material weaknesses, management has concluded that the Company did not maintain effective internal control over financial reporting as of September 30, 2020, based on the criteria established in “Internal Control-Integrated Framework” issued by the COSO.

Changes in Internal Controls

During the three months ended September 30, 2020, there were no changes in our internal control over financial reporting identified in connection with the evaluation required by paragraph (d) of Rule 13a-15 or Rule 15d-15 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

38

PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

We are not a party to any pending legal proceeding, nor is our property the subject of a pending legal proceeding, that is not in the ordinary course of business or otherwise material to the financial condition of our business. None of our directors, officers or affiliates is involved in a proceeding adverse to our business or has a material interest adverse to our business.

ITEM 1A. RISK FACTORS

The future impact of the Covid-19 pandemic on companies is evolving and we are currently unable to assess with certainty the broad effects of Covid-19 on our business.

The future impact of the Covid-19 pandemic on companies is evolving and we are currently unable to assess with certainty the broad effects of Covid-19 on our business. As of September 30, 2020, the Company had no material assets that would be subject to impairment or change in valuation due to Covid-19. However, as of September 30, 2020, the reported values of the Company’s material convertible debt and derivative liabilities are based on multiple factors, including the market price of our stock, interest rates, our stock price volatility, variable conversion prices based on market prices as defined in the respective agreements and probabilities of certain outcomes based on management projections. We believe these inputs will be subject to even more significant changes due to the impact on capital markets of Covid-19, and the future estimated fair value of these liabilities may fluctuate materially from period to period.

Without a current source of revenue, we are currently dependent on debt or equity financing to fund our operations and execute our business plan. We believe that the impact on capital markets of Covid-19 may make it more costly and more difficult for us to access these sources of funding.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

During the three months ended September 30, 2020, the Company issued a total of 71,824,289 shares of common stock for the conversion of $135,055 of principal of convertible notes payable, accrued interest payable of $14,974, and fees of $8,500. In connection with the convertible debt stock conversions, the Company reduced derivative liabilities by $117,971.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

Not Applicable.

ITEM 5. OTHER INFORMATION

None.

39

ITEM 6. EXHIBITS

2.1	Agreement and Plan of Merger, dated as of November 30, 2018, by and among Digital Locations, Inc., EllisLab, Inc., Rick Ellis and EllisLab Corp. (Incorporated by reference to the Company’s Current Report on Form 8-K filed on December 3, 2018
3.1	Articles of Incorporation of Carbon Sciences, Inc. filed with the Nevada Secretary of State on August 25, 2007 (Incorporated by reference to the Company’s Registration Statement on Form SB-2 filed on July 27, 2007).
3.2	Articles of Amendment of Articles of Incorporation of Carbon Sciences, Inc. filed with the Nevada Secretary of State on April 9, 2007 (Incorporated by reference to the Company’s Registration Statement on Form SB-2 filed on July 27, 2007).
3.3	Certificate of Amendment to Articles of Incorporation, filed with the Nevada Secretary of State on May 9, 2011 (Incorporated by reference to the Company’s Current Report on Form 8-K filed on May 16, 2011).
3.4	Certificate of Amendment to Articles of Incorporation, filed with the Nevada Secretary of State on August 1, 2011 (Incorporated by reference to the Company’s Current Report on Form 8-K filed on August 4, 2011).
3.5	Certificate of Amendment to Articles of Incorporation, filed with the Nevada Secretary of State on August 26, 2013 (Incorporated by reference to the Company’s Quarterly Report on Form 10-Q filed on November 13, 2017).
3.6	Series A Preferred Stock Certificate of Designation of Carbon Sciences, Inc. (Incorporated by reference to the Company’s Current Report on Form 8-K filed on February 17, 2016).
3.7	Series B Preferred Stock Certificate of Designation of Carbon Sciences, Inc. (Incorporated by reference to the Company’s Current Report on Form 8-K filed on March 4, 2016).
3.8	Certificate of Correction, filed with the Nevada Secretary of State on April 1, 2016 (Incorporated by reference to the Company’s Quarterly Report on Form 10-Q filed on May 16, 2016)
3.9	Certificate of Change, filed with the Nevada Secretary of State on April 14, 2016 (Incorporated by reference to the Company’s Quarterly Report on Form 10-Q filed on May 16, 2016).
3.10	Certificate of Amendment to Articles of Incorporation, filed with the Nevada Secretary of State on June 15, 2016 (Incorporated by reference to the Company’s Annual Report on Form 10-K filed on March 21, 2017)
3.11	Withdrawal of Series A Certificate of Designation of Carbon Sciences, Inc. (Incorporated by reference to the Company’s Current Report on Form 8-K filed on September 7, 2017).

40

3.12	Series A Certificate of Designation of Carbon Sciences, Inc. (Incorporated by reference to the Company’s Current Report on Form 8-K filed on September 7, 2017).
3.13	Certificate of Amendment to Articles of Incorporation, filed with the Nevada Secretary of State on November 16, 2017 (Incorporated by reference to the Company’s Current Report on Form 8-K filed on November 24, 2017)
3.14	Bylaws of Carbon Sciences, Inc. (Incorporated by reference to the Company’s Registration Statement on Form SB-2 filed on July 27, 2007).
3.15	Certificate of Designation of Series C Convertible Preferred Stock of Digital Locations, Inc. filed with the Nevada Secretary of State on November 30, 2 018 (Incorporated by reference to the Company’s Current Report on Form 8-K filed on December 3, 2018)
3.16	Certificate of Designation of Series D Convertible Preferred Stock of Digital Locations, Inc. filed with the Nevada Secretary of State on November 27, 2019 (Incorporated by reference to the Company’s Current Report on Form 8-K filed on December 3, 2019)
3.17	Certificate of Amendment to Articles of Incorporation, filed with the Nevada Secretary of State on February 13, 2020 (Incorporated by reference to the Company’s Current Report on Form 8-K filed on February 20, 2020).
4.1	Form of Warrant issued in connection with Stock Purchase Agreement entered into between the Company and the Purchasers, signatory thereto. (Incorporated by reference to the Company’s Registration Statement on S-1 filed on November 7, 2011)
10.1	Carbon Sciences, Inc. 2011 Equity Incentive Plan. (Incorporated by reference to the Company’s Registration Statement on S-1 filed on November 7, 2011)
10.2	Consulting Agreement between Carbon Sciences, Inc. and William E. Beifuss, Jr., dated May 31, 2013. (Incorporated by reference to the Company’s Annual Report on Form 10-K for the year ended December 31, 2013 filed on March 31, 2014)
10.3	Stock Option Agreement between Carbon Sciences, Inc. and Byron Elton, dated September 23, 2013. (Incorporated by reference to the Company’s Quarterly Report on Form 10-Q filed on November 13, 2017)
10.4	Stock Option Agreement between Carbon Sciences, Inc. and William Beifuss, Jr., dated September 23, 2013. (Incorporated by reference to the Company’s Quarterly Report on Form 10-Q filed on November 13, 2017)
10.5	Form of Promissory Note. (Incorporated by reference to the Company’s Current Report on Form 8-K filed on December 19, 2017)
10.6	Nonstatutory Stock Option Agreement, dated as of November 30, 2018, between Digital Locations, Inc. and Derek Jones (Incorporated by reference to the Company’s Current Report on Form 8-K filed on December 3, 2018)

41

10.7	Convertible Promissory Note, dated May 24, 2019, between Digital Locations, Inc. and Power Up Lending Group Ltd. (Incorporated by reference to the Company’s Annual Report on Form 10-K filed on April 14, 2020)
10.8	Convertible Promissory Note, dated June 27, 2019, between Digital Locations, Inc. and Power Up Lending Group Ltd. (Incorporated by reference to the Company’s Annual Report on Form 10-K filed on April 14, 2020)
10.9	Convertible Promissory Note, dated August 13, 2019, between Digital Locations, Inc. and Power Up Lending Group Ltd. (Incorporated by reference to the Company’s Annual Report on Form 10-K filed on April 14, 2020)
10.10	Convertible Promissory Note, dated January 25, 2019, between Digital Locations, Inc. and Crown Bridge Partners, LLC (Incorporated by reference to the Company’s Annual Report on Form 10-K filed on April 14, 2020)
10.11	Convertible Promissory Note, dated May 23, 2019, between Digital Locations, Inc. and Crown Bridge Partners, LLC (Incorporated by reference to the Company’s Annual Report on Form 10-K filed on April 14, 2020)
10.12	Convertible Promissory Note, dated May 23, 2019, between Digital Locations, Inc. and Crown Bridge Partners, LLC (Incorporated by reference to the Company’s Annual Report on Form 10-K filed on April 14, 2020)
10.13	Convertible Promissory Note, dated August 29, 2019, between Digital Locations, Inc. and Crown Bridge Partners, LLC (Incorporated by reference to the Company’s Annual Report on Form 10-K filed on April 14, 2020)
10.14	Convertible Promissory Note, dated March 16, 2020, between Digital Locations, Inc. and Geneva Roth Remark Holdings, Inc. (Incorporated by reference to the Company’s Quarterly Report on Form 10-Q filed on August 13, 2020)
10.15	Convertible Promissory Note, dated June 22, 2020, between Digital Locations, Inc. and Geneva Roth Remark Holdings, Inc. (Incorporated by reference to the Company’s Quarterly Report on Form 10-Q filed on August 13, 2020)
10.16	Convertible Promissory Note, dated July 7, 2020, between Digital Locations, Inc. and Geneva Roth Remark Holdings, Inc. (Incorporated by reference to the Company’s Current Report on Form 8-K filed on August 25, 2020)
10.17	Convertible Promissory Note, dated July 8, 2020, between Digital Locations, Inc. and Crown Bridge Partners, LLC (Incorporated by reference to the Company’s Current Report on Form 8-K filed on August 25, 2020)
10.18	Convertible Promissory Note, dated August 18, 2020, between Digital Locations, Inc. and Geneva Roth Remark Holdings, Inc. (Incorporated by reference to the Company’s Current Report on Form 8-K filed on August 25, 2020)
10.19*	Convertible Promissory Note, dated October 1, 2020, between Digital Locations, Inc. and Geneva Roth Remark Holdings, Inc.
10.20*	Convertible Promissory Note, dated November 9, 2020, between Digital Locations, Inc. and Geneva Roth Remark Holdings, Inc.

42

31.1*	Certification of the Chief Executive Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*	Certification of the Acting Chief Financial Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1*	Certification of the Chief Executive Officer furnished pursuant to Section 1350 of Chapter 63 of 18 U.S.C. as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2*	Certification of the Acting Chief Financial Officer furnished pursuant to Section 1350 of Chapter 63 of 18 U.S.C. as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
EX-101.INS	XBRL INSTANCE DOCUMENT
EX-101.SCH	XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
EX-101.CAL	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
EX-101.DEF	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
EX-101.LAB	XBRL TAXONOMY EXTENSION LABELS LINKBASE
EX-101.PRE	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE

*Filed herewith

43

SIGNATURES

In accordance with Section 13 or 15(d) of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Santa Barbara, State of California, on November 13, 2020.

DIGITAL LOCATIONS, INC.
By:	/s/ William E. Beifuss, Jr.
	Chief Executive Officer
	(Principal Executive Officer)
	Acting Chief Financial Officer
	(Principal Financial/Accounting Officer)

44

EX-10.19

EXHIBIT 10.19

 

 

 

 

 

 

 

 

 

 

 

 

 

EX-10.20

EXHIBIT 10.20

 

 

 

 

 

 

 

 

 

 

 

 

 

EX-31.1

EXHIBIT 31.1

CERTIFICATION

I, William E. Beifuss, Jr., certify that:

1.	I have reviewed this quarterly report on Form 10-Q of Digital Locations, Inc. for the quarter ended September 30, 2020;
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.	The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.	Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.	Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a.	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b.	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

November 13, 2020

/s/ William E. Beifuss, Jr.

William E. Beifuss, Jr.

Chief Executive Officer
(Principal Executive Officer)

EX-31.2

EXHIBIT 31.2

CERTIFICATION

I, William E. Beifuss, Jr., certify that:

1.	I have reviewed this quarterly report on Form 10-Q of Digital Locations, Inc. for the quarter ended September 30, 2020;
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.	The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.	Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.	Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a.	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b.	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

November 13, 2020

/s/ William E. Beifuss, Jr.

William E. Beifuss, Jr.

Acting Chief Financial Officer

(Principal Financial/Accounting Officer)

EX-32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Digital Locations, Inc. (the “Company”) on Form 10-Q for the quarter ended September 30, 2020 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, William E. Beifuss, Jr., Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)	The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities and Exchange Act of 1934; and
(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

November 13, 2020	/s/ William E. Beifuss, Jr.
	William E. Beifuss, Jr.
	Chief Executive Officer (Principal Executive Officer)

EX-32.2

EXHIBIT 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Digital Locations, Inc. (the “Company”) on Form 10-Q for the quarter ended September 30, 2020 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, William E. Beifuss, Jr., Acting Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)	The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities and Exchange Act of 1934; and
(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

November 13, 2020	/s/ William E. Beifuss, Jr.
	William E. Beifuss, Jr.
	Acting Chief Financial Officer
	(Principal Financial/Accounting Officer)

XML

Cover - shares	9 Months Ended
	Sep. 30, 2020	Nov. 13, 2020
Cover [Abstract]
Entity Registrant Name	Digital Locations, Inc.
Entity Central Index Key	0001407878
Document Type	10-Q
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Small Business	true
Entity Shell Company	false
Entity Emerging Growth Company	false
Entity Current Reporting Status	Yes
Document Period End Date	Sep. 30, 2020
Entity Filer Category	Non-accelerated Filer
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2020
Entity Common Stock Shares Outstanding		128,626,450
Document Quarterly Report	true
Document Transition Report	false
Entity Interactive Data Current	Yes

XML

Condensed Balance Sheets - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Current assets:
Cash	$ 35,637	$ 8,275
Prepaid expenses	0	2,808
Total current assets	35,637	11,083
Property and equipment, net	109	595
Operating lease right to use	0	7,708
Total assets	35,746	19,386
Current liabilities:
Accounts payable	218,049	126,478
Accrued expenses and other current liabilities	10,899	3,332
Accrued interest, notes payable	756,523	581,610
Operating lease liability	0	7,708
Derivative liabilities	6,423,060	6,160,895
PPP loan payable	9,501	0
Convertible note payable, in default	29,500	29,500
Convertible notes payable - related parties ($25,980 in default)	58,600	58,600
Convertible notes payable ($395 in default at September 30, 2020), net of discount of $119,412 and $258,518, respectively	2,467,374	2,378,405
Total current liabilities	9,973,506	9,346,528
Total liabilities	9,973,506	9,346,528
Stockholders' deficit:
Common stock, $0.001 par value; 2,000,000,000 shares authorized, 123,331,517 and 1,049,380 shares issued and outstanding at September 30, 2020 and December 31, 2019, respectively	123,332	1,049
Additional paid-in capital	26,501,422	25,937,634
Accumulated deficit	(36,562,529)	(35,265,842)
Total stockholders' deficit	(9,937,760)	(9,327,142)
Total liabilities and stockholders' deficit	35,746	19,386
Preferred Stock Series B [Member]
Stockholders' deficit:
Preferred stock value	15	16
Preferred Stock Series D [Member]
Stockholders' deficit:
Preferred stock value	$ 0	$ 1

XML

Condensed Balance Sheets (Parenthetical) - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Current liabilities
Convertible notes payable - related parties	$ 25,980
Convertible notes payable, net of discount	119,412	$ 258,518
Convertible note payable, in default	$ 395
Stockholders' deficit
Preferred stock, shares par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	20,000,000	20,000,000
Common stock, shares par value	$ 0.001	$ 0.001
Common stock, shares authorized	2,000,000,000	2,000,000,000
Common stock, shares issued	123,331,517	1,049,380
Common stock, shares outstanding	123,331,517	1,049,380
Preferred Stock Series B [Member]
Stockholders' deficit
Preferred stock, shares par value	$ 0.001	$ 0.001
Preferred Stock Shares Issued	15,055	16,155
Preferred Stock Shares Outstanding	15,055	16,155
Preferred Stock Series D [Member]
Stockholders' deficit
Preferred Stock Shares Issued	0	1,000
Preferred Stock Shares Outstanding	0	1,000

XML

Condensed Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Condensed Statements of Operations (Unaudited)
Revenues	$ 0	$ 0	$ 0	$ 0
Operating expenses:
General and administrative	77,250	91,153	249,836	287,580
Depreciation and amortization	162	(1)	486	359
Bad debt expense	0	356,851	0	356,851
Total operating expenses	77,412	448,003	250,322	644,790
Loss from operations	(77,412)	(448,003)	(250,322)	(644,790)
Other income (expense):
Interest expense	(142,803)	(246,490)	(490,448)	(727,290)
Gain (loss) on change in derivative liabilities	270,671	300,750	(555,917)	3,904,122
Total other income (expense)	127,868	54,260	(1,046,365)	3,176,832
Income (loss) from continuing operations before income taxes	50,456	(393,743)	(1,296,687)	2,532,042
Provision for income taxes	0	0	0	0
Income (loss) from continuing operations net of income taxes	50,456	(393,743)	(1,296,687)	2,532,042
Loss from discontinued operations, net of income taxes	0	(64,315)	0	(269,693)
Net income (loss)	$ 50,456	$ (458,058)	$ (1,296,687)	$ 2,262,349
Weighted average number of shares outstanding:
Basic	102,068,248	404,229	41,829,022	272,022
Diluted	5,800,706,942	404,229	41,829,022	16,445,029
Net income (loss) from continuing operations per common share:
Basic	$ 0.00	$ (0.97)	$ (0.03)	$ 9.31
Diluted	0.00	(0.97)	(0.03)	0.15
Net income (loss) from discontinued operations per common share:
Basic	0.00	(0.16)	(0.00)	(0.99)
Diluted	0.00	(0.16)	(0.00)	(0.99)
Total net income (loss) per common share:
Basic	0.00	(1.13)	(0.03)	8.32
Diluted	$ 0.00	$ (1.13)	$ (0.03)	$ 0.14

XML

Condensed Statement of Stockholders' Deficit (Unaudited) - USD ($)	Total	Series C Preferred Stock [Member]	Series B Preferred Stock [Member]	Series D Preferred Stock [Member]	Common Stock	Additional Paid-In Capital	Retained Earnings (Accumulated Deficit)
Balance, shares at Dec. 31, 2018		36,000	16,155		181,111
Balance, amount at Dec. 31, 2018	$ (12,673,490)	$ 36	$ 16	$ 0	$ 181	$ 25,533,544	$ (38,207,267)
Issuance of common stock for conversion of notes payable and accrued interest payable, shares					333,080
Issuance of common stock for conversion of notes payable and accrued interest payable, amount	134,476	$ 0	$ 0	$ 0	$ 333	134,476	0
Settlement of derivative liabilities	143,692	$ 0	$ 0	$ 0	$ 0	143,692	0
Return and cancellation of Series C preferred stock, shares		(36,000)
Return and cancellation of Series C preferred stock, amount	0	$ (36)	$ 0	$ 0	$ 0	36	0
Close out EllisLab Corp. equity accounts	316,985	0	0	0	0	316,985	0
Net income	2,262,349	$ 0	$ 0	$ 0	$ 0	0	2,262,349
Balance, shares at Sep. 30, 2019			16,155		326,476
Balance, amount at Sep. 30, 2019	$ (9,815,655)	$ 0	$ 16	$ 0	$ 514	26,128,733	(35,944,918)
Balance, shares at Dec. 31, 2019	1,049,380		16,155	1,000	1,049,380
Balance, amount at Dec. 31, 2019	$ (9,327,142)	$ 0	$ 16	$ 1	$ 1,049	25,937,634	(35,265,842)
Issuance of common stock for conversion of notes payable and accrued interest payable, shares					112,501,754
Issuance of common stock for conversion of notes payable and accrued interest payable, amount	256,551	$ 0	$ 0	$ 0	$ 112,502	144,049	0
Settlement of derivative liabilities	429,518	0	0	0	0	429,518	0
Net income	(1,296,687)	$ 0	$ 0	$ 0	$ 0	0	(1,296,687)
Issuance of common stock for conversion of Series B preferred stock, shares			(1,100)		9,777,778
Issuance of common stock for conversion of Series B preferred stock, amount	0	$ 0	$ (1)	$ 0	$ 9,778	(9,777)	0
Reverse split rounding of shares, shares					2,605
Reverse split rounding of shares, amount	0	$ 0	$ 0	$ 0	$ 3	(3)	0
Redemption of Series D preferred stock, shares				(1,000)
Redemption of Series D preferred stock, amount	$ 0	$ 0	$ 0	$ (1)	$ 0	1	0
Balance, shares at Sep. 30, 2020	123,331,517		15,055		123,331,517
Balance, amount at Sep. 30, 2020	$ (9,937,760)	$ 0	$ 15	$ 0	$ 123,332	$ 26,501,422	$ (36,562,529)

XML

Condensed Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Cash flows from operating activities:
Net income (loss)	$ (1,296,687)	$ 2,262,349
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization	486	360
Amortization of debt discount to interest expense	291,872	544,686
(Gain) loss on change in derivative liabilities	555,917	(3,904,122)
Bad debt expense	0	356,851
Changes in assets and liabilities:
(Increase) decrease in prepaid expenses	2,808	(9,231)
Increase (decrease) in: Accounts payable	91,571	18,585
Accrued expenses	18,317	2,326
Accrued interest, notes payable	198,577	182,604
Change in net assets of discontinued operations	0	10,843
Net cash used in operating activities	(137,139)	(534,749)
Cash flows from investing activities	0	0
Cash flows from financing activities:
Proceeds from convertible notes payable	155,000	517,000
Proceeds from PPP loan	9,501	0
Net cash provided by financing activities	164,501	517,000
Net increase (decrease) in cash	27,362	(17,749)
Cash, beginning of period	8,275	19,232
Cash, end of period	35,637	1,483
Supplemental Disclosure:
Cash paid for income taxes	0	0
Cash paid for interest	0	0
Non-cash financing and investing activities:
Debt discount for derivative liabilities	135,766	517,000
Common shares issued in conversion of debt	256,551	134,476
Common shares issued in conversion of Series B preferred shares	1	0
Reverse split rounding of shares	3	0
Redemption of Series D preferred stock	1	0
Settlement of derivative liabilities	429,518	143,692
Increase in other assets and operating lease liability	$ 0	$ 18,352

XML

ORGANIZATION AND BASIS OF PRESENTATION

9 Months Ended

Sep. 30, 2020

ORGANIZATION AND BASIS OF PRESENTATION

1. ORGANIZATION AND BASIS OF PRESENTATION

Organization

Digital Locations, Inc. (the “Company”) was incorporated in the State of Nevada on August 25, 2006 as Zingerang, Inc. On April 2, 2007, the Company changed its name to Carbon Sciences, Inc. and on November 14, 2017, the Company changed its name to Digital Locations, Inc.

On November 30, 2018, the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) pursuant to which EllisLab, Inc., an S Corporation owned 100% by Rick Ellis, merged with and into EllisLab Corp., a newly formed subsidiary of the Company (the “Merger”). EllisLab, Inc. builds software for web professionals and provides related support services.

On September 30, 2019, the Company, entered into an Agreement for the Purchase and Sale of Capital Stock of EllisLab Corp. (the “EllisLab Corp. Sale Agreement”) with Rick Ellis to sell to Rick Ellis all of the issued and outstanding shares of EllisLab Corp. for $10,000 and the 36,000 shares of the Company’s Series C preferred stock acquired by Rick Ellis in the Merger, which represents all of the issued and outstanding shares of the Series C preferred stock. In connection with the EllisLab Corp. Sale Agreement, the covenant not to compete and the lockup of stock consideration entered into in connection with the Merger were terminated and the parties’ obligations thereunder were released. Pursuant to the Ellis Lab Corp. Sale Agreement, the Company effectively divested itself of the Ellis Lab business and discontinued it.

Consequently, the revenues and expenses for EllisLab Corp. are reported as “Loss from discontinued operations, net of income taxes” in our condensed statements of operations for the three months and nine months ended September 30, 2019. The EllisLab Corp. assets and liabilities have been retroactively reclassified as assets and liabilities of discontinued operations. See Note 3. All significant intercompany accounts and transactions have been eliminated.

In November 2019, the Company announced its plan to focus its resources on developing a portfolio of cell tower sites to help meet the expected demand of rapidly growing 5G networks. The Company’s goal is to become a “landlord” of tomorrow’s wireless communications assets.

Effective February 14, 2020, the Company effected a reverse split of its common stock at a ratio of one for two hundred twenty-five shares (1:225) (the “Stock Split”) with the filing of a Certificate of Amendment to its Articles of Incorporation with the Secretary of State of Nevada. The Company has given retroactive effect for the Stock Split in its financial statements and notes thereto for all periods presented.

Basis of Presentation

The accompanying unaudited condensed financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all normal recurring adjustments considered necessary for a fair presentation have been included. Operating results for the three months and nine months ended September 30, 2020 are not necessarily indicative of the results that may be expected for the year ending December 31, 2020. For further information refer to the financial statements and notes thereto included in the Company’s Form 10-K for the year ended December 31, 2019.

Going Concern

The accompanying financial statements are prepared using accounting principles generally accepted in the United States of America applicable to a going concern, which contemplate the realization of assets and liquidation of liabilities in the normal course of business. As of September 30, 2020, our current liabilities exceeded our current assets by $9,937,869 and we had a total stockholders’ deficit of $9,937,760. In addition, subsequent to the EllisLab Corp. Sale Agreement which closed on September 30, 2019, the Company does not have any sources of revenues, and has reported negative cash flows from operations since inception. The Company currently does not have the cash resources to meet its operating commitments for the next twelve months and expects to have ongoing requirements for capital investment to implement its business plan. These factors, among others, raise substantial doubt that the Company will be able to continue as a going concern for a reasonable period of time.

The ability of the Company to continue as a going concern is dependent upon, among other things, raising additional capital. The Company has obtained operating funds primarily from the issuance of convertible debt. Management believes this funding will continue and will provide the additional cash needed to meet the Company’s obligations as they become due. There can be no assurance, however, that the Company will be successful in accomplishing its objectives. Without such additional capital we may be required to cease operations. The accompanying financial statements do not include any adjustments that might result should the Company be unable to continue as a going concern.

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

9 Months Ended

Sep. 30, 2020

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

The significant accounting policies of the Company are disclosed in Note 2 to the Notes to Financial Statements included in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on April 14, 2020. The following summary of significant accounting policies of the Company is presented to assist in understanding the Company’s interim financial statements. The financial statements and notes are representations of the Company’s management, which is responsible for their integrity and objectivity. These accounting policies conform to accounting principles generally accepted in the United States of America and have been consistently applied in the preparation of the financial statements.

Use of Estimates

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the accompanying financial statements. Significant estimates made in preparing these financial statements include the estimate of useful lives of property and equipment and intangible assets, operating lease obligations, impairment of assets, the deferred tax valuation allowance, the fair value of stock options and derivative liabilities. Actual results could differ from those estimates.

Property and Equipment

The Company’s property and equipment is stated at cost, and is depreciated using the straight-line method over the estimated useful life of the related asset as follows:

Computer equipment	3-5 years
Office furniture and equipment	7 years

Maintenance and repairs are charged to expense as incurred. Significant renewals and betterments will be capitalized. At the time of retirement or other disposition of equipment, the cost and accumulated depreciation will be removed from the accounts and the resulting gain or loss, if any, will be reflected in operations.

The Company assesses the recoverability of property and equipment by determining whether the depreciation and amortization of these assets over their remaining life can be recovered through projected undiscounted future cash flows. The amount of equipment impairment, if any, will be measured based on fair value and is charged to operations in the period in which such impairment is determined by management.

Derivative Liabilities

We have identified the conversion features of our convertible notes payable and Series B preferred stock and certain stock options and warrants as derivatives. Where the number of common shares to be issued under these agreements is indeterminate, the Company has concluded that the equity environment is tainted, and all additional options, warrants and convertible debt and equity are included in the value of the derivatives. We estimate the fair value of the derivatives using the Black-Scholes pricing model and a multinomial lattice model based on projections of various potential future outcomes. We estimate the fair value of the derivative liabilities at the inception of the financial instruments, at the date of conversions to equity and at each reporting date, recording a derivative liability, debt discount, additional paid-in capital and a gain or loss on change in derivative liabilities as applicable. These estimates are based on multiple inputs, including the market price of our stock, interest rates, our stock price volatility, variable conversion prices based on market prices as defined in the respective agreements and probabilities of certain outcomes based on management projections. These inputs are subject to significant changes from period to period and to management’s judgment; therefore, the estimated fair value of the derivative liabilities will fluctuate from period to period, and the fluctuation may be material.

Fair Value of Financial Instruments

Disclosures about fair value of financial instruments, require disclosure of the fair value information, whether or not recognized in the balance sheet, where it is practicable to estimate that value. As of September 30, 2020 and December 31, 2019, we believe the amounts reported for cash, prepaid expenses, accounts payable, accrued expenses and other current liabilities, accrued interest - notes payable and convertible notes payable approximate fair value because of their short maturities.

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASC”) Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include:

• Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;

• Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

• Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

We measure certain financial instruments at fair value on a recurring basis. Liabilities measured at fair value on a recurring basis are as follows at September 30, 2020 and December 31, 2019:

	Total		Level 1		Level 2		Level 3
September 30, 2020:
Derivative liabilities	$	6,423,060	$	-	$	-	$	6,423,060
Total liabilities measured at fair value	$	6,423,060	$	-	$	-	$	6,423,060
December 31, 2019:
Derivative liabilities	$	6,160,895	$	-	$	-	$	6,160,895
Total liabilities measured at fair value	$	6,160,895	$	-	$	-	$	6,160,895

During the nine months ended September 30, 2020, the Company had the following activity in its derivative liabilities account:

	Convertible Notes Payable			Series B Preferred Stock			Stock Options			Total
Derivative liabilities at December 31, 2019	$	3,606,194		$	2,535,359		$	19,342		$	6,160,895
Addition to liabilities for new debt/shares issued		135,766			-			-			135,766
Elimination of liabilities for debt conversions		(194,663	)		(234,855	)		-			(429,518	)
Change in fair value		(239,466	)		812,674			(17,291	)		555,917
Derivative liabilities at September 30, 2020	$	3,307,831		$	3,113,178		$	2,051		$	6,423,060

Revenue Recognition

On January 1, 2018, we adopted Accounting Standards Update No. 2014-09, “Revenue from Contracts with Customers” (Topic 606), which supersedes the revenue recognition requirements in Accounting Standards Codification (ASC) Topic 605, “Revenue Recognition” (Topic 605). The Company had no operating revenues prior to the Merger. Effective December 1, 2018, the Company’s revenues, included in loss from discontinued operations, were derived primarily from the sale of monthly and annual tech support subscriptions and partnership fees, and from software applications that customers purchase via the Company’s online store. Sales were processed using a real-time payment processing company. Revenue from product sales is recorded net of processing costs.

Under Topic 606, revenue is recognized when control of the promised goods or services is transferred to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services.

We determine revenue recognition through the following steps:

· identification of the contract, or contracts, with a customer;

· identification of the performance obligations in the contract;

· determination of the transaction price;

· allocation of the transaction price to the performance obligations in the contract; and

· recognition of revenue when, or as, we satisfy a performance obligation.

Amounts collected from customers for support subscriptions and partnership fees with a contract life of one month or greater are recorded as deferred revenue and recognized over the life of the contract.

Subsequent to the EllisLab Corp. Sale Agreement, which closed on September 30, 2019, the Company does not have any sources of revenues.

Income (Loss) per Share

Basic net income or loss per common share is computed by dividing net income or loss by the weighted average number of common shares outstanding. Diluted net income or loss per common share is computed by dividing net income or loss by the sum of the weighted average number of common shares outstanding and the dilutive potential common share equivalents then outstanding. Potential dilutive common share equivalents consist of shares issuable upon the exercise of outstanding stock options and warrants to acquire common stock, using the treasury stock method and the average market price per share during the period, and shares issuable upon exercise of convertible notes payable and convertible preferred stock.

Basic weighted average number common shares outstanding are reconciled to diluted weighted average number of common shares outstanding as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2020		2019		2020		2019
Basic weighted average number of shares		102,068,248		404,229		41,829,022		272,022
Dilutive effect of:
Series B preferred stock		5,018,333,333		-		-		3,263,636
Convertible notes payable		680,305,361		-		-		12,909,371
Diluted weighted average number of shares		5,800,706,942		404,229		41,829,022		16,445,029

Operating Lease

On September 5, 2017, we entered into an operating sublease for office space. The base rent for the sublease is $1,000 per month for a period of one year and month-to-month thereafter.

On January 1, 2019, we adopted Financial Accounting Standards Board (“FASB”) ASC 842, “Leases.” ASC 842 requires recognition of assets and liabilities for the rights and obligations created by leases and new disclosures about leases. We adopted ASC 842 using the optional modified retrospective transition method. Under this transition method, we did not recast the prior period financial statements presented.

The adoption of ASC 842 resulted in the measurement and recognition of an operating lease liability and corresponding right-of use asset (included in other assets) in the amount of $18,352 as of January 1, 2019. The operating lease liability was measured as the present value of assumed remaining lease payments using an estimated incremental borrowing rate. We amortize the right-of-use asset over the term of the lease. The right-of-use asset was fully amortized as of September 30, 2020.

Recently Issued Accounting Pronouncements

There were no new accounting pronouncements issued by the FASB during the nine months ended September 30, 2020 and through the date of filing of this report that the Company believes will have a material impact on its financial statements.

Reclassifications

Certain amounts in the condensed financial statements for the prior year periods have been reclassified to conform to the presentation for the current year periods.

XML

MERGER AND SUBSEQUENT SALE

9 Months Ended

Sep. 30, 2020

MERGER AND SUBSEQUENT SALE

NOTE 3 - MERGER AND SUBSEQUENT SALE

On November 30, 2018, the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) with the EllisLab, Inc., Rick Ellis (“Ellis”), and EllisLab Corp., a newly formed Nevada corporation and wholly owned subsidiary of the Company, pursuant to which EllisLab, Inc. merged with and into EllisLab Corp. (the “Merger”). Pursuant to the terms of the Merger Agreement, Ellis received 36,000 shares of the Company’s newly designated Series C Convertible Preferred Stock, with a stated value of $100 per share, in exchange for the cancellation of all common shares of EllisLab, Inc. owned by Ellis, which shares represented 100% of the issued and outstanding capital stock of EllisLab, Inc. The separate legal existence of EllisLab, Inc. ceased, and EllisLab Corp. became the surviving company. The acquisition of EllisLab, Inc. in the Merger has been accounted for as a purchase, and the accounts of EllisLab Corp. were consolidated with those of the Company as of December 1, 2018.

On September 30, 2019, the Company, entered into an Agreement for the Purchase and Sale of Capital Stock of EllisLab Corp. (the “EllisLab Corp. Sale Agreement”) with Ellis to sell to Ellis all of the issued and outstanding shares of EllisLab Corp. for $10,000 and the 36,000 shares of the Company’s Series C Convertible Preferred Stock owned by him, which represents all of the issued and outstanding shares of the Series C Convertible Preferred Stock. Pursuant to the Ellis Lab Corp. Sale Agreement, the Company effectively divested itself of the Ellis Lab business and discontinued it. Consequently, the revenues and expenses for EllisLab Corp. are reported as “Loss from discontinued operations, net of income taxes” in our condensed statements of operations for the three months and nine months ended September 30, 2019. When presented, the EllisLab Corp. assets and liabilities have been retroactively reclassified as assets and liabilities of discontinued operations.

XML

PROPERTY AND EQUIPMENT

9 Months Ended

Sep. 30, 2020

PROPERTY AND EQUIPMENT

NOTE 4 - PROPERTY AND EQUIPMENT

Property and equipment consisted of the following:

	September 30, 2020			December 31, 2019
Computer equipment	$	12,303		$	12,303
Office furniture and equipment		1,459			1,459
Total		13,762			13,762
Less accumulated depreciation		(13,653	)		(13,167	)
Net	$	109		$	595

Depreciation expense was $162 and $(1) for the three months ended September 30, 2020 and 2019, respectively and $486 and $359 for the nine months ended September 30, 2020 and 2019, respectively.

XML

CONVERTIBLE NOTES PAYABLE

9 Months Ended

Sep. 30, 2020

CONVERTIBLE NOTES PAYABLE

5. CONVERTIBLE NOTES PAYABLE

Convertible Promissory Note of $29,500 in Default

On March 14, 2013, we entered into an agreement to issue a 5% convertible promissory note in the principal amount of $29,500, which is convertible into shares of our common stock at a conversion price equal to the lesser of $1.50 per share or the closing price per share of common stock recorded on the trading day immediately preceding the date of conversion. The note, with a principal balance of $29,500 at September 30, 2020 and December 31, 2019, matured on March 14, 2015, and is currently in default.

Convertible Promissory Notes – Related Parties of $58,600

On December 31, 2012, we issued 5% convertible promissory notes to two employees in exchange for services rendered in the aggregate amount of $58,600. The notes are convertible into shares of our common stock at a conversion price equal to the lesser of $2.00 per share or the closing price per share of common stock recorded on the trading day immediately preceding the date of conversion. We recorded a total debt discount of $57,050 related to the conversion feature of the notes, which has been fully amortized to interest expense, along with a derivative liability at inception. One of the notes with a principal balance of $25,980 at September 30, 2020, matured on December 31, 2014 and is currently in default. The maturity date of a second note with a principal balance of $32,620 at September 30, 2020 has been extended to December 31, 2020.

March 2016 Convertible Promissory Note – $1,000,000

On March 4, 2016, we entered into an agreement to issue a 10% convertible promissory note in the aggregate principal amount of up to $1,000,000 (the “March 2016 $1,000,000 CPN”). The lender may advance the Company consideration for the note in such amounts as the lender may choose in its sole discretion. The note is convertible into shares of our common stock at a price per share equal to the lesser of: $0.03; 50% of the lowest trade price of our common stock subsequent to the effective date of the note; or the lowest effective price per share granted to any person or entity (exclusive of our officers and directors) to acquire common stock subsequent to the effective date of the note. The note initially matured, with respect to each advance, one year from the effective date of each advance. Subsequently, the lender extended the maturity date, with the note payable upon demand, but in no event later than 60 months from March 4, 2016.

On March 14, 2016, we received proceeds of $27,000 pursuant to the March 2016 $1,000,000 CPN. We recorded a debt discount of $27,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense. During the nine months ended September 30, 2020, we issued the lender a total of 4,175,861 shares of our common stock in consideration for the conversion of principal of $5,445 and accrued interest of $2,213, repaying the debt in full. No gain or loss was recorded since the conversions were completed within the terms of the note agreement.

On March 17, 2016, we received proceeds of $33,000 pursuant to the March 2016 $1,000,000 CPN. We recorded a debt discount of $33,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense. During the nine months ended September 30, 2020, we issued the lender a total of 10,332,228 shares of our common stock in consideration for the conversion of principal of $13,109 and accrued interest of $5,839, resulting in a principal balance of $19,891 as of September 30, 2020. No gain or loss was recorded since the conversions were completed within the terms of the note agreement.

On April 11, 2016, we received proceeds of $90,000 pursuant to the March 2016 $1,000,000 CPN. We recorded a debt discount of $90,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On May 20, 2016, we received proceeds of $60,000 pursuant to the March 2016 $1,000,000 CPN. We recorded a debt discount of $60,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On June 22, 2016, we received proceeds of $50,000 pursuant to the March 2016 $1,000,000 CPN. We recorded a debt discount of $50,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On July 6, 2016, we received proceeds of $87,000 pursuant to the March 2016 $1,000,000 CPN. We recorded a debt discount of $87,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On August 8, 2016, we received proceeds of $60,000 pursuant to the March 2016 $1,000,000 CPN. We recorded a debt discount of $60,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On September 13, 2016, we received proceeds of $55,000 pursuant to the March 2016 $1,000,000 CPN. We recorded a debt discount of $55,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On October 17, 2016, we received proceeds of $55,000 pursuant to the March 2016 $1,000,000 CPN. We recorded a debt discount of $55,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On November 8, 2016, we received proceeds of $55,000 pursuant to the March 2016 $1,000,000 CPN. We recorded a debt discount of $55,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On December 6, 2016, we received proceeds of $60,000 pursuant to the March 2016 $1,000,000 CPN. We recorded a debt discount of $60,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On January 10, 2017, we received proceeds of $60,000 pursuant to the March 2016 $1,000,000 CPN. We recorded a debt discount of $60,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On February 13, 2017, we received proceeds of $60,000 pursuant to the March 2016 $1,000,000 CPN. We recorded a debt discount of $60,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On March 9, 2017, we received proceeds of $60,000 pursuant to the March 2016 $1,000,000 CPN. We recorded a debt discount of $60,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On April 12, 2017, we received proceeds of $95,000 pursuant to the March 2016 $1,000,000 CPN. We recorded a debt discount of $95,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On May 8, 2017, we received proceeds of $60,000 pursuant to the March 2016 $1,000,000 CPN. We recorded a debt discount of $60,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

June 2017 Convertible Promissory Note – $500,000

On June 2, 2017, we entered into an agreement to issue a 10% convertible promissory note in the aggregate principal amount of up to $500,000 (the “June 2017 $500,000 CPN”). The lender may advance the Company consideration for the note in such amounts as the lender may choose in its sole discretion. The note is convertible into shares of our common stock at a price per share equal to the lesser of: $0.03; 50% of the lowest trade price of our common stock subsequent to the effective date of the note; or the lowest effective price per share granted to any person or entity (exclusive of our officers and directors) to acquire common stock subsequent to the effective date of the note. The note initially matured, with respect to each advance, one year from the effective date of each advance. Subsequently, the lender extended the maturity date, with the note payable upon demand, but in no event later than 60 months from June 2, 2017.

On June 2, 2017, we received proceeds of $60,000 pursuant to the June 2017 $500,000 CPN. We recorded a debt discount of $60,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On July 10, 2017, we received proceeds of $80,000 pursuant to the June 2017 $500,000 CPN. We recorded a debt discount of $80,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On August 11, 2017, we received proceeds of $80,000 pursuant to the June 2017 $500,000 CPN. We recorded a debt discount of $80,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On September 12, 2017, we received proceeds of $85,000 pursuant to the June 2017 $500,000 CPN. We recorded a debt discount of $85,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On October 13, 2017, we received proceeds of $80,000 pursuant to the June 2017 $500,000 CPN. We recorded a debt discount of $80,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On November 8, 2017, we received proceeds of $75,000 pursuant to the June 2017 $500,000 CPN. We recorded a debt discount of $75,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

December 2017 Convertible Promissory Note – $500,000

On December 14, 2017, we entered into an agreement to issue a 10% convertible promissory note in the aggregate principal amount of up to $500,000 (the “December 2017 $500,000 CPN”). The lender may advance the Company consideration for the note in such amounts as the lender may choose in its sole discretion. The note is convertible into shares of our common stock at a price per share equal to the lesser of: $0.03; 50% of the lowest trade price of our common stock subsequent to the effective date of the note; or the lowest effective price per share granted to any person or entity (exclusive of our officers and directors) to acquire common stock subsequent to the effective date of the note. The note initially matured, with respect to each advance, one year from the effective date of each advance. Subsequently, the lender extended the maturity date, with the note payable upon demand, but in no event later than 60 months from December 14, 2017.

On December 14, 2017, we received proceeds of $60,000 pursuant to the December 2017 $500,000 CPN. We recorded a debt discount of $60,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On January 11, 2018, we received proceeds of $70,000 pursuant to the December 2017 $500,000 CPN. We recorded a debt discount of $70,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On February 7, 2018, we received proceeds of $60,000 pursuant to the December 2017 $500,000 CPN. We recorded a debt discount of $60,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On March 8, 2018, we received proceeds of $55,000 pursuant to the December 2017 $500,000 CPN. We recorded a debt discount of $55,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On March 14, 2018, we received proceeds of $6,500 pursuant to the December 2017 $500,000 CPN. We recorded a debt discount of $6,500 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On April 9, 2018, we received proceeds of $77,000 pursuant to the December 2017 $500,000 CPN. We recorded a debt discount of $77,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On May 7, 2018, we received proceeds of $60,000 pursuant to the December 2017 $500,000 CPN. We recorded a debt discount of $60,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On June 7, 2018, we received proceeds of $52,000 pursuant to the December 2017 $500,000 CPN. We recorded a debt discount of $52,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On July 10, 2018, we received proceeds of $35,000 pursuant to the December 2017 $500,000 CPN. We recorded a debt discount of $35,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On August 16, 2018, we received proceeds of $24,500 pursuant to the December 2017 $500,000 CPN. We recorded a debt discount of $24,500 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

August 2018 Convertible Promissory Note – $500,000

On August 17, 2018, we entered into an agreement to issue a 10% convertible promissory note in the aggregate principal amount of up to $500,000 (the “August 2018 $500,000 CPN”). The lender may advance the Company consideration for the note in such amounts as the lender may choose in its sole discretion. The note is convertible into shares of our common stock at a price per share equal to the lesser of: $0.01; 50% of the lowest trade price of our common stock subsequent to the effective date of the note; or the lowest effective price per share granted to any person or entity (exclusive of our officers and directors) to acquire common stock subsequent to the effective date of the note. The note matures, with respect to each advance, one year from the effective date of each advance. Subsequently, the lender extended the maturity date, with the note payable upon demand, but in no event later than 60 months from August 17, 2018.

On August 17, 2018, we received proceeds of $10,500 pursuant to the August 2018 $500,000 CPN. We recorded a debt discount of $10,500 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On September 13, 2018, we received proceeds of $30,000 pursuant to the August 2018 $500,000 CPN. We recorded a debt discount of $30,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On October 8, 2018, we received proceeds of $25,000 pursuant to the August 2018 $500,000 CPN. We recorded a debt discount of $25,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On October 26, 2018, we received proceeds of $12,000 pursuant to the August 2018 $500,000 CPN. We recorded a debt discount of $12,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On November 5, 2018, we received proceeds of $25,000 pursuant to the August 2018 $500,000 CPN. We recorded a debt discount of $25,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On November 28, 2018, we received proceeds of $30,000 pursuant to the August 2018 $500,000 CPN. We recorded a debt discount of $30,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On November 30, 2018, we received proceeds of $10,000 pursuant to the August 2018 $500,000 CPN. We recorded a debt discount of $10,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On December 24, 2018, we received proceeds of $50,000 pursuant to the August 2018 $500,000 CPN. We recorded a debt discount of $50,000 related to the conversion feature of the note, along with a derivative liability at inception. The debt discount has been fully amortized to interest expense.

On January 17, 2019, we received proceeds of $25,000 pursuant to the August 2018 $500,000 CPN. We recorded a debt discount of $25,000 related to the conversion feature of the note, along with a derivative liability at inception. During the nine months ended September 30, 2020, amortization of debt discount was recorded to interest expense in the amount of $1,164 and the debt discount has been fully amortized to interest expense.

On February 25, 2019, we received proceeds of $25,000 pursuant to the August 2018 $500,000 CPN. We recorded a debt discount of $25,000 related to the conversion feature of the note, along with a derivative liability at inception. During the nine months ended September 30, 2020, amortization of debt discount was recorded to interest expense in the amount of $3,836 and the debt discount has been fully amortized to interest expense.

On March 22, 2019, we received proceeds of $25,000 pursuant to the August 2018 $500,000 CPN. We recorded a debt discount of $25,000 related to the conversion feature of the note, along with a derivative liability at inception. During the nine months ended September 30, 2020, amortization of debt discount was recorded to interest expense in the amount of $5,601 and the debt discount has been fully amortized to interest expense.

On March 26, 2019, we received proceeds of $15,000 pursuant to the August 2018 $500,000 CPN. We recorded a debt discount of $15,000 related to the conversion feature of the note, along with a derivative liability at inception. During the nine months ended September 30, 2020, amortization of debt discount was recorded to interest expense in the amount of $3,525 and the debt discount has been fully amortized to interest expense.

On April 11, 2019, we received proceeds of $15,000 pursuant to the August 2018 $500,000 CPN. We recorded a debt discount of $15,000 related to the conversion feature of the note, along with a derivative liability at inception. During the nine months ended September 30, 2020, amortization of debt discount was recorded to interest expense in the amount of $4,180 and the debt discount has been fully amortized to interest expense.

On April 19, 2019, we received proceeds of $65,000 pursuant to the August 2018 $500,000 CPN. We recorded a debt discount of $65,000 related to the conversion feature of the note, along with a derivative liability at inception. During the nine months ended September 30, 2020, amortization of debt discount was recorded to interest expense in the amount of $19,536 and the debt discount has been fully amortized to interest expense.

On June 28, 2019, we received proceeds of $30,000 pursuant to the August 2018 $500,000 CPN. We recorded a debt discount of $30,000 related to the conversion feature of the note, along with a derivative liability at inception. During the nine months ended September 30, 2020, amortization of debt discount was recorded to interest expense in the amount of $14,754 and the debt discount has been fully amortized to interest expense.

On July 29, 2019, we received proceeds of $40,000 pursuant to the August 2018 $500,000 CPN. We recorded a debt discount of $40,000 related to the conversion feature of the note, along with a derivative liability at inception. During the nine months ended September 30, 2020, amortization of debt discount was recorded to interest expense in the amount of $23,060 and the debt discount has been fully amortized to interest expense.

On September 27, 2019, we received proceeds of $33,000 pursuant to the August 2018 $500,000 CPN. We recorded a debt discount of $33,000 related to the conversion feature of the note, along with a derivative liability at inception. During the nine months ended September 30, 2020, amortization of debt discount was recorded to interest expense in the amount of $24,434 and the debt discount has been fully amortized to interest expense.

On October 8, 2019, we received proceeds of $25,000 pursuant to the August 2018 $500,000 CPN. We recorded a debt discount of $25,000 related to the conversion feature of the note, along with a derivative liability at inception. During the nine months ended September 30, 2020, amortization of debt discount was recorded to interest expense in the amount of $18,716, resulting in a remaining debt discount of $546 as of September 30, 2020.

October 2019 Convertible Promissory Note – $500,000

On October 31, 2019, we entered into an agreement to issue a 10% convertible promissory note in the aggregate principal amount of up to $500,000 (the “October 2019 $500,000 CPN”). The lender may advance the Company consideration for the note in such amounts as the lender may choose in its sole discretion. The note is convertible into shares of our common stock at a price per share equal to the lesser of: $0.01; 50% of the lowest trade price of our common stock subsequent to the effective date of the note; or the lowest effective price per share granted to any person or entity (exclusive of our officers and directors) to acquire common stock subsequent to the effective date of the note. The note matures, with respect to each advance, one year from the effective date of each advance.

On October 31, 2019, we received proceeds of $25,000 pursuant to the October 2019 $500,000 CPN. We recorded a debt discount of $25,000 related to the conversion feature of the note, along with a derivative liability at inception. During the nine months ended September 30, 2020, amortization of debt discount was recorded to interest expense in the amount of $18,716, resulting in a remaining debt discount of $2,117 as of September 30, 2020.

On November 12, 2019, we received proceeds of $25,000 pursuant to the October 2019 $500,000 CPN. We recorded a debt discount of $25,000 related to the conversion feature of the note, along with a derivative liability at inception. During the nine months ended September 30, 2020, amortization of debt discount was recorded to interest expense in the amount of $18,716, resulting in a remaining debt discount of $2,937 as of September 30, 2020.

On December 19, 2019, we received proceeds of $25,000 pursuant to the October 2019 $500,000 CPN. We recorded a debt discount of $25,000 related to the conversion feature of the note, along with a derivative liability at inception. During the nine months ended September 30, 2020, amortization of debt discount was recorded to interest expense in the amount of $18,716, resulting in a remaining debt discount of $5,464 as of September 30, 2020.

January 25, 2019 Convertible Promissory Note – $38,000

Effective January 25, 2019, the Company entered into an agreement to issue a 10% convertible note with an institutional investor in the principal amount of $38,000, which matured on January 25, 2020. The Company received proceeds of $35,000 after an original issue discount of $1,500 and payment of $1,500 in legal fees. The lender, at its option, may convert the unpaid principal balance of, and accrued interest on, the note into shares of the Company’s common stock at a 39% discount from the lowest trading price during the 15 days prior to conversion. The Company may prepay the note during the 180 days from the issuance of the note at redemption premiums ranging from 25% to 45%. After the expiration of 180 days after issuance, the Company has no right of prepayment. We recorded a debt discount of $38,000 related to the conversion feature of the note, along with a derivative liability at inception. During the nine months ended September 30, 2020, amortization of debt discount was recorded to interest expense in the amount of $1,415 and the debt discount has been fully amortized to interest expense. During the nine months ended September 30, 2020, we issued the lender a total of 12,855,132 shares of our common stock in consideration for the conversion of principal of $22,378, accrued interest of $3,800 and fees of $2,000, repaying the debt in full. No gain or loss was recorded since the conversions were completed within the terms of the note agreement.

May 23, 2019 Convertible Promissory Note – $33,000

Effective May 23, 2019, the Company entered into an agreement to issue a 10% convertible note with an institutional investor in the principal amount of $33,000. The note matured on May 23, 2020. The Company received proceeds of $30,000 after an original issue discount of $1,750 and payment of $1,250 in legal fees. The lender, at its option, may convert the unpaid principal balance of, and accrued interest on, the note into shares of the Company’s common stock at a 50% discount from the lowest trading price during the 25 days prior to conversion. The Company may prepay the note during the 180 days from the issuance of the note at redemption premiums ranging from 25% to 45%. After the expiration of 180 days after issuance, the Company has no right of prepayment. We recorded a debt discount of $33,000 related to the conversion feature of the note, along with a derivative liability at inception. During the nine months ended September 30, 2020, amortization of debt discount was recorded to interest expense in the amount of $12,984 and the debt discount has been fully amortized to interest expense. During the nine months ended September 30, 2020, we issued the lender a total of 22,057,971 shares of our common stock in consideration for the conversion of principal of $33,000, accrued interest of $3,300 and fees of $1,750, repaying the debt in full. No gain or loss was recorded since the conversions were completed within the terms of the note agreement.

May 24, 2019 Convertible Promissory Note – $33,000

Effective May 24, 2019, the Company entered into an agreement to issue a 10% convertible note with an institutional investor in the principal amount of $33,000. The note matured on May 24, 2020. On January 16, 2020, the note was assigned to another institutional investor. The Company received proceeds of $30,000 after payment of $3,000 of the fees and expenses of the lender and its counsel. The lender, at its option after 180 days from the issuance of the note, may convert the unpaid principal balance of, and accrued interest on, the note into shares of the Company’s common stock at a 39% discount from the lowest trading price during the 15 days prior to conversion. The Company may prepay the note during the 180 days from the issuance of the note at redemption premiums ranging from 20% to 45%. After the expiration of 180 days after issuance, the Company has no right of prepayment. We recorded a debt discount of $33,000 related to the conversion feature of the note, along with a derivative liability at inception. During the nine months ended September 30, 2020, amortization of debt discount was recorded to interest expense in the amount of $7,764 and the debt discount has been fully amortized to interest expense. During the nine months ended September 30, 2020, we issued the lender a total of 6,720,530 shares of our common stock in consideration for the conversion of principal of $19,600 and accrued interest of $1,650, repaying the debt in full. No gain or loss was recorded since the conversions were completed within the terms of the note agreement.

June 27, 2019 Convertible Promissory Note – $33,000

Effective June 27, 2019, the Company entered into an agreement to issue a 10% convertible note with an institutional investor in the principal amount of $33,000. The note matured on June 27, 2020. On January 16, 2020, the note was assigned to another institutional investor. The Company received proceeds of $30,000 after payment of $3,000 of the fees and expenses of the lender and its counsel. The lender, at its option after 180 days from the issuance of the note, may convert the unpaid principal balance of, and accrued interest on, the note into shares of the Company’s common stock at a 39% discount from the lowest trading price during the 15 days prior to conversion. The Company may prepay the note during the 180 days from the issuance of the note at redemption premiums ranging from 20% to 45%. After the expiration of 180 days after issuance, the Company has no right of prepayment. We recorded a debt discount of $33,000 related to the conversion feature of the note, along with a derivative liability at inception. During the nine months ended September 30, 2020, amortization of debt discount was recorded to interest expense in the amount of $16,139 and the debt discount has been fully amortized to interest expense. During the nine months ended September 30, 2020, we issued the lender a total of 16,207,380 shares of our common stock in consideration for the conversion of principal of $33,000 and accrued interest of $1,650, repaying the debt in full. No gain or loss was recorded since the conversions were completed within the terms of the note agreement.

August 13, 2019 Convertible Promissory Note – $33,000

Effective August 13, 2019, the Company entered into an agreement to issue a 10% convertible note with an institutional investor in the principal amount of $33,000. The note matures on August 13, 2020. On January 16, 2020, the note was assigned to another institutional investor. The Company received proceeds of $30,000 after payment of $3,000 of the fees and expenses of the lender and its counsel. The lender, at its option after 180 days from the issuance of the note, may convert the unpaid principal balance of, and accrued interest on, the note into shares of the Company’s common stock at a 39% discount from the lowest trading price during the 15 days prior to conversion. The Company may prepay the note during the 180 days from the issuance of the note at redemption premiums ranging from 20% to 45%. After the expiration of 180 days after issuance, the Company has no right of prepayment. We recorded a debt discount of $33,000 related to the conversion feature of the note, along with a derivative liability at inception. During the nine months ended September 30, 2020, amortization of debt discount was recorded to interest expense in the amount of $20,377 and the debt discount has been fully amortized to interest expense. During the nine months ended September 30, 2020, we issued the lender a total of 16,747,584 shares of our common stock in consideration for the conversion of principal of $33,000 and accrued interest of $2,932, repaying the debt in full. No gain or loss was recorded since the conversions were completed within the terms of the note agreement.

August 29, 2019 Convertible Promissory Note – $25,000

Effective August 29, 2019, the Company entered into an agreement to issue a 10% convertible note with an institutional investor in the principal amount of $25,000. The note matures on August 29, 2020. The Company received proceeds of $22,000 after an original issue discount of $1,500 and payment of $1,500 in legal fees. The lender, at its option, may convert the unpaid principal balance of, and accrued interest on, the note into shares of the Company’s common stock at a 50% discount from the lowest trading price during the 25 days prior to conversion. The Company may prepay the note during the 180 days from the issuance of the note at redemption premiums ranging from 25% to 45%. After the expiration of 180 days after issuance, the Company has no right of prepayment. We recorded a debt discount of $25,000 related to the conversion feature of the note, along with a derivative liability at inception. During the nine months ended September 30, 2020, amortization of debt discount was recorded to interest expense in the amount of $13,820 and the debt discount has been fully amortized to interest expense. During the nine months ended September 30, 2020, we issued the lender a total of 17,022,000 shares of our common stock in consideration for the conversion of principal of $24,605 and conversion fees of $7,000, resulting in a principal balance of $395 as of September 30, 2020. No gain or loss was recorded since the conversions were completed within the terms of the note agreement.

March 16, 2020 Convertible Promissory Note – $38,000

Effective March 16, 2020, the Company entered into a 12% convertible note with an institutional investor in the principal amount of $38,000. The note matures March 16, 2021. The Company received net proceeds of $35,000 after payment of $3,000 in legal fees and fees to the lender. The lender, at its option after 180 days from the issuance of the note, may convert the unpaid principal balance of, and accrued interest on, the note into shares of the Company’s common stock at a 45% discount from the lowest trading price during the 20 trading days prior to conversion. The Company may prepay the note during the 180 days from the issuance of the note at a redemption premium of 150%. After the expiration of 180 days after issuance, the Company has no right of prepayment. We recorded a debt discount of $18,766 related to the conversion feature of the note, along with a derivative liability at inception. During the nine months ended September 30, 2020, amortization of debt discount was recorded to interest expense in the amount of $18,766 and the debt discount has been fully amortized to interest expense. During the nine months ended September 30, 2020, we issued the lender a total of 6,383,068 shares of our common stock in consideration for the conversion of principal of $38,000 and accrued interest of $2,280, repaying the debt in full. No gain or loss was recorded since the conversions were completed within the terms of the note agreement.

June 22, 2020 Convertible Promissory Note – $28,000

Effective June 22, 2020, the Company entered into a 12% convertible note with an institutional investor in the principal amount of $28,000. The note matures June 22, 2021. The Company received net proceeds of $25,000 after payment of $3,000 in legal fees and fees to the lender. The lender, at its option after 180 days from the issuance of the note, may convert the unpaid principal balance of, and accrued interest on, the note into shares of the Company’s common stock at a 45% discount from the lowest trading price during the 20 trading days prior to conversion. The Company may prepay the note during the 180 days from the issuance of the note at a redemption premium of 150%. After the expiration of 180 days after issuance, the Company has no right of prepayment. We recorded a debt discount of $28,000 related to the conversion feature of the note, along with a derivative liability at inception. During the nine months ended September 30, 2020, amortization of debt discount was recorded to interest expense in the amount of $7,671, resulting in a remaining debt discount of $20,329 as of September 30, 2020. The note had a principal balance of $28,000 as of September 30, 2020.

July 7, 2020 Convertible Promissory Note – $33,000

Effective July 7, 2020, the Company entered into a 12% convertible note with an institutional investor in the principal amount of $33,000. The note matures July 7, 2021. The Company received net proceeds of $30,000 after payment of $3,000 in legal fees and fees to the lender. The lender, at its option after 180 days from the issuance of the note, may convert the unpaid principal balance of, and accrued interest on, the note into shares of the Company’s common stock at a 45% discount from the lowest trading price during the 20 trading days prior to conversion. The Company may prepay the note during the 180 days from the issuance of the note at a redemption premium of 150%. After the expiration of 180 days after issuance, the Company has no right of prepayment. We recorded a debt discount of $33,000 related to the conversion feature of the note, along with a derivative liability at inception. During the nine months ended September 30, 2020, amortization of debt discount was recorded to interest expense in the amount of $6,521, resulting in a remaining debt discount of $26,479 as of September 30, 2020. The note had a principal balance of $33,000 as of September 30, 2020.

July 8, 2020 Convertible Promissory Note – $40,000

Effective July 8, 2020, the Company entered into an agreement to issue a 10% convertible note with an institutional investor in the principal amount of $40,000. The note matures on July 8, 2021 and the Company has no right of prepayment. The Company received proceeds of $35,000 after an original issue discount of $2,200 and payment of $2,800 in legal fees. The lender, at its option, may convert the unpaid principal balance of, and accrued interest on, the note into shares of the Company’s common stock at a 50% discount from the lowest trading price during the 25 days prior to conversion. After the expiration of 180 days after issuance, the Company has no right of prepayment. We recorded a debt discount of $40,000 related to the conversion feature of the note, along with a derivative liability at inception. During the nine months ended September 30, 2020, amortization of debt discount was recorded to interest expense in the amount of $7,574, resulting in a remaining debt discount of $32,426 as of September 30, 2020. The note had a principal balance of $40,000 as of September 30, 2020.

August 18, 2020 Convertible Promissory Note – $33,000

Effective August 18, 2020, the Company entered into a 12% convertible note with an institutional investor in the principal amount of $33,000. The note matures August 18, 2021. The Company received net proceeds of $30,000 after payment of $3,000 in legal fees and fees to the lender. The lender, at its option after 180 days from the issuance of the note, may convert the unpaid principal balance of, and accrued interest on, the note into shares of the Company’s common stock at a 45% discount from the lowest trading price during the 20 trading days prior to conversion. The Company may prepay the note during the 180 days from the issuance of the note at a redemption premium of 150%. After the expiration of 180 days after issuance, the Company has no right of prepayment. We recorded a debt discount of $33,000 related to the conversion feature of the note, along with a derivative liability at inception. During the nine months ended September 30, 2020, amortization of debt discount was recorded to interest expense in the amount of $3,888, resulting in a remaining debt discount of $29,112 as of September 30, 2020. The note had a principal balance of $33,000 as of September 30, 2020.

Total accrued interest payable on notes payable was $756,523 and $581,610 as of September 30, 2020 and December 31, 2019, respectively.

XML

PPP LOAN PAYABLE

9 Months Ended

Sep. 30, 2020

PPP LOAN PAYABLE

6. PPP LOAN PAYABLE

A loan to the Company in the principal amount of $9,501 was approved under the terms and conditions of the Paycheck Protection Program of the United States Small Business Administration (“SBA”) and the CARES Act (2020) (H.R. 748) (15 U.S.C. 636 et seq.) (the “Act”) and was funded in May 2020. The loan may be forgiven pursuant to the provisions of the Act.

XML

CAPITAL STOCK

9 Months Ended

Sep. 30, 2020

CAPITAL STOCK

7. CAPITAL STOCK

At September 30, 2020, the Company’s authorized stock consisted of 2,000,000,000 shares of common stock, with a par value of $0.001 per share. The Company is also authorized to issue 20,000,000 shares of preferred stock, with a par value of $0.001 per share. The rights, preferences and privileges of the holders of the preferred stock will be determined by the Board of Directors prior to issuance of such shares.

Series B Preferred Stock

On March 2, 2016, the Company filed a Certificate of Designation for its Series B Preferred Stock (the “Series B Certificate”) with the Secretary of State of Nevada designating 30,000 shares of its authorized preferred stock as Series B Preferred Stock. The shares of Series B Preferred Stock have a par value of $0.001 per share.

The total face value of this entire series is three million dollars ($3,000,000). Each share of Series B Preferred Stock has a stated face value of One Hundred Dollars ($100) (“Share Value”) and is convertible into shares of fully paid and non-assessable shares of common stock of the Company.

As of September 30, 2020 and December 31, 2019, the Company had 15,055 and 16,155 shares of Series B Preferred Stock outstanding, respectively, with a face value of $1,505,500 and $1,615,500, respectively. These shares were issued in March 2016 for the redemption and cancellation of $1,615,362 of convertible promissory notes and $264,530 of accrued interest payable. Effective February 26, 2020, William Beifuss, Jr., the Company’s President, converted 1,100 shares of Series B preferred stock into 9,777,778 shares of the Company’s common stock. Mr. Beifuss previously acquired the Series B shares from a lender in a private transaction.

The holders of outstanding shares of the Series B Preferred Stock (the “Series B Holders”) are entitled to receive dividends pari passu with the holders of Common Stock, except upon a liquidation, dissolution and winding up of the Company, in which case the Series B Preferred Stock has a preference. Such dividends will be paid equally to all outstanding shares of Series B Preferred Stock and Common Stock, on an as-if-converted basis with respect to the Series B Preferred Stock. The Series B Holders may elect to use the most favorable conversion price for the purpose of determining the as-if-converted number of shares.

In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, the Series B Holder shall be entitled to receive, out of the assets of the Company available for distribution to its shareholders upon such liquidation, whether such assets are capital or surplus of any nature, an amount equal to one hundred dollars ($100) for each such share of the Series B Preferred Stock (as adjusted for any combinations, consolidations, stock distributions, stock splits or stock dividends with respect to such shares), plus all dividends, if any, declared and unpaid thereon as of the date of such distribution, before any payment is made or any assets distributed to the holders of the Common Stock. After such payment, the remaining assets of the Company will be distributed to the holders of Common Stock.

If the assets to be distributed to the Series B Holders are insufficient to permit the receipt by such Holders of the full preferential amounts, then all of such assets will be distributed among such Holders ratably in accordance with the number of such shares then held by each such Holder.

The sale of all or substantially all of the Company’s assets, any consolidation or merger of the Company with or into any other entity or person, or any other corporate reorganization, in which the stockholders of the Company immediately prior to such consolidation, merger or reorganization, own less than fifty percent (50%) of the Company’s voting power immediately after such consolidation, merger or reorganization, or any transaction or series of related transactions to which the Company is a party in which in excess of fifty percent (50%) of the Company’s voting power is transferred, excluding any consolidation or merger effected exclusively to change the domicile of the Company, is deemed to be a liquidation, dissolution or winding up.

The Series B Preferred Stock is convertible into Common Stock.

The Series B Holder has the right, at any time, at its election, to convert all or part of the Share Value into shares of Common Stock. The conversion price is the lesser of (1) Fifty Percent (50%) of the lowest trade price of Common Stock recorded on any trade day after December 12, 2012 or (2) the lowest effective price per share granted to any person or entity, including the Series B Holder but excluding officers and directors of the Company, to acquire Common Stock, or adjusted, whether by operation of purchase price adjustment, settlement agreements, exchange agreements, reset provision, floating conversion or otherwise, any outstanding warrant, option or other right to acquire Common Stock or outstanding Common Stock equivalents (the “Conversion Price”).

The conversion formula is as follows: The number of shares receivable upon conversion equals the Share Value divided by the Conversion Price. A conversion notice (the “Conversion Notice”) may be delivered to Company by any method of the Series B Holder’s choice (including but not limited to email, facsimile, mail, overnight courier, or personal delivery), and all conversions will be cashless and not require further payment from the Holder. If no objection is delivered from the Company to the Series B Holder, with respect to any variable or calculation reflected in the Conversion Notice, within 24 hours of delivery of the Conversion Notice, the Company will thereafter be deemed to have irrevocably confirmed and ratified such notice of conversion and waived any objection. The Company will deliver the shares of Common Stock from any conversion to the Series B Holder (in any name directed by the Series B Holder) within three (3) business days of Conversion Notice delivery. If the Company is participating in the Depository Trust Company (“DTC”) Fast Automated Securities Transfer (“FAST”) program, then upon request of the Holder and provided that the shares to be issued are eligible for transfer under Rule 144 of the Securities Act of 1933, as amended (the “Securities Act”), or are effectively registered under the Securities Act, the Company will cause its transfer agent to electronically issue the Common Stock issuable upon conversion to the Holder through the DTC Direct Registration System (“DRS”). If the Company is not participating in the DTC FAST program, then the Company agrees in good faith to apply and cause the approval for participation in the DTC FAST program.

The Conversion Price is subject to equitable adjustments for stock splits, stock dividends or rights offerings by the Company relating to the Company’s securities or the securities of any subsidiary of the Company, combinations, recapitalization, reclassifications, extraordinary distributions and similar events. No fractional shares of the Common Stock shall be issuable upon the conversion of shares of the Series B Preferred Stock and the Company shall pay the cash equivalent of any fractional share upon such conversion.

If the Company fails to deliver shares in accordance with the required time frame, then for each conversion, a penalty of $1,500 per day will be assessed for each day after the third business day (inclusive of the day of the conversion) until share delivery is made. Such penalty may be converted into Common Stock at the Conversion Price or payable in cash, at the sole option of the Series B Holder (under the Holder’s and the Company’s expectations that any penalty amounts shall tack back to the original date of the issuance of Series B Preferred Stock, consistent with applicable securities laws).

In no event will the Series B Holder be entitled to convert any Series B Preferred Stock, such that upon conversion the sum of (1) the number of shares of Common Stock beneficially owned by the Holder and its affiliates (other than shares of Common Stock which may be deemed beneficially owned through the ownership of the unconverted portion of this Series B Preferred Stock or the unexercised or unconverted portion of any other security of the Company subject to a limitation on conversion or exercise analogous to these limitations), and (2) the number of shares of Common Stock issuable upon the conversion of Series B Preferred Stock, would result in beneficial ownership by the Holder and its affiliates of more than 4.99% of the outstanding shares of Common Stock. The limitations on conversion may be waived by the Holder upon, at the election of the Series B Holder, not less than 61 days prior notice to the Company, and the provisions of the conversion limitation shall continue to apply until such 61st day (or such later date, as determined by the Series B Holder, as may be specified in such notice of waiver).

Except as required by law, the Series B Holders are not entitled to vote, as a separate class or otherwise, on any matter presented to the stockholders of the Company for their action or consideration at any meeting of stockholders of the Company (or by written consent of stockholders in lieu of meeting). Each Holder of outstanding shares of Series B Preferred Stock will be entitled, on the same basis as holders of Common Stock, to receive notice of such action or meeting.

So long as any shares of the Series B Preferred Stock remain outstanding, the Company will not, without first obtaining the approval (by vote or written consent, as provided by law) of the holders of at least a majority of the then outstanding shares of Series B Preferred Stock voting together as one class: (a) alter or change the rights, preferences or privileges of the shares of the Series B Preferred Stock so as to affect materially and adversely such shares; or (b) create any new class of shares having preference over the Series B Preferred Stock.

The Series B Holder has the right, at its sole discretion, to elect a fixed conversion price for the Series B Preferred Stock. The Fixed Conversion Price may not be lower than the Conversion Price. The Company will not, by amendment of its Certificate of Incorporation, bylaws or through any reorganization, transfer of assets, consolidation, merger, scheme of arrangement, dissolution, issue or sale of securities, or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of the Series B Certificate, and will at all times carry out all the provisions of the Series B Certificate.

Series C Preferred Stock

In November 2018, the Company filed a Certificate of Designation for its Series C Preferred Stock (the “Series C Certificate”) with the Secretary of State of Nevada designating 36,000 shares of its authorized preferred stock as Series C Preferred Stock. The shares of Series C Preferred Stock have a par value of $0.001 per share. The total face value of this entire series is three million six hundred thousand dollars ($3,600,000). Each share of Series C Preferred Stock has a stated face value of One Hundred Dollars ($100) (“Share Value”) and is convertible into shares of fully paid and non-assessable shares of common stock of the Company.

As discussed in Note 3, the Company issued 36,000 shares of Series C Preferred Stock to the owner of the common stock of EllisLab, Inc. in the Merger, which shares were surrendered and cancelled on September 30, 2019 pursuant to the sale of EllisLab Corp.

The holders of outstanding shares of the Series C Preferred Stock (the “Series C Holders”) shall be entitled to receive dividends pari passu (on a pro rata basis) with the holders of Series B Preferred Stock and Common Stock, except upon a liquidation, dissolution and winding up of the Company. Such dividends shall be paid equally to all outstanding shares of Series C Preferred Stock, Series B Preferred Stock and common stock, on an as-if-converted basis with respect to the Series C Preferred Stock and Series B Preferred Stock.

In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, the Holder of each outstanding share of the Series C Preferred Stock shall be entitled to receive, on a pro rata basis with the outstanding Series B Preferred Stock, out of the assets of the Company available for distribution to its shareholders upon such liquidation, whether such assets are capital or surplus of any nature, an amount equal to one hundred dollars ($100.00) for each such share of the Series C Preferred Stock (as adjusted for any combinations. consolidations, stock distributions, stock splits or stock dividends with respect to such shares), plus all dividends, if any, declared and unpaid thereon as of the date of such distribution, before any payment shall be made or any assets distributed to the holders of common stock, and, after such payment, the remaining assets of the Company shall be distributed to the holders of common stock.

Each share of Series C Preferred Stock is convertible into twenty thousand (20,000) shares of the Company’s fully paid and nonassessable shares of common stock, as adjusted. The Series C Preferred Stock have the respective rights, privileges and designations as are set forth in the Certificate of Designations, Preferences, Rights and Limitations of Series C Preferred Stock appended hereto as Exhibit 4.1. The Series C Preferred Stock contains a blocker that prevents the Holder from converting the Series C Preferred Stock if such exercise would result in beneficial ownership of more than 4.99% of the outstanding shares of the Company’s stock, without at least 61 days of prior notice. Under the Series C Preferred Stock, the Holder is also subject to the Rule 144 restrictions of an affiliate.

Except as required by law or as specifically provided in the Certificate of Designation, the Series C Holders shall not be entitled to vote, as a separate class or otherwise, on any matter presented to the stockholders of the Company for their action or consideration at any meeting of stockholders of the Company (or by written consent of stockholders in lieu of meeting); provided, however, that each Series C Holder shall be entitled, on the same basis as holders of Common Stock, to receive notice of such action or meeting.

Series D Preferred Stock

On November 27, 2019, the Company filed a Certificate of Designation for its Series D Preferred Stock (the “Series D Certificate”) with the Secretary of State of Nevada which designates 1,000 shares of the Company’s preferred stock par value $0.001 per share as Series D Preferred Stock. William E. Beifuss, Jr., the Company’s President and Chief Executive Officer, was issued 1,000 shares of Series D Preferred Stock valued at $15,000 by an independent valuation firm, which shares were outstanding as of December 31, 2019. The 1,000 shares of Series D preferred stock were automatically redeemed on January 11, 2020, 45 days after the effective date of the Series D Certificate.

Pursuant to the terms of the Designation, holders of Series D Preferred Stock shall not be entitled to dividends or a liquidation preference and shall have no conversion rights. For so long as any shares of the Series D Preferred Stock remain issued and outstanding, the holders thereof, voting separately as a class, shall have the right to vote in an amount equal to fifty-one percent (51%) of the total voting power of the Company’s shareholders. Such vote shall be determined by the holder(s) of a majority of the then issued and outstanding shares of Series D Preferred Stock.

The shares of the Series D Preferred Stock shall be automatically, and without any required action by the Company or the holders thereof, redeemed by the Company at their par value on the first to occur of the following triggering events: (i) a date forty-five (45) days as after the Effective Date, (ii) on the date that Mr. Beifuss. ceases, for any reason, to serve as officer, director or consultant of the Company, it being understood that if Mr. Beifuss continues without interruption to serve thereafter in one or more capacities as officer, director or consultant of the Company this shall not be considered a cessation of service, or (iii) on the date that the Company’s shares of common stock first trade on any national securities exchange and such listing is conditioned upon the elimination of the preferential voting rights of the Series D Preferred Stock set forth in the Certificate of Designation

Common Stock

Effective February 14, 2020, the Company effected a reverse split of its common stock at a ratio of one for two hundred twenty-five shares (1:225) with the filing of a Certificate of Amendment to its Articles of Incorporation with the Secretary of State of Nevada. The Company has given retroactive effect for the reverse stock split in its financial statements and notes thereto for all periods presented.

As of September 30, 2020 and December 31, 2019, the Company had 123,331,517 and 1,049,380 shares of common stock issued and outstanding, respectively.

During the nine months ended September 30, 2020, the Company issued a total of 122,279,532 shares of common stock: 112,501,754 shares for the conversion of $222,137 of principal of convertible notes payable, accrued interest payable of $23,664, and fees of $10,750; 9,777,778 shares for the conversion of 1,100 shares of Series B preferred stock recorded at par value; and 2,605 shares for the rounding of shares in the February 2020 reverse stock split recorded at par value of $3. In connection with the convertible debt and Series B preferred stock conversions, the Company reduced derivative liabilities by $429,518. There was no gain or loss on settlement of debt due to the conversions occurring within the terms of the convertible notes.

During the nine months ended September 30, 2019, the Company issued a total of 333,080 shares of common stock at fair value in consideration for the conversion of $125,521 of convertible promissory notes, accrued interest payable of $9,038 and fees of $250. In connection with the debt conversions, the Company reduced derivative liabilities by $143,692. There was no gain or loss on settlement of debt due to the conversions occurring within the terms of the convertible notes.

XML

STOCK OPTIONS AND WARRANTS

9 Months Ended

Sep. 30, 2020

STOCK OPTIONS AND WARRANTS

8. STOCK OPTIONS AND WARRANTS

As of September 30, 2020, the Board of Directors of the Company had granted non-qualified stock options and warrants exercisable for a total of 177,778 shares of common stock to its employees, officers, and consultants.

We recognized no stock-based compensation expense for the three months and nine months ended September 30, 2020 and 2019.

As of September 30, 2020, we had no unrecognized stock-based compensation expense.

A summary of the Company’s stock options and warrants as of September 30, 2020, and changes during the nine months then ended is as follows:

	Shares			Weighted Average Exercise Price		Weighted Average Remaining Contract Term (Years)		Aggregate Intrinsic Value
Outstanding at December 31, 2019		184,001		$	1.544		8.65
Granted		-		$	-
Exercised		-		$	-
Forfeited or expired		(6,223	)	$	13.50
Outstanding at September 30, 2020		177,778		$	1.13		8.17	$	-

The aggregate intrinsic value in the preceding table represents the total pretax intrinsic value, based on the closing price of our common stock of $0.0095 as of September 30, 2020, which would have been received by the holders of in-the-money options and warrants had the holders exercised their options and warrants as of that date.

XML

DERIVATIVE LIABILITIES

9 Months Ended

Sep. 30, 2020

DERIVATIVE LIABILITIES

9. DERIVATIVE LIABILITIES

The fair value of the Company’s derivative liabilities is estimated at the issuance date and is revalued at each subsequent reporting date. We estimate the fair value of derivative liabilities associated with our convertible notes payable, Series B preferred stock and warrants using a multinomial lattice model based on projections of various potential future outcomes. Where the number of warrants or common shares to be issued under these agreements is indeterminate, the Company has concluded that the equity environment is tainted, and all additional warrants and convertible debt and equity are included in the value of the derivatives.

The significant assumptions used in the valuation of the derivative liabilities at September 30, 2020 are as follows:

Conversion to stock	Monthly
Stock price on the valuation date	$	0.0095
Risk free interest rates	0.00% - 2.84		%
Years to maturity	0.08 - 15.0
Expected volatility	86.6%–549.2		%

The value of our derivative liabilities was estimated as follows at:

	September 30, 2020		December 31, 2019
Convertible notes payable	$	3,307,831	$	3,606,194
Series B preferred stock		3,113,178		2,535,359
Warrants		2,051		19,342
Total	$	6,423,060	$	6,160,895

The calculation input assumptions are subject to significant changes from period to period and to management’s judgment; therefore, the estimated fair value of the derivative liability will fluctuate from period to period, and the fluctuation may be material.

XML

RELATED PARTY TRANSACTIONS

9 Months Ended

Sep. 30, 2020

RELATED PARTY TRANSACTIONS

10. RELATED PARTY TRANSACTIONS

Pursuant to a written consulting agreement, dated May 31, 2013 and amended effective November 1, 2016, William E. Beifuss, Jr., our current President, Chief Executive Officer and Acting Chief Financial Officer, is to receive fees for services of $10,000 per month. Fees payable to Mr. Beifuss of $80,000 and $10,000 are included in accounts payable as of September 30, 2020 and December 31, 2019, respectively.

As discussed in Note 7, the Company issued 36,000 shares of Series C Preferred Stock to Rick Ellis, the former Chief Executive Officer of the Company and Chief Executive Officer of EllisLab Corp., in the EllisLab Corp. Merger, which shares were surrendered and cancelled on September 30, 2019 pursuant to the EllisLab Corp. Sale Agreement.

As discussed in Note 7, in November 2019, the Company issued to Mr. Beifuss 1,000 shares of Series D Preferred Stock for services valued at $15,000 by an independent valuation firm. The shares were automatically redeemed in January 2020, 120 days after the effective date of the related Series D Preferred Stock Certificate.

As discussed in Note 7, effective February 26, 2020, Mr. Beifuss converted 1,100 shares of Series B preferred stock into 9,777,778 shares of the Company’s common stock. Mr. Beifuss previously acquired the Series B shares from a lender in a private transaction. The transaction was recorded at the par value of the common stock.

See Note 5 for discussion of convertible notes payable with related parties.

XML

COMMITMENTS AND CONTINGENCIES

9 Months Ended

Sep. 30, 2020

COMMITMENTS AND CONTINGENCIES

11. COMMITMENTS AND CONTINGENCIES

Operating Lease

On September 5, 2017, we entered into an operating sublease for office space. The base rent for the sublease is $1,000 per month for a period of one year and month-to-month thereafter. Management has assumed a three-year life for the sublease arrangement. On January 1, 2019, we adopted ASC 842, “Leases,” which resulted in the recognition of an operating lease liability and corresponding right-of use asset (“ROU”) in the amount of $18,352.

As of September 30, 2020 and December 31, 2019, the operating lease liability (recorded as a current liability) and ROU asset had a balance of $0 and $7,708, respectively.

For the three months ended September 30, 2020 and 2019, the Company recognized operating lease cost of $3,000. For the nine months ended September 30, 2020 and 2019, the Company recognized operating lease cost of $9,000.

XML

SUBSEQUENT EVENTS

9 Months Ended

Sep. 30, 2020

SUBSEQUENT EVENTS

12. SUBSEQUENT EVENTS

Management has evaluated subsequent events according to the requirements of ASC TOPIC 855, and has reported the following:

Convertible Notes

Effective October 1, 2020, the Company entered into a 12% convertible note with an institutional investor in the principal amount of $33,000. The note matures on October 1, 2021. The Company received net proceeds of $30,000 after payment of $3,000 in legal fees and other fees to the lender. The lender, at its option after 180 days from the issuance of the note, may convert the unpaid principal balance of, and accrued interest on, the note into shares of the Company’s common stock at a 45% discount from the lowest trading price during the 20 trading days prior to conversion. The Company may prepay the note during the 180 days from the issuance of the note at a redemption premium of 150%. After the expiration of 180 days after issuance, the Company has no right of prepayment.

Effective November 9, 2020, the Company entered into a 12% convertible note with an institutional investor in the principal amount of $35,000. The note matures on November 9, 2021. The Company received net proceeds of $31,500 after payment of $3,500 in legal fees and fees to the lender. The lender, at its option after 180 days from the issuance of the note, may convert the unpaid principal balance of, and accrued interest on, the note into shares of the Company’s common stock at a 45% discount from the lowest trading price during the 20 trading days prior to conversion. The Company may prepay the note during the 180 days from the issuance of the note at a redemption premium of 150%. After the expiration of 180 days after issuance, the Company has no right of prepayment.

Convertible Note Conversions

Subsequent to September 30, 2020, a lender converted a $5,440 of principal of the March 2016 $1,000,000 CPN and $2,502 of accrued interest into 5,294,933 shares of the Company’s common stock.

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)

9 Months Ended

Sep. 30, 2020

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Use of Estimates

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the accompanying financial statements. Significant estimates made in preparing these financial statements include the estimate of useful lives of property and equipment and intangible assets, operating lease obligations, impairment of assets, the deferred tax valuation allowance, the fair value of stock options and derivative liabilities. Actual results could differ from those estimates.

Property and Equipment

The Company’s property and equipment is stated at cost, and is depreciated using the straight-line method over the estimated useful life of the related asset as follows:

Computer equipment	3-5 years
Office furniture and equipment	7 years

Maintenance and repairs are charged to expense as incurred. Significant renewals and betterments will be capitalized. At the time of retirement or other disposition of equipment, the cost and accumulated depreciation will be removed from the accounts and the resulting gain or loss, if any, will be reflected in operations.

The Company assesses the recoverability of property and equipment by determining whether the depreciation and amortization of these assets over their remaining life can be recovered through projected undiscounted future cash flows. The amount of equipment impairment, if any, will be measured based on fair value and is charged to operations in the period in which such impairment is determined by management.

Derivative Liabilities

We have identified the conversion features of our convertible notes payable and Series B preferred stock and certain stock options and warrants as derivatives. Where the number of common shares to be issued under these agreements is indeterminate, the Company has concluded that the equity environment is tainted, and all additional options, warrants and convertible debt and equity are included in the value of the derivatives. We estimate the fair value of the derivatives using the Black-Scholes pricing model and a multinomial lattice model based on projections of various potential future outcomes. We estimate the fair value of the derivative liabilities at the inception of the financial instruments, at the date of conversions to equity and at each reporting date, recording a derivative liability, debt discount, additional paid-in capital and a gain or loss on change in derivative liabilities as applicable. These estimates are based on multiple inputs, including the market price of our stock, interest rates, our stock price volatility, variable conversion prices based on market prices as defined in the respective agreements and probabilities of certain outcomes based on management projections. These inputs are subject to significant changes from period to period and to management’s judgment; therefore, the estimated fair value of the derivative liabilities will fluctuate from period to period, and the fluctuation may be material.

Fair Value of Financial Instruments

Disclosures about fair value of financial instruments, require disclosure of the fair value information, whether or not recognized in the balance sheet, where it is practicable to estimate that value. As of September 30, 2020 and December 31, 2019, we believe the amounts reported for cash, prepaid expenses, accounts payable, accrued expenses and other current liabilities, accrued interest - notes payable and convertible notes payable approximate fair value because of their short maturities.

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASC”) Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include:

• Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;

• Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

• Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

We measure certain financial instruments at fair value on a recurring basis. Liabilities measured at fair value on a recurring basis are as follows at September 30, 2020 and December 31, 2019:

	Total		Level 1		Level 2		Level 3
September 30, 2020:
Derivative liabilities	$	6,423,060	$	-	$	-	$	6,423,060
Total liabilities measured at fair value	$	6,423,060	$	-	$	-	$	6,423,060
December 31, 2019:
Derivative liabilities	$	6,160,895	$	-	$	-	$	6,160,895
Total liabilities measured at fair value	$	6,160,895	$	-	$	-	$	6,160,895

During the nine months ended September 30, 2020, the Company had the following activity in its derivative liabilities account:

	Convertible Notes Payable			Series B Preferred Stock			Stock Options			Total
Derivative liabilities at December 31, 2019	$	3,606,194		$	2,535,359		$	19,342		$	6,160,895
Addition to liabilities for new debt/shares issued		135,766			-			-			135,766
Elimination of liabilities for debt conversions		(194,663	)		(234,855	)		-			(429,518	)
Change in fair value		(239,466	)		812,674			(17,291	)		555,917
Derivative liabilities at September 30, 2020	$	3,307,831		$	3,113,178		$	2,051		$	6,423,060

Revenue Recognition

On January 1, 2018, we adopted Accounting Standards Update No. 2014-09, “Revenue from Contracts with Customers” (Topic 606), which supersedes the revenue recognition requirements in Accounting Standards Codification (ASC) Topic 605, “Revenue Recognition” (Topic 605). The Company had no operating revenues prior to the Merger. Effective December 1, 2018, the Company’s revenues, included in loss from discontinued operations, were derived primarily from the sale of monthly and annual tech support subscriptions and partnership fees, and from software applications that customers purchase via the Company’s online store. Sales were processed using a real-time payment processing company. Revenue from product sales is recorded net of processing costs.

Under Topic 606, revenue is recognized when control of the promised goods or services is transferred to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services.

We determine revenue recognition through the following steps:

· identification of the contract, or contracts, with a customer;

· identification of the performance obligations in the contract;

· determination of the transaction price;

· allocation of the transaction price to the performance obligations in the contract; and

· recognition of revenue when, or as, we satisfy a performance obligation.

Amounts collected from customers for support subscriptions and partnership fees with a contract life of one month or greater are recorded as deferred revenue and recognized over the life of the contract.

Subsequent to the EllisLab Corp. Sale Agreement, which closed on September 30, 2019, the Company does not have any sources of revenues.

Income (Loss) per Share

Basic net income or loss per common share is computed by dividing net income or loss by the weighted average number of common shares outstanding. Diluted net income or loss per common share is computed by dividing net income or loss by the sum of the weighted average number of common shares outstanding and the dilutive potential common share equivalents then outstanding. Potential dilutive common share equivalents consist of shares issuable upon the exercise of outstanding stock options and warrants to acquire common stock, using the treasury stock method and the average market price per share during the period, and shares issuable upon exercise of convertible notes payable and convertible preferred stock.

Basic weighted average number common shares outstanding are reconciled to diluted weighted average number of common shares outstanding as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2020		2019		2020		2019
Basic weighted average number of shares		102,068,248		404,229		41,829,022		272,022
Dilutive effect of:
Series B preferred stock		5,018,333,333		-		-		3,263,636
Convertible notes payable		680,305,361		-		-		12,909,371
Diluted weighted average number of shares		5,800,706,942		404,229		41,829,022		16,445,029

Operating Lease

On September 5, 2017, we entered into an operating sublease for office space. The base rent for the sublease is $1,000 per month for a period of one year and month-to-month thereafter.

On January 1, 2019, we adopted Financial Accounting Standards Board (“FASB”) ASC 842, “Leases.” ASC 842 requires recognition of assets and liabilities for the rights and obligations created by leases and new disclosures about leases. We adopted ASC 842 using the optional modified retrospective transition method. Under this transition method, we did not recast the prior period financial statements presented.

The adoption of ASC 842 resulted in the measurement and recognition of an operating lease liability and corresponding right-of use asset (included in other assets) in the amount of $18,352 as of January 1, 2019. The operating lease liability was measured as the present value of assumed remaining lease payments using an estimated incremental borrowing rate. We amortize the right-of-use asset over the term of the lease. The right-of-use asset was fully amortized as of September 30, 2020.

Recently Issued Accounting Pronouncements

There were no new accounting pronouncements issued by the FASB during the nine months ended September 30, 2020 and through the date of filing of this report that the Company believes will have a material impact on its financial statements.

Reclassifications

 Certain amounts in the condensed financial statements for the prior year periods have been reclassified to conform to the presentation for the current year periods.

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

9 Months Ended

Sep. 30, 2020

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Schedule of Property and Equipment estimated useful life

Computer equipment	3-5 years
Office furniture and equipment	7 years

Schedule of fair value measured, asset and liabilities

	Total		Level 1		Level 2		Level 3
September 30, 2020:
Derivative liabilities	$	6,423,060	$	-	$	-	$	6,423,060
Total liabilities measured at fair value	$	6,423,060	$	-	$	-	$	6,423,060
December 31, 2019:
Derivative liabilities	$	6,160,895	$	-	$	-	$	6,160,895
Total liabilities measured at fair value	$	6,160,895	$	-	$	-	$	6,160,895

Schedule of derivative liabilities

	Convertible Notes Payable			Series B Preferred Stock			Stock Options			Total
Derivative liabilities at December 31, 2019	$	3,606,194		$	2,535,359		$	19,342		$	6,160,895
Addition to liabilities for new debt/shares issued		135,766			-			-			135,766
Elimination of liabilities for debt conversions		(194,663	)		(234,855	)		-			(429,518	)
Change in fair value		(239,466	)		812,674			(17,291	)		555,917
Derivative liabilities at September 30, 2020	$	3,307,831		$	3,113,178		$	2,051		$	6,423,060

Schedule of weighted average number common shares outstanding

	Three Months Ended September 30,				Nine Months Ended September 30,
	2020		2019		2020		2019
Basic weighted average number of shares		102,068,248		404,229		41,829,022		272,022
Dilutive effect of:
Series B preferred stock		5,018,333,333		-		-		3,263,636
Convertible notes payable		680,305,361		-		-		12,909,371
Diluted weighted average number of shares		5,800,706,942		404,229		41,829,022		16,445,029

XML

PROPERTY AND EQUIPMENT (Tables)

9 Months Ended

Sep. 30, 2020

PROPERTY AND EQUIPMENT

Schedule of Property and equipment

	September 30, 2020			December 31, 2019
Computer equipment	$	12,303		$	12,303
Office furniture and equipment		1,459			1,459
Total		13,762			13,762
Less accumulated depreciation		(13,653	)		(13,167	)
Net	$	109		$	595

XML

STOCK OPTIONS AND WARRANTS (Tables)

9 Months Ended

Sep. 30, 2020

STOCK OPTIONS AND WARRANTS (Tables)

Schedule of Stock Options, Activity

	Shares			Weighted Average Exercise Price		Weighted Average Remaining Contract Term (Years)		Aggregate Intrinsic Value
Outstanding at December 31, 2019		184,001		$	1.544		8.65
Granted		-		$	-
Exercised		-		$	-
Forfeited or expired		(6,223	)	$	13.50
Outstanding at September 30, 2020		177,778		$	1.13		8.17	$	-

XML

DERIVATIVE LIABILITIES (Tables)

9 Months Ended

Sep. 30, 2020

DERIVATIVE LIABILITIES

Schedule of derivative liabilities at fair value

Conversion to stock	Monthly
Stock price on the valuation date	$	0.0095
Risk free interest rates	0.00% - 2.84		%
Years to maturity	0.08 - 15.0
Expected volatility	86.6%–549.2		%

Schedule of estimated value of derivative liabilities

	September 30, 2020		December 31, 2019
Convertible notes payable	$	3,307,831	$	3,606,194
Series B preferred stock		3,113,178		2,535,359
Warrants		2,051		19,342
Total	$	6,423,060	$	6,160,895

XML

ORGANIZATION AND BASIS OF PRESENTATION (Details Narrative) - USD ($)	1 Months Ended	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2020	Dec. 31, 2019	Dec. 31, 2018	Nov. 30, 2018
Working capital deficit		$ (9,937,869)
Total stockholders' deficit	$ (9,815,655)	$ (9,937,760)	$ (9,327,142)	$ (12,673,490)
Reverse stock split		Reverse split of its common stock at a ratio of one for two hundred twenty-five shares (1:225)
Purchase and Sale Agreement[Member] | EllisLab, Inc [Member] | Series C Convertible Preferred Stock [Member]
Sale of Common stock issued and outstanding shares, amount	$ 10,000
Sale of Common stock issued and outstanding shares, shares	36,000
Merger Agreement[Member] | EllisLab, Inc [Member] | Series C Convertible Preferred Stock [Member]
Ownership percentage					100.00%

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)	9 Months Ended
	Sep. 30, 2020
Computer Equipment [Member] | Minimum [Member]
Estimated useful lives	3 years
Computer Equipment [Member] | Maximum [Member]
Estimated useful lives	5 years
Office Furniture and Equipment [Member]
Estimated useful lives	7 years

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1) - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Derivative liabilities	$ 6,423,060	$ 6,160,895
Total liabilities measured at fair value		6,160,895
Level 1 [Member]
Derivative liabilities	0	0
Total liabilities measured at fair value	0	0
Level 2 [Member]
Derivative liabilities	0	0
Total liabilities measured at fair value	0	0
Level 3 [Member]
Derivative liabilities	6,423,060	6,160,895
Total liabilities measured at fair value	$ 6,423,060	$ 6,160,895

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 2)	9 Months Ended
	Sep. 30, 2020 USD ($)
Derivative liability beginning	$ 6,160,895
Addition to liabilities for new debt/shares issued	135,766
Elimination of liability for debt conversion	(429,518)
Change in fair value	555,917
Derivative liability ending	6,423,060
Stock Options [Member]
Derivative liability beginning	19,342
Addition to liabilities for new debt/shares issued	0
Elimination of liability for debt conversion	0
Change in fair value	(17,291)
Derivative liability ending	2,051
Convertible Notes Payable [Member]
Derivative liability beginning	3,606,194
Addition to liabilities for new debt/shares issued	135,766
Elimination of liability for debt conversion	(194,663)
Change in fair value	(239,466)
Derivative liability ending	3,307,831
Preferred Stock Series B [Member]
Derivative liability beginning	2,535,359
Addition to liabilities for new debt/shares issued	0
Elimination of liability for debt conversion	(234,855)
Change in fair value	812,674
Derivative liability ending	$ 3,113,178

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 3) - shares	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Basic weighted average number of shares	102,068,248	404,229	41,829,022	272,022
Dilutive effect of:
Diluted weighted average number of shares	5,800,706,942	404,229	41,829,022	16,445,029
Convertible Notes Payable [Member]
Dilutive effect of:
Diluted weighted average number of shares	680,305,361			12,909,371
Preferred Stock Series B [Member]
Dilutive effect of:
Diluted weighted average number of shares	5,018,333,333			3,263,636

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)		1 Months Ended	9 Months Ended
	Sep. 05, 2017	Sep. 05, 2017	Sep. 30, 2020	Sep. 30, 2019
Frquency of periodic payment of rent		Monthly
Rent	$ 1,000
Increase in other assets and operating lease liability			$ 0	$ 18,352
Jan 1 2019 [Member]
Increase in other assets and operating lease liability			$ 18,352

XML

MERGER AND SUBSEQUENT SALE (Details Narrative) - EllisLab, Inc [Member] - Series C Convertible Preferred Stock [Member] - USD ($)	1 Months Ended
	Sep. 30, 2019	Nov. 30, 2018
Merger Agreement[Member]
Share price		$ 100
Business combination, consideration transferred, shares issued		36,000
Ownership percentage		100.00%
Purchase and Sale Agreement[Member]
Sale of Common stock issued and outstanding shares, shares	36,000
Sale of Common stock issued and outstanding shares, amount	$ 10,000

XML

PROPERTY AND EQUIPMENT (Details) - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Total	$ 13,762	$ 13,762
Less accumulated depreciation	(13,653)	(13,167)
Net	109	595
Computer Equipment [Member]
Total	12,303	12,303
Office Furniture and Equipment [Member]
Total	$ 1,459	$ 1,459

XML

PROPERTY AND EQUIPMENT (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
PROPERTY AND EQUIPMENT
Depreciation and amortization	$ 162	$ (1)	$ 486	$ 359

XML

CONVERTIBLE NOTES PAYABLE (Details Narrative)																																				1 Months Ended																															9 Months Ended		12 Months Ended
	Nov. 12, 2019 USD ($)	Oct. 08, 2019 USD ($)	Aug. 13, 2019 USD ($)	Apr. 11, 2019 USD ($)	Nov. 05, 2018 USD ($)	Oct. 08, 2018 USD ($)	Sep. 13, 2018 USD ($)	Jul. 10, 2018 USD ($)	Jun. 07, 2018 USD ($)	May 07, 2018 USD ($)	Apr. 09, 2018 USD ($)	Mar. 14, 2018 USD ($)	Mar. 08, 2018 USD ($)	Feb. 07, 2018 USD ($)	Jan. 11, 2018 USD ($)	Dec. 14, 2017 USD ($) integer $ / shares	Nov. 08, 2017 USD ($)	Oct. 13, 2017 USD ($)	Sep. 12, 2017 USD ($)	Aug. 11, 2017 USD ($)	Jul. 10, 2017 USD ($)	Jun. 02, 2017 USD ($) integer $ / shares	May 08, 2017 USD ($)	Apr. 12, 2017 USD ($)	Mar. 09, 2017 USD ($)	Jan. 10, 2017 USD ($)	Dec. 06, 2016 USD ($)	Nov. 08, 2016 USD ($)	Sep. 13, 2016 USD ($)	Aug. 08, 2016 USD ($)	Jul. 06, 2016 USD ($)	Apr. 11, 2016 USD ($)	Mar. 14, 2016 USD ($)	Mar. 04, 2016 USD ($) integer $ / shares	Mar. 14, 2013 USD ($) $ / shares	Jun. 22, 2020 USD ($)	Mar. 16, 2020 USD ($)	Dec. 19, 2019 USD ($)	Oct. 31, 2019 USD ($)	Sep. 27, 2019 USD ($)	Aug. 29, 2019 USD ($)	Jul. 29, 2019 USD ($)	Jun. 28, 2019 USD ($)	Jun. 27, 2019 USD ($)	May 24, 2019 USD ($)	May 23, 2019 USD ($)	Apr. 19, 2019 USD ($)	Mar. 26, 2019 USD ($)	Mar. 22, 2019 USD ($)	Feb. 25, 2019 USD ($)	Jan. 25, 2019 USD ($)	Jan. 17, 2019 USD ($)	Dec. 24, 2018 USD ($)	Nov. 30, 2018 USD ($)	Nov. 28, 2018 USD ($)	Nov. 23, 2018 USD ($)	Oct. 26, 2018 USD ($)	Aug. 17, 2018 USD ($) $ / shares	Aug. 16, 2018 USD ($)	Sep. 05, 2017	Feb. 13, 2017 USD ($)	Oct. 17, 2016 USD ($)	Jun. 22, 2016 USD ($)	May 20, 2016 USD ($)	Mar. 17, 2016 USD ($)	Dec. 31, 2012 USD ($)	Sep. 30, 2020 USD ($) shares	Sep. 30, 2019 USD ($) shares	Dec. 31, 2018 USD ($)	Dec. 31, 2019 USD ($) shares
Common stock shares issed | shares																																																																			123,331,517			1,049,380
Common stock shares issued upon conversion																																																																			$ 13,109	$ 125,521
Debt instrument, principal amount																																																																			19,891
Accrued interest																																																																			756,523			$ 581,610
Amortization of debt discount to interest expense																																																																			291,872	$ 544,686
Accrued interest																																																																			$ 2,502
Frequency of periodic payments																																																												Monthly
Debt conversion converted instrument, shares issued | shares																																																																			112,501,754	33,080
July, 8 2020 Convertible Promissory Note [Member]
Debt Instrument, maturity date																																																																			Jul. 08, 2021
Fees and expenses																																																																			$ 2,800
Debt instrument remaining discount																																																																			32,426
Proceeds from convertible promissory notes																																																																			35,000
Debt instrument																																																																			40,000
Debt discount																																																																			40,000
Amortization of debt discount to interest expense																																																																			$ 7,574
Debt instrument, convertible, terms of conversion feature																																																																			The lender, at its option, may convert the unpaid principal balance of, and accrued interest on, the note into shares of the Company’s common stock at a 50% discount from the lowest trading price during the 25 days prior to conversion. After the expiration of 180 days after issuance, the Company has no right of prepayment.
Debt instrument, interest rate																																																																			10.00%
Convertible promissory note, principal amount																																																																			$ 2,200
July, 7 2020 Convertible Promissory Note [Member]
Debt Instrument, maturity date																																																																			Jul. 07, 2021
Fees and expenses																																																																			$ 3,000
Debt instrument remaining discount																																																																			26,479
Proceeds from convertible promissory notes																																																																			30,000
Debt instrument																																																																			33,000
Debt discount																																																																			33,000
Amortization of debt discount to interest expense																																																																			$ 6,521
Debt instrument, convertible, terms of conversion feature																																																																			The lender, at its option after 180 days from the issuance of the note, may convert the unpaid principal balance of, and accrued interest on, the note into shares of the Company’s common stock at a 45% discount from the lowest trading price during the 20 trading days prior to conversion. The Company may prepay the note during the 180 days from the issuance of the note at a redemption premium of 150%. After the expiration of 180 days after issuance, the Company has no right of prepayment.
Debt instrument, interest rate																																																																			12.00%
Convertible promissory note, principal amount																																																																			$ 33,000
June 2020 Convertible Promissory Note [Member]
Debt Instrument, maturity date																																				Jun. 21, 2021
Fees and expenses																																				$ 3,000
Proceeds from convertible promissory notes																																				25,000
Debt discount																																				28,000																															27,386
Amortization of debt discount to interest expense																																				$ 614																															614
Debt instrument, convertible, terms of conversion feature																																				The lender, at its option after 180 days from the issuance of the note, may convert the unpaid principal balance of, and accrued interest on, the note into shares of the Company’s common stock at a 45% discount from the lowest trading price during the 20 trading days prior to conversion. The Company may prepay the note during the 180 days from the issuance of the note at a redemption premium of 150%. After the expiration of 180 days after issuance, the Company has no right of prepayment.
Debt instrument, interest rate																																				12.00%
Convertible promissory note, principal amount																																																																			28,000
June 2019 Convertible Promissory Note [Member]
Debt Instrument, maturity date																																												Jun. 27, 2020
Fees and expenses																																												$ 3,000
Proceeds from convertible promissory notes																																												30,000
Debt discount																																												$ 33,000
Amortization of debt discount to interest expense																																																																			16,139
Debt instrument, convertible, terms of conversion feature																																												The lender, at its option after 180 days from the issuance of the note, may convert the unpaid principal balance of, and accrued interest on, the note into shares of the Company’s common stock at a 39% discount from the lowest trading price during the 15 days prior to conversion. The Company may prepay the note during the 180 days from the issuance of the note at redemption premiums ranging from 20% to 45%. After the expiration of 180 days after issuance, the Company has no right of prepayment.
Debt instrument, interest rate																																												10.00%
Convertible promissory note, principal amount																																												$ 33,000																							$ 33,000
Common stock shares issued in consideration for conversion of debt, Shares | shares																																																																			16,207,380
Common stock shares issued in consideration for conversion of debt, Amount																																																																			$ 33,000
Accrued interest																																																																			1,650
May 2019 Convertible Promissory Note One [Member]
Debt Instrument, maturity date																																													May 24, 2020
Fees and expenses																																													$ 3,000
Proceeds from convertible promissory notes																																													30,000
Debt discount																																													$ 33,000
Amortization of debt discount to interest expense																																																																			$ 7,764
Debt instrument, convertible, terms of conversion feature																																													The lender, at its option after 180 days from the issuance of the note, may convert the unpaid principal balance of, and accrued interest on, the note into shares of the Company’s common stock at a 39% discount from the lowest trading price during the 15 days prior to conversion. The Company may prepay the note during the 180 days from the issuance of the note at redemption premiums ranging from 20% to 45%. After the expiration of 180 days after issuance, the Company has no right of prepayment
Debt instrument, interest rate																																													10.00%
Convertible promissory note, principal amount																																													$ 33,000
Common stock shares issued in consideration for conversion of debt, Shares | shares																																																																			6,720,530
Common stock shares issued in consideration for conversion of debt, Amount																																																																			$ 19,600
Accrued interest																																																																			1,650
May 2019 Convertible Promissory Note [Member]
Debt Instrument, maturity date																																														May 23, 2020
Fees and expenses																																														$ 1,250																					1,750
Proceeds from convertible promissory notes																																														30,000
Debt discount																																														$ 33,000
Amortization of debt discount to interest expense																																																																			$ 12,984
Debt instrument, convertible, terms of conversion feature																																														The lender, at its option, may convert the unpaid principal balance of, and accrued interest on, the note into shares of the Company’s common stock at a 50% discount from the lowest trading price during the 25 days prior to conversion. The Company may prepay the note during the 180 days from the issuance of the note at redemption premiums ranging from 25% to 45%. After the expiration of 180 days after issuance, the Company has no right of prepayment.
Debt instrument, interest rate																																														10.00%
Convertible promissory note, principal amount																																														$ 33,000
Common stock shares issued in consideration for conversion of debt, Shares | shares																																																																			22,057,971
Common stock shares issued in consideration for conversion of debt, Amount																																																																			$ 33,000
Original issue discount																																														$ 1,750
March 2019 Convertible Promissory Note [Member]
Debt Instrument, maturity date																																					Mar. 16, 2021
Fees and expenses																																					$ 3,000
Proceeds from convertible promissory notes																																					32,000
Debt discount																																					$ 18,766
Amortization of debt discount to interest expense																																																																			18,766
Debt instrument, convertible, terms of conversion feature																																					The lender, at its option after 180 days from the issuance of the note, may convert the unpaid principal balance of, and accrued interest on, the note into shares of the Company’s common stock at a 45% discount from the lowest trading price during the 20 trading days prior to conversion. The Company may prepay the note during the 180 days from the issuance of the note at a redemption premium of 150%. After the expiration of 180 days after issuance, the Company has no right of prepayment
Debt instrument, interest rate																																					12.00%
Convertible promissory note, principal amount																																					$ 35,000																														$ 38,000
Common stock shares issued in consideration for conversion of debt, Shares | shares																																																																			6,383,068
Common stock shares issued in consideration for conversion of debt, Amount																																																																			$ 38,000
Accrued interest																																																																			2,280
January 2019 Convertible Promissory Note [Member] | Lender [Member]
Debt Instrument, maturity date																																																			Jan. 25, 2020
Fees and expenses																																																			$ 1,500																2,000
Proceeds from convertible promissory notes																																																			35,000
Debt discount																																																			$ 38,000
Amortization of debt discount to interest expense																																																																			$ 1,415
Debt instrument, convertible, terms of conversion feature																																																			The lender, at its option, may convert the unpaid principal balance of, and accrued interest on, the note into shares of the Company’s common stock at a 39% discount from the lowest trading price during the 15 days prior to conversion. The Company may prepay the note during the 180 days from the issuance of the note at redemption premiums ranging from 25% to 45%. After the expiration of 180 days after issuance, the Company has no right of prepayment.
Debt instrument, interest rate																																																			10.00%
Common stock shares issued in consideration for conversion of debt, Shares | shares																																																																			12,855,132
Common stock shares issued in consideration for conversion of debt, Amount																																																			$ 38,000																$ 22,378
Accrued interest																																																																			3,800
Issuance discount																																																			$ 1,500
December 2018 Convertible Promissory Note [Member]
Amortization of debt discount to interest expense																																																																					$ 2,351
Convertible Notes Payable [Member] | October 2019 Convertible Promissory Note [Member]
Debt Instrument, maturity date																																							Oct. 31, 2019
Debt instrument remaining discount																																																																			2,117
Debt discount																																							$ 25,000
Amortization of debt discount to interest expense																																																																			$ 18,716
Debt instrument, convertible, terms of conversion feature																																							The lender may advance the Company consideration for the note in such amounts as the lender may choose in its sole discretion. The note is convertible into shares of our common stock at a price per share equal to the lesser of: $0.01; 50% of the lowest trade price of our common stock subsequent to the effective date of the note; or the lowest effective price per share granted to any person or entity (exclusive of our officers and directors) to acquire common stock subsequent to the effective date of the note. The note matures, with respect to each advance, one year from the effective date of each advance.
Debt instrument, interest rate																																							10.00%
Convertible promissory note, principal amount																																							$ 500,000
Convertible Notes Payable 2 [Member] | Related Parties [Member]
Debt discount																																																																		$ 57,050
Debt instrument, convertible, terms of conversion feature																																																																		The notes are convertible into shares of our common stock at a conversion price equal to the lesser of $2.00 per share or the closing price per share of common stock recorded on the trading day immediately preceding the date of conversion.
Debt instrument, interest rate																																																																		5.00%
Convertible promissory note, principal amount																																																																		$ 58,600
Convertible Notes Payable 2 [Member] | Related Parties [Member] | Note One [Member]
Debt Instrument, maturity date																																																																			Dec. 31, 2014
Convertible promissory note, principal amount																																																																			$ 25,980
Convertible Notes Payable 2 [Member] | Related Parties [Member] | Note Two [Member]
Debt Instrument, maturity date																																																																			Dec. 31, 2020
Convertible promissory note, principal amount																																																																			$ 32,620
Convertible Notes Payable 2 [Member] | October 2019 Convertible Promissory Note [Member]
Debt instrument remaining discount																																																																			5,464
Proceeds from convertible promissory notes																																						$ 25,000
Debt discount																																						25,000
Amortization of debt discount to interest expense																																																																			18,716
Convertible promissory note, principal amount																																						$ 500,000
Convertible Notes Payable 1 [Member] | Accounts Payable [Member]
Debt Instrument, maturity date																																			Mar. 14, 2015
Debt instrument, interest rate																																			5.00%
Convertible promissory note, principal amount																																			$ 29,500																																29,500			$ 29,500
Debt Instrument, conversion price | $ / shares																																			$ 1.50
Convertible Notes Payable 1 [Member] | October 2019 Convertible Promissory Note [Member]
Debt instrument remaining discount																																																																			2,937
Proceeds from convertible promissory notes	$ 25,000																																			$ 25,000
Debt discount	25,000
Amortization of debt discount to interest expense																																																																			18,716
Convertible promissory note, principal amount	$ 500,000
Convertible Notes Payable 1 [Member] | August 2019 Convertible Promissory Note [Member]
Fees and expenses																																									$ 1,500															$ 3,000
Debt instrument remaining discount																																									1,500
Proceeds from convertible promissory notes																																									22,000
Debt discount																																									$ 25,000
Amortization of debt discount to interest expense																																																																			13,820
Debt instrument, convertible, terms of conversion feature																																									The lender, at its option, may convert the unpaid principal balance of, and accrued interest on, the note into shares of the Company’s common stock at a 50% discount from the lowest trading price during the 25 days prior to conversion. The Company may prepay the note during the 180 days from the issuance of the note at redemption premiums ranging from 25% to 45%. After the expiration of 180 days after issuance, the Company has no right of prepayment
Debt instrument, interest rate																																									10.00%
Convertible promissory note, principal amount																																									$ 25,000																	$ 500,000									$ 395
Common stock shares issued in consideration for conversion of debt, Shares | shares																																																																			17,022,000
Common stock shares issued in consideration for conversion of debt, Amount																																																																			$ 24,605
Conversion fees																																																																			7,000
Convertible Notes Payable 58 [Member] | August 2018 Convertible Promissory Note [Member]
Proceeds from convertible promissory notes																																								$ 33,000
Debt discount																																								33,000
Amortization of debt discount to interest expense																																																																			24,434
Convertible promissory note, principal amount																																								$ 500,000
Convertible Notes Payable 57 [Member] | August 2018 Convertible Promissory Note [Member]
Proceeds from convertible promissory notes																																										$ 40,000
Debt discount																																										40,000
Amortization of debt discount to interest expense																																																																			23,060
Convertible promissory note, principal amount																																										$ 500,000
Convertible Notes Payable 3 [Member] | March 2016 Convertible Promissory Note [Member]
Debt Instrument, maturity date																																		Mar. 04, 2016
Debt instrument, convertible, terms of conversion feature																																		Convertible into shares of our common stock at a price per share equal to the lesser of: $0.03; 50% of the lowest trade price of our common stock subsequent to the effective date of the note; or the lowest effective price per share granted to any person or entity (exclusive of our officers and directors) to acquire common stock subsequent to the effective date of the note.
Debt instrument, interest rate																																		10.00%
Convertible promissory note, principal amount																																		$ 1,000,000
Debt Instrument, conversion price | $ / shares																																		$ 0.03
Frequency of periodic payments																																		Monthly
Number of installments | integer																																		60
Convertible Notes Payable 55 [Member] | August 2018 Convertible Promissory Note [Member]
Proceeds from convertible promissory notes																																											$ 30,000
Debt discount																																											30,000
Amortization of debt discount to interest expense																																																																			14,754
Convertible promissory note, principal amount																																											$ 500,000															$ 500,000
Convertible Notes Payable 54 [Member] | August 2018 Convertible Promissory Note [Member]
Proceeds from convertible promissory notes																																															$ 65,000
Debt discount																																															65,000
Amortization of debt discount to interest expense																																																																			19,536
Convertible promissory note, principal amount																																															$ 65,000
Convertible Notes Payable 53 [Member] | August 2018 Convertible Promissory Note [Member]
Proceeds from convertible promissory notes				$ 15,000
Debt discount				15,000
Amortization of debt discount to interest expense																																																																			4,180
Convertible promissory note, principal amount				$ 500,000
Convertible Notes Payable 41 [Member] | August 2018 Convertible Promissory Note [Member]
Proceeds from convertible promissory notes		$ 25,000				$ 25,000
Debt discount		25,000				25,000																																																													1,546
Amortization of debt discount to interest expense						25,000																																																													18,716
Convertible promissory note, principal amount		$ 500,000				$ 500,000
Convertible Notes Payable 40 [Member] | August 2018 Convertible Promissory Note [Member]
Proceeds from convertible promissory notes							$ 30,000
Debt discount							30,000
Amortization of debt discount to interest expense							30,000
Convertible promissory note, principal amount							$ 500,000
Convertible Notes Payable 44 [Member] | August 2018 Convertible Promissory Note [Member]
Proceeds from convertible promissory notes																																																									$ 12,000
Debt discount																																																									12,000
Amortization of debt discount to interest expense																																																									12,000
Convertible promissory note, principal amount																																																									$ 500,000
Convertible Notes Payable 45 [Member] | August 2018 Convertible Promissory Note [Member]
Proceeds from convertible promissory notes					$ 25,000
Debt discount					25,000
Amortization of debt discount to interest expense					25,000
Convertible promissory note, principal amount					$ 500,000
Convertible Notes Payable 46 [Member] | August 2018 Convertible Promissory Note [Member]
Proceeds from convertible promissory notes																																																							$ 30,000
Debt discount																																																							30,000
Amortization of debt discount to interest expense																																																							30,000
Convertible promissory note, principal amount																																																							$ 30,000
Convertible Notes Payable 47 [Member] | August 2018 Convertible Promissory Note [Member]
Proceeds from convertible promissory notes																																																						$ 10,000
Debt discount																																																						10,000
Amortization of debt discount to interest expense																																																						10,000															849
Convertible promissory note, principal amount																																																						$ 500,000
Convertible Notes Payable 48 [Member] | August 2018 Convertible Promissory Note [Member]
Proceeds from convertible promissory notes																																																					$ 50,000
Debt discount																																																					50,000
Amortization of debt discount to interest expense																																																					50,000																$ 959
Convertible promissory note, principal amount																																																					$ 500,000
Convertible Notes Payable 38 [Member] | August 2018 Convertible Promissory Note [Member]
Debt instrument, convertible, terms of conversion feature																																																										Convertible into shares of our common stock at a price per share equal to the lesser of: $0.01; 50% of the lowest trade price of our common stock subsequent to the effective date of the note; or the lowest effective price per share granted to any person or entity (exclusive of our officers and directors) to acquire common stock subsequent to the effective date of the note.
Debt instrument, interest rate																																																										10.00%
Convertible promissory note, principal amount																																																										$ 500,000
Debt Instrument, conversion price | $ / shares																																																										$ 0.01
Convertible Notes Payable 49 [Member] | August 2018 Convertible Promissory Note [Member]
Proceeds from convertible promissory notes																																																				$ 25,000
Debt discount																																																				25,000															1,164
Convertible promissory note, principal amount																																																				$ 500,000
Convertible Notes Payable 50 [Member] | August 2018 Convertible Promissory Note [Member]
Proceeds from convertible promissory notes																																																		$ 25,000
Debt discount																																																		25,000																	3,836
Convertible promissory note, principal amount																																																		$ 500,000
Convertible Notes Payable 51 [Member] | August 2018 Convertible Promissory Note [Member]
Proceeds from convertible promissory notes																																																	$ 25,000
Debt discount																																																	25,000																		5,601
Convertible promissory note, principal amount																																																	$ 500,000
Convertible Notes Payable 52 [Member] | August 2018 Convertible Promissory Note [Member]
Proceeds from convertible promissory notes																																																$ 15,000
Debt discount																																																15,000
Amortization of debt discount to interest expense																																																																			3,525
Convertible promissory note, principal amount																																																$ 500,000										$ 500,000
Convertible Notes Payable 4 [Member] | March 2016 Convertible Promissory Note [Member]
Common stock shares issued upon conversion																																																																			$ 5,445
Proceeds from convertible promissory notes																																	$ 27,000
Debt discount																																	27,000
Convertible promissory note, principal amount																																	$ 1,000,000
Debt conversion converted instrument, shares issued | shares																																																																			175,861
Debt conversion converted amount, accrued interest																																																																			$ 2,213
Convertible Notes Payable 20 [Member] | June 2017 Convertible Promissory Note [Member]
Debt Instrument, maturity date																						Jun. 02, 2017
Debt instrument, convertible, terms of conversion feature																						Convertible into shares of our common stock at a price per share equal to the lesser of: $0.03; 50% of the lowest trade price of our common stock subsequent to the effective date of the note; or the lowest effective price per share granted to any person or entity (exclusive of our officers and directors) to acquire common stock subsequent to the effective date of the note.
Debt instrument, interest rate																						10.00%
Convertible promissory note, principal amount																						$ 500,000
Debt Instrument, conversion price | $ / shares																						$ 0.03
Number of installments | integer																						60
Convertible Notes Payable 27 [Member] | December 2017 Convertible Promissory Note [Member]
Debt instrument, convertible, terms of conversion feature																Convertible into shares of our common stock at a price per share equal to the lesser of: $0.03; 50% of the lowest trade price of our common stock subsequent to the effective date of the note; or the lowest effective price per share granted to any person or entity (exclusive of our officers and directors) to acquire common stock subsequent to the effective date of the note.
Debt instrument, interest rate																10.00%
Convertible promissory note, principal amount																$ 500,000
Debt Instrument, conversion price | $ / shares																$ 0.03
Number of installments | integer																60
Convertible Notes Payable 39 [Member] | August 2018 Convertible Promissory Note [Member]
Proceeds from convertible promissory notes																																																										10,500
Debt discount																																																										10,500
Amortization of debt discount to interest expense																																																										10,500
Convertible promissory note, principal amount																																																										$ 500,000
Convertible Notes Payable 5 [Member] | March 2016 Convertible Promissory Note [Member]
Proceeds from convertible promissory notes																																																																	$ 33,000
Debt discount																																																																	33,000
Convertible promissory note, principal amount																																		$ 1,000,000																															$ 1,000,000
Convertible Notes Payable 6 [Member] | March 2016 Convertible Promissory Note [Member]
Proceeds from convertible promissory notes																																$ 90,000
Debt discount																																90,000
Convertible promissory note, principal amount																																$ 1,000,000
Convertible Notes Payable 7 [Member] | March 2016 Convertible Promissory Note [Member]
Proceeds from convertible promissory notes																																																																$ 60,000
Debt discount																																																																60,000
Convertible promissory note, principal amount																																																																$ 1,000,000
Convertible Notes Payable 8 [Member] | March 2016 Convertible Promissory Note [Member]
Proceeds from convertible promissory notes																																																															$ 50,000
Debt discount																																																															50,000
Convertible promissory note, principal amount																																																															$ 1,000,000
Convertible Notes Payable 9 [Member] | March 2016 Convertible Promissory Note [Member]
Proceeds from convertible promissory notes																															$ 87,000
Debt discount																															87,000
Convertible promissory note, principal amount																															$ 1,000,000
Convertible Notes Payable 10 [Member] | March 2016 Convertible Promissory Note [Member]
Proceeds from convertible promissory notes																														$ 60,000
Debt discount																														60,000
Convertible promissory note, principal amount																														$ 1,000,000
Convertible Notes Payable 11 [Member] | March 2016 Convertible Promissory Note [Member]
Proceeds from convertible promissory notes																													$ 55,000
Debt discount																													55,000
Convertible promissory note, principal amount																													$ 1,000,000
Convertible Notes Payable 12 [Member] | March 2016 Convertible Promissory Note [Member]
Proceeds from convertible promissory notes																																																														$ 55,000
Debt discount																																																														55,000
Convertible promissory note, principal amount																																																														$ 1,000,000
Convertible Notes Payable 13 [Member] | March 2016 Convertible Promissory Note [Member]
Proceeds from convertible promissory notes																												$ 55,000
Debt discount																												55,000
Convertible promissory note, principal amount																												$ 1,000,000
Convertible Notes Payable 14 [Member] | March 2016 Convertible Promissory Note [Member]
Proceeds from convertible promissory notes																											$ 60,000
Debt discount																											60,000
Convertible promissory note, principal amount																											$ 1,000,000
Convertible Notes Payable 15 [Member] | March 2016 Convertible Promissory Note [Member]
Proceeds from convertible promissory notes																										$ 60,000
Debt discount																										60,000
Convertible promissory note, principal amount																										$ 1,000,000
Convertible Notes Payable 16 [Member] | March 2016 Convertible Promissory Note [Member]
Proceeds from convertible promissory notes																																																													$ 60,000
Debt discount																																																													60,000
Convertible promissory note, principal amount																																																													$ 1,000,000
Convertible Notes Payable 17 [Member] | March 2016 Convertible Promissory Note [Member]
Proceeds from convertible promissory notes																									$ 60,000
Debt discount																									60,000
Convertible promissory note, principal amount																									$ 1,000,000
Convertible Notes Payable 18 [Member] | March 2016 Convertible Promissory Note [Member]
Proceeds from convertible promissory notes																								$ 95,000
Debt discount																								95,000
Convertible promissory note, principal amount																								$ 1,000,000
Convertible Notes Payable 19 [Member] | March 2016 Convertible Promissory Note [Member]
Proceeds from convertible promissory notes																							$ 60,000
Debt discount																							60,000
Convertible promissory note, principal amount																							$ 1,000,000
Convertible Notes Payable 21 [Member] | June 2017 Convertible Promissory Note [Member]
Proceeds from convertible promissory notes																						$ 60,000
Debt discount																						60,000
Convertible promissory note, principal amount																						$ 500,000
Convertible Notes Payable 22 [Member] | June 2017 Convertible Promissory Note [Member]
Proceeds from convertible promissory notes																					$ 80,000
Debt discount																					80,000
Convertible promissory note, principal amount																					500,000
Amortization of debt discount																					$ 80,000
Convertible Notes Payable 23 [Member] | June 2017 Convertible Promissory Note [Member]
Proceeds from convertible promissory notes																				$ 80,000
Debt discount																				80,000
Convertible promissory note, principal amount																				500,000
Amortization of debt discount																				$ 80,000
Convertible Notes Payable 24 [Member] | June 2017 Convertible Promissory Note [Member]
Proceeds from convertible promissory notes																			$ 85,000
Debt discount																			85,000
Convertible promissory note, principal amount																			500,000
Amortization of debt discount																			$ 85,000
Convertible Notes Payable 25 [Member] | June 2017 Convertible Promissory Note [Member]
Proceeds from convertible promissory notes																		$ 80,000
Debt discount																		80,000
Convertible promissory note, principal amount																		500,000
Amortization of debt discount																		$ 80,000
Convertible Notes Payable 26 [Member] | June 2017 Convertible Promissory Note [Member]
Proceeds from convertible promissory notes																	$ 75,000
Debt discount																	75,000
Convertible promissory note, principal amount																	5,000,000
Amortization of debt discount																	$ 75,000
Convertible Notes Payable 28 [Member] | December 2017 Convertible Promissory Note [Member]
Proceeds from convertible promissory notes																$ 60,000
Debt discount																60,000
Convertible promissory note, principal amount																500,000
Amortization of debt discount																$ 60,000
Convertible Notes Payable 29 [Member] | December 2017 Convertible Promissory Note [Member]
Proceeds from convertible promissory notes															$ 70,000
Debt discount															70,000
Amortization of debt discount to interest expense															70,000
Convertible promissory note, principal amount															$ 500,000
Convertible Notes Payable 30 [Member] | December 2017 Convertible Promissory Note [Member]
Proceeds from convertible promissory notes														$ 60,000
Debt discount														60,000
Amortization of debt discount to interest expense														60,000
Convertible promissory note, principal amount														$ 500,000
Convertible Notes Payable 31 [Member] | December 2017 Convertible Promissory Note [Member]
Proceeds from convertible promissory notes													$ 55,000
Debt discount													55,000
Amortization of debt discount to interest expense													55,000
Convertible promissory note, principal amount													$ 500,000
Convertible Notes Payable 32 [Member] | December 2017 Convertible Promissory Note [Member]
Proceeds from convertible promissory notes												$ 6,500
Debt discount												6,500
Amortization of debt discount to interest expense												6,500
Convertible promissory note, principal amount												$ 500,000
Convertible Notes Payable 33 [Member] | December 2017 Convertible Promissory Note [Member]
Proceeds from convertible promissory notes											$ 77,000
Debt discount											77,000
Amortization of debt discount to interest expense											77,000
Convertible promissory note, principal amount											$ 500,000
Convertible Notes Payable 34 [Member] | December 2017 Convertible Promissory Note [Member]
Proceeds from convertible promissory notes										$ 60,000
Debt discount										60,000
Amortization of debt discount to interest expense										60,000
Convertible promissory note, principal amount										$ 500,000
Convertible Notes Payable 35 [Member] | December 2017 Convertible Promissory Note [Member]
Proceeds from convertible promissory notes									$ 52,000
Debt discount									52,000
Amortization of debt discount to interest expense									52,000
Convertible promissory note, principal amount									$ 500,000
Convertible Notes Payable 36 [Member] | December 2017 Convertible Promissory Note [Member]
Proceeds from convertible promissory notes								$ 35,000
Debt discount								35,000
Amortization of debt discount to interest expense								35,000
Convertible promissory note, principal amount								$ 500,000
Convertible Notes Payable 37 [Member] | December 2017 Convertible Promissory Note [Member]
Proceeds from convertible promissory notes																																																											$ 24,500
Debt discount																																																											24,500
Amortization of debt discount to interest expense																																																											24,500
Convertible promissory note, principal amount																																																											$ 500,000
August 18, 2020 [Member] | Convertible Notes Payable [Member]
Debt Instrument, maturity date																																																																			Aug. 18, 2021
Fees and expenses																																																																			$ 3,000
Debt instrument remaining discount																																																																			29,112
Proceeds from convertible promissory notes																																																																			30,000
Debt instrument																																																																			33,000
Debt discount																																																																			33,000
Amortization of debt discount to interest expense																																																																			$ 3,888
Debt instrument, convertible, terms of conversion feature																																																																			The lender, at its option after 180 days from the issuance of the note, may convert the unpaid principal balance of, and accrued interest on, the note into shares of the Company’s common stock at a 45% discount from the lowest trading price during the 20 trading days prior to conversion. The Company may prepay the note during the 180 days from the issuance of the note at a redemption premium of 150%. After the expiration of 180 days after issuance, the Company has no right of prepayment.
August 2019 [Member] | Convertible Notes Payable 3 [Member]
Debt Instrument, maturity date			Aug. 13, 2020
Fees and expenses			$ 3,000																																																					$ 3,000
Proceeds from convertible promissory notes			33,000
Debt discount			$ 33,000
Debt instrument, convertible, terms of conversion feature			The lender, at its option after 180 days from the issuance of the note, may convert the unpaid principal balance of, and accrued interest on, the note into shares of the Company’s common stock at a 39% discount from the lowest trading price during the 15 days prior to conversion. The Company may prepay the note during the 180 days from the issuance of the note at redemption premiums ranging from 20% to 45%. After the expiration of 180 days after issuance, the Company has no right of prepayment
Debt instrument, interest rate			10.00%
Convertible promissory note, principal amount			$ 33,000
Common stock shares issued in consideration for conversion of debt, Shares | shares																																																																			16,747,584
Common stock shares issued in consideration for conversion of debt, Amount																																																																			$ 2,932
Interest expense																																																																			$ 20,377

XML

PPP LOAN PAYABLE (Details Narrative)	Sep. 30, 2020 USD ($)
Paycheck Protection Program [Member]
Loan payable, principal amount	$ 9,501

XML

CAPITAL STOCK (Details Narrative) - USD ($)		1 Months Ended					9 Months Ended
	Jan. 11, 2020	Feb. 29, 2020	Feb. 26, 2020	Feb. 14, 2020	Nov. 30, 2018	Mar. 31, 2016	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019	Nov. 27, 2019	Mar. 02, 2016
Reverse stock split description				The Company effected a reverse split of its common stock at a ratio of one for two hundred twenty-five shares (1:225) with the filing of a Certificate of Amendment to its Articles of Incorporation
Common stock, shares outstanding							123,331,517		1,049,380
Common stock, par value							$ 0.001		$ 0.001
Common stock, shares issued							123,331,517		1,049,380
Common stock, authorized shares							2,000,000,000		2,000,000,000
Preferred stock, par value							$ 0.001		$ 0.001
Preferred stock, authorized shares							20,000,000		20,000,000
Debt conversion original debt amount							$ 13,109	$ 125,521
Common stock, shares issued during period							122,279,532
Issuance of common stock for conversion of notes payable and accrued interest payable, shares							112,501,754	33,080
Penalty per day for failer to deliver of shares							$ 1,500
Accrued interest payable							23,664	$ 9,038
Fees							10,750	250
Derivative liability							$ 429,518	$ 143,692
Reverse split rounding of shares, amount							$ 3
Common stock shares issued upon preferred stock conversion							9,777,778
Preferred stock converted							1,100
Reverse split rounding of shares, shares		$ 2,605
Convertible Promissory Notes [Member]
Debt conversion original debt amount						$ 1,615,362
Accrued Interest Payable [Member]
Debt conversion original debt amount						$ 264,530
EllisLab, Inc [Member]
Series C preferred stock outstanding								36,000
Preferred Stock Series B [Member]
Preferred stock, par value							$ 0.001		$ 0.001		$ 0.001
Preferred stock, authorized shares											30,000
Preferred stock share issued							15,055		16,155
Conversion price description							The conversion price is the lesser of (1) Fifty Percent (50%) of the lowest trade price of Common Stock recorded on any trade day after December 12, 2012 or (2) the lowest effective price per share granted to any person or entity, including the Holder but excluding officers and directors of the Company, to acquire Common Stock, or adjusted, whether by operation of purchase price adjustment, settlement agreements, exchange agreements, reset provision, floating conversion or otherwise, any outstanding warrant, option or other right to acquire Common Stock or outstanding Common Stock equivalents (the "Conversion Price").
Preferred stock including additional paid in capital							$ 3,000,000
Preferred stock, outstanding shares							15,055		16,155
Preferred stock value outstanding							$ 1,505,500		$ 1,615,500
Outstanding common share, percentage							4.99%
Preferred Stock Series D [Member]
Preferred stock, par value										$ 0.01
Voting right percentage	51.00%						0.00%
Preferred stock face value					$ 3,600,000				$ 15,000
Preferred stock share issued							0		1,000
Redemption of share	1,000
Description of redemption	Series D preferred stock were automatically redeemed on 45 days after the effective date of the Series D Certificate
Preferred stock, outstanding shares							0		1,000
Preferred Stock Series C [Member]
Reverse stock split description					Whether such assets are capital or surplus of any nature, an amount equal to one hundred dollars ($100.00) for each such share of the Series C Preferred Stock (as adjusted for any combinations. Consolidations.
Preferred stock, par value					$ 0.001
Preferred stock, authorized shares					36,000
Preferred stock face value					$ 3,600,000
Conversion price description					Each share of Series C Preferred Stock is convertible into twenty thousand (20,000) shares of the Company’s fully paid and nonassessable shares of common stock, as adjusted
Outstanding common share, percentage					4.99%
Preferred stock face value per shares					$ 100
William E. Beifuss Jr. [Member] | Preferred Stock Series B [Member]
Common stock shares issued upon preferred stock conversion			9,777,778
Preferred stock converted			1,100

XML

STOCK OPTIONS AND WARRANTS (Details)	9 Months Ended
	Sep. 30, 2020 $ / shares shares
Number of stock options and warrants shares
Outstanding shares, Beginning Balance	184,001
Granted
Exercised
Forfeited or expired	(6,223)
Outstanding shares, Ending Balance	177,778
Weighted Average Exercise Price
Weighted average exercise price, Beginning Balance | $ / shares	$ 1.544
Weighted average exercise price Forfeited or expired | $ / shares	13.50
Weighted average exercise price, Ending Balance | $ / shares	$ 1.13
Weighted Average Remaining Contract Term (Years)
Weighted Average Remaining Contract Term, Beginning Balance	8 years 7 months 24 days
Weighted Average Remaining Contract Term, Granted
Weighted Average Remaining Contract Term, Exercised
Weighted Average Remaining Contract Term, Forfeited or expired
Weighted Average Remaining Contract Term, Ending Balance	8 years 2 months 1 day

XML

STOCK OPTIONS AND WARRANTS (Details Narrative)	Sep. 30, 2020 $ / shares shares
Number of non-qualified stock options and warrants exercisable | shares	177,778
Stock Option And Warrants [Member]
Closing price of common stock | $ / shares	$ 0.0095

XML

DERIVATIVE LIABILITIES (Details)	9 Months Ended
	Sep. 30, 2020 $ / shares
Conversion to stock	Monthly
Stock price on the valuation date	$ 0.0095
Minimum [Member]
Years to maturity	29 days
Risk free interest rates	0.00%
Expected volatility	86.60%
Maximum [Member]
Years to maturity	15 years
Risk free interest rates	2.84%
Expected volatility	549.20%

XML

DERIVATIVE LIABILITIES (Details 1) - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Derivative liability	$ 6,423,060	$ 6,160,895
Convertible Notes Payable [Member]
Derivative liability	3,307,831	3,606,194
Preferred Stock Series B [Member]
Derivative liability	3,113,178	2,535,359
Warrants [Member]
Derivative liability	$ 2,051	$ 19,342

XML

RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)	1 Months Ended		9 Months Ended
	Feb. 26, 2020	Sep. 30, 2019	Sep. 30, 2020	Dec. 31, 2019
Preferred stock converted			1,100
Common stock shares issued upon preferred stock conversion			9,777,778
Common stock, issued, shares			122,279,532
Fees payable			$ 218,049	$ 126,478
Preferred Stock Series B [Member]
Conversion price description			The conversion price is the lesser of (1) Fifty Percent (50%) of the lowest trade price of Common Stock recorded on any trade day after December 12, 2012 or (2) the lowest effective price per share granted to any person or entity, including the Holder but excluding officers and directors of the Company, to acquire Common Stock, or adjusted, whether by operation of purchase price adjustment, settlement agreements, exchange agreements, reset provision, floating conversion or otherwise, any outstanding warrant, option or other right to acquire Common Stock or outstanding Common Stock equivalents (the "Conversion Price").
Series C Convertible Preferred Stock [Member] | Purchase and Sale Agreement[Member] | EllisLab, Inc [Member]
Sale of Common stock issued and outstanding shares, shares		36,000
William E. Beifuss Jr. [Member]
Consulting fees for service, per month			$ 10,000
William E. Beifuss Jr. [Member] | Preferred Stock Series B [Member]
Preferred stock converted	1,100
Common stock shares issued upon preferred stock conversion	9,777,778
Mr. Beifuss [Member]
Fees payable			$ 80,000	$ 10,000
Mr. Beifuss [Member] | Preferred Stock Series D [Member] | November 2019 [Member]
Common stock, issued, shares			1,000
Common shares issued, amount			$ 15,000
Conversion price description			The shares were automatically redeemed in January 2020, 120 days after the effective date of the related Series D Preferred Stock Certificate

XML

COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)		1 Months Ended	3 Months Ended		9 Months Ended
	Sep. 05, 2017	Sep. 05, 2017	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Frquency of periodic payment of rent		Monthly
Rent	$ 1,000
Operating lease right to use			$ 0		$ 0		$ 7,708
Operating lease cost			$ 3,000	$ 3,000	9,000	$ 9,000
Increase in other assets and operating lease liability					0	$ 18,352
Jan 1 2019 [Member]
Increase in other assets and operating lease liability					$ 18,352

XML

SUBSEQUENT EVENT (Details Narrative) - USD ($)		1 Months Ended	9 Months Ended
	Nov. 09, 2020	Oct. 01, 2020	Sep. 30, 2020
Legal fees			$ 5,440
Issuance of common stock for conversion of notes payable and accrued interest payable, amount			$ 1,000,000
Issuance of common stock for conversion of notes payable and accrued interest payable, shares			5,294,933
Accrued interest			$ 2,502
Subsequent Event [Member] | Convertible Notes Payable One [Member]
Legal fees	$ 3,500
Convertible promissory note, principal amount	$ 35,000
Debt instrument, interest rate	12.00%
Proceeds from convertible promissory notes	$ 31,500
Debt Instrument, maturity date	Nov. 09, 2021
Debt instrument, convertible, terms of conversion feature	The lender, at its option after 180 days from the issuance of the note, may convert the unpaid principal balance of, and accrued interest on, the note into shares of the Company’s common stock at a 45% discount from the lowest trading price during the 20 trading days prior to conversion. The Company may prepay the note during the 180 days from the issuance of the note at a redemption premium of 150%. After the expiration of 180 days after issuance, the Company has no right of prepayment.
Subsequent Event [Member] | Convertible Notes Payable [Member]
Legal fees		$ 3,000
Convertible promissory note, principal amount		$ 33,000
Debt instrument, interest rate		12.00%
Proceeds from convertible promissory notes		$ 30,000
Debt Instrument, maturity date		Oct. 01, 2021
Debt instrument, convertible, terms of conversion feature		The lender, at its option after 180 days from the issuance of the note, may convert the unpaid principal balance of, and accrued interest on, the note into shares of the Company’s common stock at a 45% discount from the lowest trading price during the 20 trading days prior to conversion. The Company may prepay the note during the 180 days from the issuance of the note at a redemption premium of 150%. After the expiration of 180 days after issuance, the Company has no right of prepayment.